| Board of Directors as at 26 March 2024 | |
| John Devine - Chair and Independent Non-Executive | |
| David Todd - Independent Non-Executive | |
| Jeremy Anderson - Non-Executive | |
| Jason Barron - Non-Executive | |
| Michael Ebert - Non-Executive | |
| Jonathan Magee - Non-Executive | |
| Caroline Stewart - Non-Executive | |
| Beatriz Martin - Chief Executive Officer (CEO) | |
| Caroline Waddington - Chief Financial Officer (CFO) | |
| Edward Jenkins - Chief Risk Officer (CRO) | |
| Company Secretary | |
| Paul Hare | |
| Company Registration Number | 02500199 |
| 2023 | 1 | 2022 | 1 | 2021 | 1 | 2020 | 2 | 2019 | 2 | ||
| Earnings Net (loss)/profit before tax (USD million): | |||||||||||
| Continuing operations | (1,736) | (331) | (5,386) | 191 | 163 | ||||||
| Discontinued operations | – | – | – | 10 | 27 | ||||||
| Total | (1,736) | (331) | (5,386) | 201 | 190 | ||||||
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||||
| Extracts from Consolidated Statement of Financial Position (USD million): | |||||||||||
| Total Assets | 122,418 | 183,246 | 244,515 | 290,246 | 226,248 | ||||||
| Total Asset (reduction)/growth | (33.2)% | (25.1)% | (15.8)% | 28.3% | (2.4)% | ||||||
| Return on Total Assets | (1.4)% | (0.2)% | (2.2)% | 0.1% | 0.1% | ||||||
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||||
| Capital (USD million): | |||||||||||
| Risk Weighted Assets | 34,698 | 60,646 | 3 | 62,643 | 106,476 | 77,108 | |||||
| Tier 1 capital | 13,889 | 15,809 | 15,022 | 20,520 | 20,293 | ||||||
| Tier 1 capital ratio (%) | 40.0% | 26.0% | 24.0% | 19.3% | 26.3% | ||||||
| Return on Tier 1 capital | (12.5)% | (2.1)% | (35.9)% | 1.0% | 0.9% | ||||||
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||||
| Liquidity (USD million): | |||||||||||
| Liquidity Buffer | 14,255 | 13,968 | 24,280 | 13,663 | 16,255 | ||||||
|
1
All operations were reported as continued in 2023, 2022 and 2021.
|
|||||||||||
|
2
Discontinued operations in 2019 and 2020 relate to transfer of EU business to European based CS group entities.
|
|||||||||||
|
3
RWA numbers have been restated to align with December 2022 COREP resubmission numbers
|
|||||||||||
|
|
|||||||||||
| 2023 | 1 | 2022 | 1 | 2021 | 1 | 2020 | 2 | 2019 | 2 | ||
| Consolidated Statement of Income (USD million) | |||||||||||
| Net revenues | 1,413 | 2,328 | (2,151) | 2,312 | 2,049 | ||||||
| Total operating expenses | (3,149) | (2,659) | (3,235) | (2,121) | (1,886) | ||||||
| (Loss)/Profit before tax from continuing operations | (1,736) | (331) | (5,386) | 191 | 163 | ||||||
| (Loss)/Profit before tax from discontinuing operations | – | – | – | 10 | 27 | ||||||
| (Loss)/Profit before tax | (1,736) | (331) | (5,386) | 201 | 190 | ||||||
| Income tax (expense)/benefit from continuing operations | (57) | (354) | 43 | 12 | 150 | ||||||
| Income tax expense from discontinuing operations | – | – | – | (2) | (4) | ||||||
| (Loss)/Profit after tax | (1,793) | (685) | (5,343) | 211 | 336 | ||||||
|
1
All operations were reported as continued in 2023, 2022 and 2021.
|
|||||||||||
|
2
Discontinued operations in 2019 and 2020 relate to transfer of EU business to European based CS group entities
|
|||||||||||
|
|
|||||||||||
| 2023 | 1 | 2022 | 1 | Variance | % Variance | ||||
| Reconciliation of reportable segment revenues (USD million) 2 | |||||||||
| Total Revenues | |||||||||
| Total Investment Bank | 85 | 194 | (109) | (56)% | |||||
| Total Transition | 221 | 427 | (206) | (48)% | |||||
| - NCL Credit | (62) | 325 | (387) | (119)% | |||||
| - NCL Securitised Products | (33) | (5) | (28) | 560% | |||||
| - NCL Equities | 201 | 922 | (721) | (78)% | |||||
| - NCL Macro | (73) | (17) | (56) | 329% | |||||
| - NCL Management | 69 | (16) | 85 | (531)% | |||||
| - NCL Others | 4 | (2) | 6 | (300)% | |||||
| Total Non Core & Legacy | 106 | 1,207 | (1,101) | (91)% | |||||
| Other | 11 | 6 | 5 | 83% | |||||
| Corporate Centre | 6 | 119 | (113) | (95)% | |||||
| Total reportable revenues | 429 | 1,953 | (1,524) | (78)% | |||||
| Transfer pricing and cross divisional revenue share agreements | 67 | 193 | (126) | (65)% | |||||
| Treasury funding | 694 | (60) | 754 | (1,257)% | |||||
| Corporate Functions | (48) | 57 | (105) | (184)% | |||||
| Allowance for credit losses | (40) | 158 | (198) | 125% | |||||
| CSi group (US GAAP to IFRS) reconciliations 3 | 311 | 27 | 284 | 1,052% | |||||
| Net revenues as per Consolidated Statement of income | 1,413 | 2,328 | (915) | (39)% | |||||
|
1
2023 Net revenues reflect the change in operating segments and 2022 net revenue being restated following implementation of post-merger plan to move certain assets and liabilities of the IB to NCL.
|
|||||||||
|
2
In accordance with IFRS 8, Reportable segments are reported above under US GAAP, as reviewed by the Board of Directors.
|
|||||||||
|
3
This is the difference between the monthly board summaries which are prepared on a US GAAP basis and the CSi group financials prepared in accordance with IFRS.
|
|||||||||
| 2023 | 2022 | Variance | % Variance | ||||||
| Operating expenses (USD million) | |||||||||
| Compensation and benefits | (642) | (551) | (91) | 17% | |||||
| General, administrative and trading expenses | (2,460) | (2,061) | (399) | 19% | |||||
| Of which Impairment of intangible assets and ROU assets 1 | (531) | (27) | (504) | 1,867% | |||||
| Restructuring expenses | (47) | (47) | – | 0% | |||||
| Total operating expenses | (3,149) | (2,659) | (490) | 18% | |||||
|
1
Refer to Note 12 General, Adminstrative and Trading Expenses
|
|||||||||
| Extracts from Consolidated Statement of Financial Position (USD million) | 2023 | 2022 | Variance | % Variance | |||||
| Assets | |||||||||
| Cash and due from banks | 3,627 | 4,149 | (522) | (13)% | |||||
| Interest-bearing deposits with banks | 8,319 | 12,085 | (3,766) | (31)% | |||||
| Securities purchased under resale agreements and securities borrowing transactions | 1,304 | 10,527 | (9,223) | (88)% | |||||
| Trading financial assets mandatorily at fair value through profit or loss | 63,309 | 107,973 | (44,664) | (41)% | |||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 24,588 | 22,831 | 1,757 | 8% | |||||
| Other assets | 17,629 | 21,744 | (4,115) | (19)% | |||||
| Other (aggregated remaining balance sheet assets lines) | 3,642 | 3,937 | (295) | (7)% | |||||
| Total assets | 122,418 | 183,246 | (60,828) | (33)% | |||||
| Liabilities | |||||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 60,519 | 93,397 | (32,878) | (35)% | |||||
| Financial liabilities designated at fair value through profit or loss | 16,050 | 27,169 | (11,119) | (41)% | |||||
| Borrowings | 12,622 | 6,025 | 6,597 | 109% | |||||
| Other liabilities | 9,025 | 16,675 | (7,650) | (46)% | |||||
| Debt in issuance | 8,108 | 18,309 | (10,201) | (56)% | |||||
| Other (aggregated remaining balance sheet liabilities lines) | 1,131 | 3,767 | (2,636) | (70)% | |||||
| Total liabilities | 107,455 | 165,342 | (57,887) | (35)% | |||||
| Total shareholders’ equity | 14,963 | 17,904 | (2,941) | (16)% | |||||
| RISK TYPE | DESCRIPTION | HOW RISKS ARE MANAGED |
| Business and Capital Risk | Business risk is the risk of underperforming against financial objectives as a result of revenue shortfalls and/or cost target overruns. Capital risk is the risk that the bank does not maintain adequate capital to support its activities while exceeding its regulatory requirements and meeting its internal capital goals. | The CSi Strategic Risk Management ('SRM') department is responsible for oversight of business and capital risks as managed by UK Capital Management and CFO functions. SRM ensures accurate ongoing reporting and monitoring of these risks within the risk appetite framework. Broader themes linked to business and capital risk, e.g. implications of strategic change and transformation risks including those related to UBS integration, are also considered in the course of CSi's risk identification and assessment process. Next to monitoring internal and regulatory capital ratio targets as well as financial reporting, the principal measurement tools used by SRM are firm-wide stress testing and the internal capital adequacy assessment process. |
| Climate Change | Climate-related risks are potentially adverse direct and indirect impacts on the banks financial metrics, operations or reputation due to transitional or physical effects of climate change. Climate-related risks could manifest themselves through existing risk types such as credit risk, market risk, non-financial risk, business risk or reputational risk. | Climate change risk is managed centrally by the Climate Risk and Sustainability department. For CSi, the CSi SRM department ensures accurate ongoing reporting and monitoring within the risk appetite framework. The theme of climate change risk has been explicitly considered in the course of CSi’s risk identification and assessment process as well as its risk appetite and risk reporting. As part of the climate change risk assessment, CSi has considered credit exposure to sectors with the closest nexus to the physical and transition implications of climate change risk. Sectors include fossil fuels as well as energy, transport, property, and agriculture. Metrics for CSi have been defined as part of the Risk Identification and Risk Appetite Framework, while scenario capabilities have been established across market risk (short-term analysis), single clients (for large Oil & Gas companies), and portfolio level (using the BoE climate scenario). The CSi strategy to wind-down entity activities, achieving material de-risking of the legacy portfolios, implies climate-related risks will substantially reduce over time, while no new business opportunities will be explored. Further alignment and integration with the UBS sustainability and climate risk framework is expected during 2024. |
| Credit Risk | The risk of a loss arising as a result of a borrower or counterparty failing to meet its financial obligations or as a result of deterioration in the credit quality of the borrower, or counterparty. | Credit risk in CSi is overseen and controlled by the UK Chief Credit Office ('UK CCO'), with support from the Credit Risk NCL function, which is part of the UBS Group Risk Control function, and sits in the second line of defence. Credit Risk NCL is an independent function with responsibility for approving credit limits, monitoring and managing individual exposures and assessing and managing the quality of the segment and business area credit portfolios and allowances. All credit limits in CSi are subject to approval by Credit Risk UK based employees. Credit Risk maintains a Watchlist which serves as a tool for monitoring and reporting counterparties with negative factors requiring enhanced monitoring but which are not severe enough for the counterparty to be considered impaired. Counterparties are subject to additional scrutiny through watchlist committees and escalation to senior management. Watchlist counterparties are classified as Amber when they are performing but potential weaknesses (early signs of potential financial difficulty) have been identified, which require closer and continuous monitoring. Counterparties are classified as Red if they are performing but well-defined weaknesses and actual stress are apparent. Credit Risk also relies on the NCL CRO function regarding recovery management services to manage and resolve troubled or impaired exposures, establishing appropriate provisions for impaired loans and maximising recovery throughout the workout process, thereby protecting CSi’s capital and reputation and minimising potential litigation risks. |
| Treasury and Liquidity Risk | Treasury risks cover the market risks arising from structural exposures including pension risks, and the risk of insufficient funding or liquidity. Liquidity Risk is the risk of being unable to meet both expected and unexpected current and forecasted cash flows and collateral needs. Funding risk is the risk of being unable to borrow funds to support the firm's current business and desired strategy. | CSi Treasury Risk and Control ('TR&C') function is responsible for the oversight of Treasury and the business divisions involved in managing CSi’s liquidity risks as a second line of defence. TR&C is responsible for ensuring that CSi maintains adequate liquidity and achieves full compliance with CSi’s Risk Appetite Framework and Strategic Risk Objectives, and adherence to all applicable risk constraints covering short-term, medium-term and longer-term liquidity, based on regulatory and internal risk metrics (including those based on the internal liquidity stress testing framework). TR&C ensures that various risk controls appropriately limit funding concentration to tenors, products, currencies and counterparties as part of the framework and are adhered to. The liquidity and funding profile reflects CSi’s respective strategies and risk appetites, and is driven by business activity levels and the overall operating environment. |
| RISK TYPE | DESCRIPTION | HOW RISKS ARE MANAGED |
| Market Risk | The risk of a loss arising from adverse changes in interest rates, credit spreads, foreign currency exchange rates, equity and commodity prices, and other relevant market parameters, such as volatilities and correlations. | Market Risk in CSi is overseen and controlled by the CSi Market Risk department which sits in the second line of defence. CSi has policies and processes in place to ensure that market risk is captured, accurately modelled and reported, and effectively managed. Trading and non-trading portfolios are managed at various organisational levels, from the overall risk positions at the Bank level down to specific portfolios. CSi uses market risk measurement and management methods in line with regulatory and industry standards. The principal portfolio measurement tools are Value-at-Risk ('VaR'), scenarios and sensitivity analyses, which complement each other in measuring market risk. A Counterparty Market Risk function is focused on assessing and risk managing counterparty market risk, thereby improving the way in which risk is measured by leveraging the subject matter expertise of market risk managers. This team closely collaborates with the Counterparty Credit Risk team within the Investment Bank and Non-Core & Legacy to further progress how risk of counterparties is assessed allowing for enhanced credit decision making. |
| Model Risk | Model Risk is the potential for financial loss, negative reputational impact and/or adverse regulatory action from decisions made based on model outputs that may be incorrect or used inappropriately. | Model Risk Management's role is to verify whether the model is performing as expected and is appropriate for its intended use. This includes: • Maintaining a bank-wide model inventory, model type classification, risk tiering and inventory attestation; • Training; • Performing independent validation and approval of Models; • Communicating model validation plans and schedules to relevant review committees and stakeholders; • Managing validation outcomes, findings and any required follow-up actions, and reporting/ communicating them to the relevant review committees and stakeholders; • Defining model risk Key Risk Indicators ('KRIs') and assessing, aggregating and reporting model risks; • Escalating policy violations to the Model Risk Steering Committee ('MRSC'), CSi Board Risk Committee, and other relevant group/ regional/ legal entity/ divisional committees. |
| Non-Financial Risk | Non-financial risk is the risk of an adverse direct or indirect impact originating from sources outside the financial markets, including but not limited to operational risk, technology risk, cyber risk, compliance risk, regulatory risk, legal risk and conduct risk. Non-financial risk is inherent in most aspects of its business, including the systems and processes that support its activities. | Non-Financial Risk oversees the CS group’s established Non-Financial Risk Framework (‘NFRF’), providing a consistent and unified approach to evaluating and monitoring CSi's non-financial risks. The NFRF sets common minimum standards across non-financial risk and control processes and review and challenge activities. Risk and control assessments are in place across all divisions and functions, consisting of the risk and control self-assessment, compliance risk assessment and legal risk assessment. Key non-financial risks are identified annually and represent the most significant risks requiring senior management attention. Where appropriate, remediation plans are put in place with ownership by CSi's senior management, and with ongoing Board level oversight at the CSi Board Risk Committee. |
| Reputational Risk | Reputational Risk is the risk arising from negative perception on the part of its stakeholders (i.e. customers, counterparties, shareholders, investors, employees, regulators) that can adversely affect its ability to maintain existing, or establish new, business relationships and continued access to sources of funding. | The Reputational Risk Review Process ('RRRP') is a senior level independent review of issues that may have an impact on the Bank’s reputation. An employee who determines that they are engaged in, or considering an activity that may put the Bank’s reputation at risk must submit that activity through the RRRP for review before the Bank is committed to pursuing or executing it from a legal or relationship standpoint. Reputational Risk Approvers ('RRAs') are subject matter experts and senior risk managers independent from the business. All RRA decisions in the RRRP are predicated on the relevant Divisional Approver’s ('DA') review and approval. The RRA is responsible for holistically assessing whether the identified reputational risks and the mitigation presented by the business (and other support areas) is acceptable and the proposed activity is within the Bank’s risk appetite for reputational risk. The RRA may also escalate a submission to the Divisional Client risk committee ('DCRC') or Group Client Risk Committee ('GCRC') based on guidance from governing bodies, or at their discretion. The DCRC is comprised of senior regional management from the divisions, corporate functions and CSi entity management. Clients deemed to carry the highest compliance and reputational risks are escalated to the GCRC. Once a submission has been escalated, the final decision cannot be taken until the escalation process has been concluded. Reputational Risk submissions subject to committee escalation are also aligned to UBS's risk appetite. |
| Sovereign | Financial Institutions | Corporate | Total | AnnualΔ | |||||||||||||||||||
|
31 December 2023 (USD millions) |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Net Exposure as % of All Country Exposures |
||||||||||||
| United States | 544 | 544 | 4,573 | 1,167 | 1,020 | 850 | 6,137 | 2,561 | (2,387) | (267) | 23% | ||||||||||||
| United Kingdom | 146 | 146 | 2,137 | 1,498 | 514 | 461 | 2,797 | 2,104 | (2,772) | (2,231) | 19% | ||||||||||||
| Germany | 326 | 171 | 1,972 | 1,319 | 38 | 38 | 2,336 | 1,528 | 508 | 372 | 14% | ||||||||||||
| Japan | 571 | 571 | 806 | 86 | 510 | 510 | 1,888 | 1,167 | 649 | 673 | 10% | ||||||||||||
| France | 130 | 125 | 1,847 | 880 | 132 | 90 | 2,108 | 1,095 | (383) | (321) | 10% | ||||||||||||
| Australia | 484 | 484 | 23 | 2 | 7 | 7 | 515 | 494 | 378 | 402 | 4% | ||||||||||||
| Netherlands | - | - | 717 | 370 | 82 | 82 | 799 | 451 | (566) | (339) | 4% | ||||||||||||
| Switzerland | 2 | 2 | 273 | 222 | 29 | 29 | 305 | 253 | (814) | (748) | 2% | ||||||||||||
| Italy | 129 | 88 | 66 | 47 | 62 | 52 | 257 | 187 | (158) | (145) | 2% | ||||||||||||
| Saudi Arabia | 122 | 122 | - | - | - | - | 122 | 122 | 59 | 59 | 1% | ||||||||||||
| Total | 2,455 | 2,254 | 12,414 | 5,590 | 2,394 | 2,119 | 17,263 | 9,963 | (5,487) | (2,546) | 88% | ||||||||||||
|
1) Russia and Turkiye are not included in the top 10 country exposures. The Net Exposure for Russia was USD 9 million (2022: USD 38 million) and for Turkiye was USD 27 million (2022: USD 13 million).
|
|||||||||||||||||||||||
| Sovereign | Financial Institutions | Corporate | Total | AnnualΔ | |||||||||||||||||||
|
31 December 2022 (USD millions) |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
Net Exposure as % of All Country Exposures |
||||||||||||
| United Kingdom | 62 | 62 | 3,969 | 2,892 | 1,537 | 1,381 | 5,568 | 4,335 | (1,215) | 532 | 29% | ||||||||||||
| United States | 0 | 0 | 6,211 | 2,013 | 2,312 | 815 | 8,524 | 2,829 | 69 | (1,790) | 19% | ||||||||||||
| France | 287 | 287 | 1,883 | 859 | 321 | 270 | 2,492 | 1,415 | (422) | 257 | 10% | ||||||||||||
| Germany | 187 | 30 | 1,451 | 935 | 191 | 191 | 1,828 | 1,156 | (1,176) | (133) | 8% | ||||||||||||
| Switzerland | 12 | 5 | 642 | 547 | 466 | 450 | 1,119 | 1,002 | (3) | 24 | 7% | ||||||||||||
| Netherlands | - | - | 1,140 | 569 | 225 | 221 | 1,365 | 790 | (240) | (87) | 5% | ||||||||||||
| Japan | - | - | 787 | 42 | 452 | 452 | 1,239 | 494 | (691) | (30) | 3% | ||||||||||||
| Italy | 164 | 122 | 185 | 145 | 66 | 66 | 415 | 333 | (352) | (222) | 2% | ||||||||||||
| Luxembourg | - | - | 864 | 225 | 32 | 32 | 896 | 257 | (363) | (148) | 2% | ||||||||||||
| China | 206 | 206 | 15 | 15 | 15 | 15 | 236 | 236 | 150 | 162 | 2% | ||||||||||||
| Total | 918 | 712 | 17,147 | 8,242 | 5,616 | 3,892 | 23,682 | 12,846 | (4,242) | (1,436) | 87% | ||||||||||||
|
1) Russia and Turkiye are not included in the top 10 country exposures. The Net Exposure for Russia was USD 38 million (2021: USD 61million) and for Turkiye was USD 13 million (2021: USD 83 million).
|
|||||||||||||||||||||||
| 2023 | 2022 | Annual Δ | |||||||||||||
|
Industry Segments (USD millions) |
Gross Exposure |
Net Exposure |
Net Exposure as % of All Industry Exposures |
Gross Exposure |
Net Exposure |
Gross Exposure |
Net Exposure |
||||||||
| Central Clearing Parties | 6,430 | 3,951 | 35% | 6,633 | 4,136 | (203) | (185) | ||||||||
| Banks | 3,106 | 2,881 | 25% | 1,835 | 1,568 | 1,271 | 1,313 | ||||||||
| Sovereigns, Monetary Authorities, Central and Development Banks | 4,398 | 576 | 5% | 6,865 | 2,173 | (2,467) | (1,597) | ||||||||
| Funds and Trusts | 1,108 | 573 | 5% | 1,290 | 515 | (182) | 58 | ||||||||
| Media and Telecommunications | 370 | 348 | 3% | 451 | 332 | (80) | 16 | ||||||||
| Securitisations | 348 | 348 | 3% | 448 | 448 | (101) | (101) | ||||||||
| Utilities | 1,055 | 336 | 3% | 1,426 | 467 | (371) | (130) | ||||||||
| Insurance | 420 | 324 | 3% | 545 | 446 | (125) | (122) | ||||||||
| Automotive | 400 | 264 | 2% | 1,523 | 715 | (1,124) | (451) | ||||||||
| Other Financial Companies | 225 | 210 | 2% | 274 | 259 | (50) | (50) | ||||||||
| Total | 17,859 | 9,811 | 87% | 21,290 | 11,059 | (3,431) | (1,249) | ||||||||
| Risk | Time Period | Materiality | |||
| Reputational Risk: Possible mismanagement of climate risk in the bank, including missing sustainability targets at global level. | Short Term | High | |||
| Regulatory Compliance: Expectations from regulators increase and may lead to significant budget requests. | Short Term | Medium | |||
| Liquidity Risk: Significant concentration of gross undrawn amounts with clients in climate sensitive sectors | Medium Term | Medium | |||
| Litigation Risk: This covers the risk of future litigation due to climate related issues like greenwashing, inadequate disclosure scrutiny facilitating finance for fossil fuels etc. It appears likely that the trends of litigation are upward and will extend to banks more generally, alongside potential for reputational impacts. | Medium Term | Medium | |||
| Business Continuity Risk: Increase frequency and intensity of natural disasters may lead to greater risk exposures towards business continuity management | Medium Term | Medium |
| Risk Area | Scenario Analysis | Purpose | Scope | ||||
| Market Risk | Equity and Credit Concentration Analysis | Assessment of the transition risk in the MtM trading book over a short term | Sensitivity of the credit and equity portfolios in the trading book | ||||
| Credit Risk | Single Name Analysis of top counterparties | Counterparty-level analyses for 100 counterparty names selected based on the Bank of England ('BoE')'s Climate Biennial Exploratory Scenario ('CBES') 2021 guidance covering both transition and physical risk over the long term | Stress loss calculation is performed using assumed rating downgrade sensitivities over a 30-year period for the selected 100 names. | ||||
| Portfolio Stress Analysis using macro expansion of Late Action scenario | Portfolio Stress Test analysis projecting stress losses and RWAs over a five-year period for transition risk | Stress scenario to test resilience of the Credit Risk portfolio to climate transition risk. | |||||
| Non-Financial Risk | Greenwashing Litigation Risk Scenario | Assessment of climate-related litigation risk over the short/medium term | Potential future exposure and susceptibility to ESG Greenwashing litigation risk events. | ||||
| Resiliency Scenario | Assessment of climate-related Physical Risk over Short/Medium Term | Assessment to check how resilient the Offices and Data Center locations providing critical intra group services are to an extreme climate event. |
| 2023 | 2022 | 1 | |||||||
| Disclosure | UK | CSi | UK | CSi | |||||
| Full time Employee ('FTE') | 3,358 | 2,055 | 3,720 | 2,372 | |||||
| Energy consumption used to calculate emissions (kWh) | 46,092,488 | 28,207,285 | 55,805,990 | 35,585,852 | |||||
| Building Energy Use (kWh) | 46,073,051 | 28,195,390 | 55,782,040 | 35,570,580 | |||||
| Transport Energy Use (km) | 19,437 | 11,895 | 23,950 | 15,272 | |||||
| Emissions from stationary combustion of gas (Scope 1) | 283 | 173 | 328 | 209 | |||||
| Emissions from combustion of fuel for transport purposes (Scope 1) | - | - | - | - | |||||
| Emissions from business travel in rental cars or employee-owned vehicles where company is responsible for purchasing the fuel (Scope 3) | 3 | 2 | 4 | 3 | |||||
| Emissions from purchased electricity (Scope 2, location-based) | 8,652 | 5,295 | 10,346 | 6,597 | |||||
| Emissions from purchased electricity (Scope 2, market-based) | - | - | 1,431 | 912 | |||||
| Total gross location-based Co2e based on above | 8,935 | 5,468 | 10,674 | 6,806 | |||||
| Total gross market-based CO2e based on above | 283 | 173 | 582 | 371 | |||||
| GHG Intensity (tCO2e gross location-based GHG emissions/FTE) | 2.66 | 2.66 | 2.87 | 2.87 | |||||
|
1
2022 GHG emissions have been restated, resultant of adoption of UBS Group reporting systems and processes.
|
|||||||||
|
|
|||||||||
|
Board member since |
Independence |
Audit Committee |
Risk Committee |
Nomination Committee |
Advisory Remuneration Committee |
Conflicts Committee |
Disclosure Committee |
||||||||||
| John Devine, Chair | 2017 | independent | member | member | chair | member | chair | - | |||||||||
| David Todd | 2022 | independent | chair | chair | member | member | member | - | |||||||||
| Jonathan Magee | 2023 | - | member | member | - | chair* | - | - | |||||||||
| Jeremy Anderson | 2023 | - | member | member | member | member | - | - | |||||||||
| Jason Barron | 2023 | - | - | - | - | - | - | - | |||||||||
| Michael Ebert | 2023 | - | - | - | - | - | - | - | |||||||||
| Caroline Stewart | 2023 | - | - | - | - | - | - | - | |||||||||
| Beatriz Martin - CEO | 2023 | - | - | - | - | - | - | - | |||||||||
| Caroline Waddington, CFO | 2017 | - | - | - | - | - | - | chair | |||||||||
| Edward Jenkins, CRO | 2022 | - | - | - | - | - | - | member | |||||||||
|
*subject to regulatory approval
|
|||||||||||||||||
| Appointments: | |||
| Francesca McDonagh | 25.01.23 | ||
| Michael Ebert | 25.01.23 | ||
| Jeremy Anderson | 14.08.23 | ||
| Jason Barron | 14.08.23 | ||
| Jonathan Magee | 14.08.23 | ||
| Beatriz Martin | 14.08.23 | ||
| Caroline Stewart | 14.08.23 | ||
| The following ceased to be directors: | |||
| Richard Meddings | 12.06.23 | ||
| Francesca McDonagh | 12.06.23 | ||
| Doris Honold | 31.07.23 | ||
| Debra Davies | 01.08.23 | ||
| Christopher Horne | 11.12.23 | ||
| Reference to note |
Year ended 31 December |
||||||
| 2023 | 2022 | ||||||
| Consolidated Statement of Income (USD million) | |||||||
| Interest income | 5 |
|
|
||||
| - of which Interest income from instruments at amortised cost |
|
|
|||||
| Interest expense | 5 |
( |
( |
||||
| - of which Interest expense on instruments at amortised cost |
( |
( |
|||||
| Net interest income/(expense) |
|
( |
|||||
| Commission and fee income | 6 |
|
|
||||
| Allowance for credit losses | 8 |
( |
|
||||
| Net gains from financial assets/liabilities at fair value through profit or loss | 9 |
|
|
||||
| Other revenues | 10 |
|
|
||||
| Net revenues |
|
|
|||||
| Compensation and benefits | 11 |
( |
( |
||||
| General, administrative and trading expenses | 12 |
( |
( |
||||
| - of which Impairment on Intangibles and ROU asset |
( |
( |
|||||
| Restructuring expenses | 13 |
( |
( |
||||
| Total operating expenses |
( |
( |
|||||
| Loss before taxes |
( |
( |
|||||
| Income tax expense | 14 |
( |
( |
||||
| Loss for the year |
( |
( |
|||||
| Year ended 31 December | |||||
| 2023 | 2022 | ||||
| Consolidated Statement of Comprehensive Income (USD million) | |||||
| Loss for the year |
( |
( |
|||
| Cash flow hedges - effective portion of changes in fair value |
|
|
|||
| Related tax on cash flow hedges – effective portion of changes in fair value |
|
( |
|||
| Items that are or may be reclassified subsequently to Statement of income |
|
|
|||
| Remeasurements of defined benefit asset |
( |
( |
|||
| Related tax on remeasurements of defined benefit asset |
|
|
|||
| Realised losses relating to credit risk on designated financial liabilities extinguished during the period reclassed to retained earnings |
|
( |
|||
| Unrealised (losses)/gains on designated financial liabilities relating to credit risk |
( |
|
|||
| Related tax on unrealised gain/(loss) on designated financial liabilities relating to credit risk |
|
( |
|||
| Items that will not be reclassified to Statement of income |
( |
( |
|||
| Total other comprehensive loss for the period (net of taxes) |
( |
( |
|||
| Total comprehensive loss |
( |
( |
|||
| Attributable to Credit Suisse International shareholders |
( |
( |
|||
| Reference to note |
As at 31 December |
||||||
| 2023 | 2022 | ||||||
| Assets (USD million) | |||||||
| Cash and due from banks |
|
|
|||||
| Interest-bearing deposits with banks |
|
|
|||||
| Securities purchased under resale agreements and securities borrowing transactions | 16 |
|
|
||||
| Trading financial assets mandatorily at fair value through profit or loss 1 | 17 |
|
|
||||
| of which positive market values from derivative instruments | 17 |
|
|
||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 18 |
|
|
||||
| Loans and advances | 20 |
|
|
||||
| Current tax assets |
|
|
|||||
| Other assets | 21 |
|
|
||||
| Property and equipment | 23 |
|
|
||||
| Intangible assets | 24 |
|
|
||||
| Total assets |
|
|
|||||
| Liabilities (USD million) | |||||||
| Due to banks |
|
|
|||||
| Securities sold under repurchase agreements and securities lending transactions | 16 |
|
|
||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 17 |
|
|
||||
| of which negative market values from derivative instruments | 17 |
|
|
||||
| Financial liabilities designated at fair value through profit or loss | 19 |
|
|
||||
| Borrowings |
|
|
|||||
| Current tax liabilities |
|
|
|||||
| Deferred tax liabilities | 15 |
|
|
||||
| Other liabilities | 21 |
|
|
||||
| Provisions | 25 |
|
|
||||
| Debt in issuance | 26 |
|
|
||||
| Lease liabilities | 22 |
|
|
||||
| Total liabilities |
|
|
|||||
| Shareholders’ equity (USD million) | |||||||
| Share capital | 28 |
|
|
||||
| Other equity instrument |
|
|
|||||
| Capital contribution | 28 |
|
|
||||
| Retained earnings |
|
|
|||||
| Accumulated other comprehensive income | 27 |
( |
( |
||||
| Total shareholders’ equity |
|
|
|||||
| Total liabilities and shareholders' equity |
|
|
|||||
|
1
Trading Financial assets mandatorily at fair value through profit or loss includes trading assets pledged of USD
|
|||||||
| Reference to note |
As at 31 December |
||||||
| 2023 | 2022 | ||||||
| Assets (USD million) | |||||||
| Cash and due from banks | 3,616 | 4,133 | |||||
| Interest-bearing deposits with banks | 8,319 | 12,085 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | 16 | 1,304 | 10,527 | ||||
| Trading financial assets mandatorily at fair value through profit or loss 1 | 17 | 63,354 | 107,987 | ||||
| of which positive market values from derivative instruments | 17 | 57,337 | 90,188 | ||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 18 | 24,395 | 22,258 | ||||
| Loans and advances | 20 | 3,411 | 2,973 | ||||
| Current tax assets | 121 | 110 | |||||
| Other assets | 21 | 17,629 | 21,744 | ||||
| Property and equipment | 23 | 27 | 372 | ||||
| Intangible assets | 24 | 83 | 482 | ||||
| Total assets | 122,259 | 182,671 | |||||
| Liabilities (USD million) | |||||||
| Due to banks | 31 | 266 | |||||
| Securities sold under repurchase agreements and securities lending transactions | 16 | 358 | 2,924 | ||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 17 | 60,519 | 93,661 | ||||
| of which negative market values from derivative instruments | 17 | 58,562 | 88,737 | ||||
| Financial liabilities designated at fair value through profit or loss | 19 | 15,891 | 26,332 | ||||
| Borrowings | 12,622 | 6,025 | |||||
| Current tax liabilities | 3 | 3 | |||||
| Deferred Tax Liabilites | 15 | 59 | – | ||||
| Other liabilities | 21 | 9,025 | 16,674 | ||||
| Provisions | 25 | 168 | 45 | ||||
| Debt in issuance | 26 | 8,108 | 18,308 | ||||
| Lease liabilities | 22 | 512 | 529 | ||||
| Total liabilities | 107,296 | 164,767 | |||||
| Shareholders’ equity (USD million) | |||||||
| Share capital | 28 | 7,267 | 11,366 | ||||
| Other equity instrument | 1,200 | 1,200 | |||||
| Capital contribution | 28 | 887 | 887 | ||||
| Retained earnings | 6,058 | 4,852 | |||||
| Accumulated other comprehensive income | 27 | (449) | (401) | ||||
| Total shareholders’ equity | 14,963 | 17,904 | |||||
| Total liabilities and shareholders’ equity | 122,259 | 182,671 | |||||
|
1
Trading Financial assets mandatorily at fair value through profit or loss includes trading assets pledged of USD 3,742 million (2022: USD 10,616 million). For further details, refer Note 37- Assets Pledged or Assigned
|
|||||||
|
|
Share Capital |
Capital Contribution |
Other Equity Instruments |
Retained Earnings |
AOCI |
1 |
Total |
||||||||
| Consolidated Statement of Changes in Equity (USD million) | |||||||||||||||
| Balance at 1 January 2023 |
|
|
|
|
( |
|
|||||||||
| Net loss for the year |
|
|
|
( |
|
( |
|||||||||
| Unrealised gain on designated financial liabilities relating to credit risk |
|
|
|
|
( |
( |
|||||||||
| Related tax on unrealised gain on designated financial liabilities relating to credit risk |
|
|
|
|
|
|
|||||||||
| Cash flow hedges – effective portion of changes in fair value |
|
|
|
|
|
|
|||||||||
| Remeasurement of defined benefit pension assets |
|
|
|
|
( |
( |
|||||||||
| Related tax on remeasurement of defined benefit pension assets |
|
|
|
|
|
|
|||||||||
| Total comprehensive loss for the period |
|
|
|
( |
( |
( |
|||||||||
| Transactions with owners of the Company | |||||||||||||||
| Capital reduction |
( |
|
|
|
|
|
|||||||||
| Dividend payment |
|
|
|
( |
|
( |
|||||||||
| Balance at 31 December 2023 |
|
|
|
|
( |
|
|||||||||
| Consolidated Statement of Changes in Equity (USD million) | |||||||||||||||
| Balance at 1 January 2022 |
|
|
|
|
( |
|
|||||||||
| Net loss for the period |
|
|
|
( |
|
( |
|||||||||
| Realised gain/(loss) relating to credit risk on designated financial liabilities extinguished during year reclassed to retained earnings |
|
|
|
|
( |
|
|||||||||
| Unrealised gain on designated financial liabilities relating to credit risk |
|
|
|
|
|
|
|||||||||
| Related tax on unrealised gain on designated financial liabilities relating to credit risk |
|
|
|
|
( |
( |
|||||||||
| Cash flow hedges - effective portion of changes in fair value |
|
|
|
|
|
|
|||||||||
| Related tax on cash flow hedges – effective portion of changes in fair value |
|
|
|
|
( |
( |
|||||||||
| Remeasurement of defined benefit pension assets |
|
|
|
|
( |
( |
|||||||||
| Related tax on remeasurement of defined benefit pension assets |
|
|
|
|
|
|
|||||||||
| Total comprehensive loss for the period |
|
|
|
( |
( |
( |
|||||||||
| Transactions with owners of the Company | |||||||||||||||
| Additional Tier 1 Capital issuance |
|
|
|
|
|
|
|||||||||
| Balance at 31 December 2022 |
|
|
|
|
( |
|
|||||||||
|
1
AOCI refers to Accumulated Other Comprehensive Income
|
|||||||||||||||
|
|
Share Capital |
Capital contribution |
Other Equity Instruments |
Retained Earnings |
AOCI |
1 |
Total |
||||||||
| Bank Statement of Changes in Equity (USD million) | |||||||||||||||
| Balance at 1 January 2023 | 11,366 | 887 | 1,200 | 4,852 | (401) | 17,904 | |||||||||
| Net loss for the year | – | – | – | (1,793) | – | (1,793) | |||||||||
| Unrealised loss on designated financial liabilities relating to credit risk | – | – | – | – | (23) | (23) | |||||||||
| Related tax on unrealised loss on designated financial liabilities relating to credit risk | – | – | – | – | 3 | 3 | |||||||||
| Cash flow hedges – effective portion of changes in fair value | – | – | – | – | 12 | 12 | |||||||||
| Remeasurement of defined benefit pension assets | – | – | – | – | (56) | (56) | |||||||||
| Related tax on defined benefit pension assets | – | – | – | – | 16 | 16 | |||||||||
| Total comprehensive loss for the period | – | – | – | (1,793) | (48) | (1,841) | |||||||||
| Transactions with owners of the Company | |||||||||||||||
| Capital reduction | (4,099) | – | – | 4,099 | – | – | |||||||||
| Dividend payment | – | – | – | (1,100) | – | (1,100) | |||||||||
| Balance at 31 December 2023 | 7,267 | 887 | 1,200 | 6,058 | (449) | 14,963 | |||||||||
| Bank Statement of Changes in Equity (USD million) | |||||||||||||||
| Balance at 1 January 2022 | 11,366 | 887 | – | 5,536 | (160) | 17,629 | |||||||||
| Net loss for the year | – | – | – | (685) | – | (685) | |||||||||
| Realised gain/(loss) relating to credit risk on designated financial liabilities extinguished during year reclassed to retained earnings | – | – | – | 1 | (1) | – | |||||||||
| Unrealised gain on designated financial liabilities relating to credit risk | – | – | – | – | 31 | 31 | |||||||||
| Related tax on unrealised gain on designated financial liabilities relating to credit risk | – | – | – | – | (3) | (3) | |||||||||
| Cash flow hedges – effective portion of changes in fair value | – | – | – | – | 3 | 3 | |||||||||
| Related tax on cash flow hedges – effective portion of changes in fair value | – | – | – | – | (3) | (3) | |||||||||
| Remeasurement of defined benefit pension assets | – | – | – | – | (358) | (358) | |||||||||
| Related tax on defined benefit pension assets | – | – | – | – | 90 | 90 | |||||||||
| Total comprehensive loss for the period | – | – | – | (684) | (241) | (925) | |||||||||
| Transactions with owners of the Company | |||||||||||||||
| Additional Tier 1 Capital issuance | – | – | 1,200 | – | – | 1,200 | |||||||||
| Balance at 31 December 2022 | 11,366 | 887 | 1,200 | 4,852 | (401) | 17,904 | |||||||||
|
1
AOCI refers to Accumulated Other Comprehensive Income
|
|||||||||||||||
| Year ended 31 December | |||||||
|
Reference to note |
2023 |
2022 |
|||||
| Cash flows from operating activities (USD million) | |||||||
| Loss before tax for the period |
( |
( |
|||||
| Adjustments to reconcile loss before tax to net cash generated from/(used in) operating activities (USD million) | |||||||
| Non-cash items included in loss before tax and other adjustments: | |||||||
| Depreciation, impairment and amortisation | 12, 23, 24 |
|
|
||||
| Share based compensation charge/(Reversal of charge) |
|
( |
|||||
| Pension plan credits | 30 |
( |
( |
||||
| Accrued interest on debt in issuance | 5 |
|
|
||||
| Accrued interest on lease liability | 5 |
|
|
||||
| Net unearned income on loans and advances | 20 |
|
( |
||||
| Provision for credit losses/(Release of allowance for loan losses) | 8 |
|
( |
||||
| Foreign exchange loss/(gain) 2 |
|
( |
|||||
| Provisions | 25 |
|
|
||||
| Total adjustments |
|
( |
|||||
| Cash generated from /(used in) before changes in operating assets and liabilities |
|
( |
|||||
| Net (increase)/decrease in operating assets: | |||||||
| Interest bearing deposit with banks |
|
|
|||||
| Securities purchased under resale agreements and securities borrowing transactions | 16 |
|
( |
||||
| Trading financial assets mandatorily at fair value through profit or loss | 17 |
|
|
||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 18 |
( |
|
||||
| Loans and advances | 20 |
( |
|
||||
| Other assets | 21 |
|
|
||||
| Net decrease in operating assets |
|
|
|||||
| Net increase/ (decrease) in operating liabilities: | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 16 |
( |
( |
||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 17 |
( |
( |
||||
| Financial liabilities designated at fair value through profit or loss | 19 |
( |
( |
||||
| Borrowings |
|
|
|||||
| Share based compensation (Reported as other liabilities & provisions) | 21, 25 |
( |
( |
||||
| Other liabilities and provisions | 21, 25 |
( |
( |
||||
| Net decrease in operating liabilities |
( |
( |
|||||
| Income taxes refunded |
|
|
|||||
| Income taxes paid |
( |
( |
|||||
| Group relief received/ (paid) |
|
( |
|||||
| Net cash generated from operating activities |
|
|
|||||
| Cash flows from investing activities (USD million) | |||||||
| Proceeds from property, equipment and intangible assets | 23, 24 |
|
|
||||
| Capital expenditures for property, equipment and intangible assets | 23, 24 |
( |
( |
||||
| Proceeds from sale of investment property |
|
|
|||||
| Net cash used in investing activities |
( |
( |
|||||
| Cash flow from financing activities (USD million) | |||||||
| Issuances of debt in issuance | 26 |
|
|
||||
| Repayments of debt in issuance | 26 |
( |
( |
||||
| Repayments of lease liability | 22 |
( |
( |
||||
| Issuance of Additional Tier I Capital |
|
|
|||||
| Dividend payout |
( |
|
|||||
| Net cash flow used in financing activities |
( |
( |
|||||
| Net change in cash and cash equivalents |
( |
|
|||||
| Cash and cash equivalents at beginning of period 1 |
|
|
|||||
| Effect of exchange rate fluctuations on cash and cash equivalents |
|
( |
|||||
| Cash and cash equivalents at end of period (USD million) |
|
|
|||||
| Cash and due from banks |
|
|
|||||
| Due to banks |
( |
( |
|||||
| Cash and cash equivalents at end of period (USD million) 1 |
|
|
|||||
|
Interest received was USD
|
|||||||
|
1
At 2023, USD
|
|||||||
|
2
Foreign Exchange loss/(gain) includes FX movement on Investing and Financing activity and Cash & Cash Equivalents.
|
|||||||
| Year ended 31 December | |||||||
|
Reference to notes |
2023 |
2022 |
|||||
| Cash flows from operating activities (USD million) | |||||||
| Loss before tax for the period | (1,736) | (331) | |||||
| Adjustments to reconcile loss to net cash generated from/(used in) operating activities (USD million) | |||||||
| Non-cash items included in loss before tax and other adjustments: | |||||||
| Depreciation, impairment and amortisation | 12, 23, 24 | 771 | 233 | ||||
| Share based compensation charge/(Reversal of charge) | 59 | (27) | |||||
| Pension plan credits | 30 | (25) | (9) | ||||
| Accrued interest on debt in issuance | 5 | 734 | 515 | ||||
| Accrued interest on lease liability | 5 | 16 | 17 | ||||
| Net unearned income on loans and advances | 20 | – | (2) | ||||
| Provision for credit losses/(Release of allowance for loan losses) | 8 | 37 | (158) | ||||
| Foreign exchange loss/(gain) 2 | 313 | (2,330) | |||||
| Provisions | 25 | 323 | 114 | ||||
| Total adjustments | 2,228 | (1,647) | |||||
| Cash generated from /(used in) before changes in operating assets and liabilities | 492 | (1,978) | |||||
| Net decrease/(increase) in operating assets: | |||||||
| Interest bearing deposits with banks | 3,766 | 1,199 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | 16 | 9,223 | (1,625) | ||||
| Trading financial assets mandatorily at fair value through profit or loss | 17 | 44,633 | 35,938 | ||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 18 | (2,142) | 15,645 | ||||
| Loans and advances | 20 | (476) | – | ||||
| Other assets | 21 | 4,104 | 12,728 | ||||
| Net decrease in operating assets | 59,108 | 63,885 | |||||
| Net (decrease)/increase in operating liabilities: | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 16 | (2,566) | (447) | ||||
| Trading financial liabilities at fair value through profit or loss | 17 | (33,142) | (28,394) | ||||
| Financial liabilities designated at fair value through profit or loss | 19 | (10,447) | (8,496) | ||||
| Borrowings | 6,597 | 4,555 | |||||
| Share Based Compensation (Reported as other liabilities & provisions) | 21, 25 | (75) | (127) | ||||
| Other liabilities and provisions | 21, 25 | (8,583) | (7,672) | ||||
| Net decrease in operating liabilities | (48,216) | (40,581) | |||||
| Income taxes refunded | 10 | – | |||||
| Income taxes paid | (13) | (21) | |||||
| Group relief received/ (paid) | 10 | (13) | |||||
| Net cash generated from operating activities | 11,391 | 21,292 | |||||
| Cash flows from investing activities (USD million) | |||||||
| Proceeds from property, equipment and intangible assets | 23, 24 | 12 | 5 | ||||
| Capital expenditures for property, equipment and intangible assets | 23, 24 | (38) | (183) | ||||
| Net cash used in investing activities | (26) | (178) | |||||
| Cash flows from financing activities (USD million) | |||||||
| Issuances of debt in issuance | 26 | 8,452 | 645 | ||||
| Repayments of debt in issuance | 26 | (19,038) | (20,218) | ||||
| Repayments of lease liability | 22 | (62) | (47) | ||||
| Dividend payout | (1,100) | – | |||||
| Issuance of Additional Tier I Capital | – | 1,200 | |||||
| Net cash flow used in financing activities | (11,748) | (18,420) | |||||
| Net (decrease)/ increase in cash and cash equivalents | (383) | 2,694 | |||||
| Cash and cash equivalents at beginning of period 1 | 3,867 | 1,248 | |||||
| Effect of exchange rate fluctuations on cash and cash equivalents | 101 | (75) | |||||
| Cash and cash equivalents at end of period (USD million) | 3,585 | 3,867 | |||||
| Cash and due from banks | 3,616 | 4,133 | |||||
| Due to banks | (31) | (266) | |||||
| Cash and cash equivalents at end of period (USD million) 1 | 3,585 | 3,867 | |||||
|
Interest received was USD 2,973 million (2022: USD 1,560 million), interest paid was USD 2,518 million (2022: USD 1,631 million).
|
|||||||
|
1
At 2023, USD 31 million (2022: USD 62 million) was not available for use by CSi relating to mandatory deposits at central banks.
|
|||||||
|
2
Foreign Exchange loss/(gain) includes FX movement on Investing and Financing activity and Cash & Cash Equivalents.
|
|||||||
| Long leasehold buildings | 67 years | ||
| Leasehold improvements | lower of lease term or useful life, generally not exceeding 10 years | ||
| Computer equipment | 3–7 years | ||
| Office equipment | 5 years |
| 2023 | 2022 | 1 | |||
| Revenues (USD million) | |||||
| Investment Bank | 85 | 194 | |||
| Transition | 221 | 427 | |||
| Non-Core Legacy | 106 | 1,207 | |||
| - NCL Credit | (62) | 325 | |||
| - NCL Securitized Products | (33) | (5) | |||
| - NCL Equities | 201 | 922 | |||
| - NCL Macro | (73) | (17) | |||
| - NCL Management | 69 | (16) | |||
| - NCL Others | 4 | (2) | |||
| Other | 11 | 6 | |||
| Corporate centre (includes ARU) | 6 | 119 | |||
| Total | 429 | 1,953 | |||
|
1
Prior period numbers have been restated to conform to current period's presenation.
|
|||||
| 2023 | 2022 | 1 | |||
| Consolidated Income before taxes (USD million) | |||||
| Investment Bank | (215) | (158) | |||
| Transition | 199 | 323 | |||
| Non-Core Legacy | (1,510) | (655) | |||
| - NCL Credit | (350) | (138) | |||
| - NCL Securitized Products | (45) | (31) | |||
| - NCL Equities | (295) | 102 | |||
| - NCL Macro | (70) | (314) | |||
| - NCL Management | (755) | (266) | |||
| - NCL Others | 5 | (8) | |||
| Other | (24) | (30) | |||
| Corporate centre (includes ARU) | (17) | 50 | |||
| Total | (1,567) | (470) | |||
|
1
Prior period numbers have been restated to conform to current period's presenation.
|
|||||
| 2023 | 2022 | 2 | |||
| Reconciliation of reportable segment revenues (USD million) | |||||
| Total revenues for reportable segments | 429 | 1,953 | |||
| Transfer pricing agreements and cross divisional revenue share agreements | 67 | 193 | |||
| Treasury funding | 694 | (60) | |||
| Corporate Functions | (48) | 57 | |||
| Allowance for Credit Losses | (40) | 158 | |||
| CSi group to primary reporting reconciliations 1 | 311 | 27 | |||
| Net revenues as per Consolidated Statement of Income | 1,413 | 2,328 | |||
|
1
This is the difference between the monthly board summaries which are prepared on a US GAAP basis and the CSi group financials prepared in accordance with IFRS.
|
|||||
|
2
Prior period numbers have been restated to conform to current period’s presenation.
|
|||||
| 2023 | 2022 | 2 | |||
| Reconciliation of reportable segment income before taxes (USD million) | |||||
| Losses before taxes for reportable segments | (1,567) | (470) | |||
| Corporate Functions | (675) | (20) | |||
| CSi group to primary reporting reconciliations 1 | 506 | 159 | |||
| (Loss)/Profit before taxes as per Consolidated Statement of Income | (1,736) | (331) | |||
|
1
This is the difference between the monthly board summaries which are prepared on a US GAAP basis and the CSi group financials prepared in accordance with IFRS.
|
|||||
|
2
Prior period numbers have been restated to conform to current period’s presenation.
|
|||||
| 2023 | 2022 | ||||
| Net interest income/(expense) (USD million) | |||||
| Loans and advances | 221 | 111 | |||
| Securities purchased under resale agreements and securities borrowing transactions | 1,182 | 836 | |||
| Cash collateral paid on OTC derivatives transactions | 780 | 364 | |||
| Interest income on cash and cash equivalents | 793 | 317 | |||
| Interest income | 2,976 | 1,628 | |||
| Due to banks | – | (9) | |||
| Borrowings | (576) | (150) | |||
| Securities sold under repurchase agreements and securities lending transactions | (463) | (529) | |||
| Debt in issuance | (734) | (515) | |||
| Lease liabilities | (16) | (17) | |||
| Cash collateral received on OTC derivatives transactions | (743) | (450) | |||
| Interest expense | (2,532) | (1,670) | |||
| Net interest income/(expense) | 444 | (42) | |||
| of which | |||||
| Interest income on financial assets measured at fair value through profit or loss | 781 | 885 | |||
| Interest income on financial assets measured at amortised cost | 2,195 | 743 | |||
| Interest expenses on financial liabilities measured at fair value through profit or loss | (404) | (520) | |||
| Interest expenses on financial liabilities measured at amortised cost | (2,128) | (1,150) | |||
| 2023 | 2022 | ||||
| Commission and fee income (USD million) | |||||
| Lending business | 10 | 43 | |||
| Brokerage | 52 | 139 | |||
| Underwriting | 21 | 56 | |||
| Other client services | 56 | 187 | |||
| Total commission and fee income | 139 | 425 | |||
| 2023 | 2022 | ||||
| Fee income from financial instruments (USD million) | |||||
| Commitment fees | 4 | 5 | |||
| Other services | – | 1 | |||
| Total fee income | 4 | 6 | |||
| 2023 | 2 | 2022 | 2 | ||
| Type of Services (USD million) | |||||
| Lending business 1 | 1 | 17 | |||
| Other securities business | 42 | 59 | |||
| Brokerage | 10 | 81 | |||
| Underwriting | 20 | 56 | |||
| Transfer pricing arrangement and other services | 110 | 328 | |||
| Total | 183 | 541 | |||
|
1
Lending fees include loan syndication fees received by the CSi group for arranging loans for which it retains no part of the loan package (or retains a part at the same effective interest rate for comparable risk as other participants).
|
|||||
|
2
The table above differs from note 6 – Commission and Fee income as it includes only those contracts with customers that are in scope of IFRS 15 – Revenue from contracts with customers.
|
|||||
| Contract balances (USD million) | 2023 | 2022 | |||
| Contract receivables | 14 | 53 |
| 2023 | 2022 | ||||
| Additional/Release of allowance for credit losses (USD million) | |||||
| Allowances for credit losses | (94) | (13) | |||
| Allowances for off-balance sheet exposure | (1) | (7) | |||
| Additional allowance for credit losses | (95) | (20) | |||
| Release of allowance for credit losses | 24 | 170 | |||
| Release of allowance for off-balance sheet exposures | 3 | 8 | |||
| Release of allowance for credit losses | 27 | 178 | |||
| (Additional allowance)/Release for credit losses | (68) | 158 | |||
| 2023 | 2022 | ||||
| Net gains/(losses) from financial assets/liabilities at fair value through profit or loss (USD million) | |||||
| Net gains/(losses) from financial assets/liabilities mandatorily measured at fair value through profit or loss | 1,710 | (911) | |||
| Net (losses)/gains from financial liabilities designated at fair value through profit or loss | (914) | 2,514 | |||
| Total net gains from financial assets/liabilities at fair value through profit or loss | 796 | 1,603 | |||
| 2023 | 2022 | ||||
| Total net gains/(losses) from trading financial assets/liabilities mandatorily measured at fair value through profit or loss | 1,744 | (873) | |||
| Non-trading financial assets mandatorily measured at fair value through profit or loss (USD million) | |||||
| Securities purchased under resale agreements and securities borrowing transactions | 5 | 2 | |||
| Loans and advances | 23 | 3 | |||
| Other financial assets | (62) | (43) | |||
| Total net gains/(losses) from non trading financial assets mandatorily measured at fair value through profit or loss | (34) | (38) | |||
| Total net gains/(losses) from financial assets/liabilities mandatorily measured at fair value through profit or loss | 1,710 | (911) | |||
| 2023 | 2022 | ||||||||
|
Profit or Loss |
OCI |
Profit or Loss |
OCI |
||||||
| Net gains/(losses) from financial liabilities designated at fair value through profit or loss (USD million) | |||||||||
| Securities sold under repurchase agreements and securities lending transactions | 2 | – | (1) | – | |||||
| Borrowings | (637) | – | 592 | – | |||||
| Debt in issuance | (399) | (23) | 1,723 | 30 | |||||
| Other financial liabilities designated at fair value through profit or loss | 120 | – | 200 | – | |||||
| Total net gains/(losses) from financial liabilities designated at fair value through profit or loss | (914) | (23) | 2,514 | 30 | |||||
| 2023 | 2022 | ||||
| Other revenues (USD million) | |||||
| Transfer pricing arrangements | 54 | 143 | |||
| Other | 48 | 41 | |||
| Total other revenues | 102 | 184 | |||
| 2023 | 2022 | ||||
| Compensation and benefits (USD million) | |||||
| Salaries and variable compensation | (551) | (379) | |||
| Social security costs | (75) | (76) | |||
| Pension costs | (9) | (29) | |||
| Other | (7) | (67) | |||
| Total compensation and benefits | (642) | (551) | |||
| 2023 | 2022 | 1 | |||
| Division | |||||
| Front Office | 726 | 1,069 | |||
| Corporate Functions | 1,154 | 1,355 | |||
| Total monthly average | 1,880 | 2,424 | |||
|
1
The disclosure has been restated to give effect to the reorganisation of businesses.
|
|||||
| 2023 | 2022 | ||||
| General, administrative and trading expenses (USD million) | |||||
| Brokerage charges and clearing house fees | (188) | (426) | |||
| Insurance charges | (1) | (5) | |||
| Trading expenses | (189) | (431) | |||
| Depreciation and amortisation expenses 1 | (250) | (195) | |||
| Litigation | (182) | (112) | |||
| Auditor's remuneration | (7) | (6) | |||
| Professional services | (823) | (786) | |||
| Impairment of intangible assets and ROU assets | (531) | (27) | |||
| Occupancy Expenses | (250) | (91) | |||
| Net overheads allocated to other CS group entities | 180 | 220 | |||
| Transfer pricing arrangements | (292) | (467) | |||
| UK Bank Levy | (6) | (11) | |||
| Other | (110) | (155) | |||
| General and administrative expenses | (2,271) | (1,630) | |||
| Total general, administrative and trading expenses | (2,460) | (2,061) | |||
|
1
Depreciation and amortisation expense includes depreciation on leasehold improvements of USD 68 million (2022:USD 28 million) and depreciation on right-of-use assets of USD 57 million in 2023 (2022: USD 10 million).
|
|||||
| CSi Auditor’s remuneration (USD ‘000) | 2023 | 2022 | ||
| Fees payable to the Bank’s auditors for the audit of the Bank’s annual financial statements | (5,631) | (4,637) | ||
| Audit-related assurance services | (1,084) | (1,190) | ||
| Total fees | (6,715) | (5,827) |
| 2023 | 2022 | ||||
| Restructuring expenses by type (USD million) | |||||
| Compensation and benefits-related expenses | (15) | (27) | |||
| of which severance | (11) | (12) | |||
| of which accelerated deferred compensation | (4) | (15) | |||
| General and administrative-related expenses | (32) | (20) | |||
| Total Restructuring expenses | (47) | (47) | |||
| Severance expenses | |||||
| 2023 | 2022 | ||||
| Restructuring provision (USD million) | |||||
| Balance at beginning of the period/year | 12 | 4 | |||
| Net additional charges | 50 | 12 | |||
| Utilisation and foreign exchange fluctuations | (35) | (4) | |||
| Balance at end of the period/year | 27 | 12 | |||
|
Liability relating to accelerated deferred compensation, not included in the above table, is included in Share-based compensation liability. For details, refer Note 21 - Other Assets and Other Liabilities.
|
|||||
|
Amortisation relating to internally developed software, not included in the above table, is included in accumulated depreciation for intangible assets. For details, refer Note 24 - Intangible assets.
|
|||||
| Group and Bank | 2023 | 2022 | |||
| Current and deferred taxes (USD million) | |||||
| Current tax | |||||
| Current tax benefit for the period 1 | 24 | 17 | |||
| Adjustments in respect of previous periods | (4) | (3) | |||
| Current income tax benefit | 20 | 14 | |||
| Deferred tax | |||||
| Deferred tax expense for the period | (77) | (344) | |||
| Adjustments in respect of previous periods | – | 2 | |||
| Effect of changes in tax rate | – | (26) | |||
| Deferred income tax (expense) | (77) | (368) | |||
| Income tax (expense) | (57) | (354) | |||
|
1
Withholding taxes are included within income taxes.
|
|||||
| Group and Bank | 2023 | 2022 | |||
| Reconciliation of taxes computed at the UK statutory rate (USD million) | |||||
| Loss before tax | (1,736) | (331) | |||
| Income tax benefit computed at the statutory rate of 23.52% (2022: 19%) | 408 | 63 | |||
| (Increase)/decrease in income taxes resulting from: | |||||
| Other permanent differences | (25) | (9) | |||
| Adjustment for losses attributable to non-UK operations | – | 11 | |||
| Impact of UK bank corporation tax surcharge | (5) | (20) | |||
| Non-recoverable foreign taxes including withholding taxes 1 | (13) | (21) | |||
| Other movement in unrecognised deferred tax assets | (418) | (122) | |||
| Impairment of deferred tax assets following the strategic review | – | (215) | |||
| Adjustments to current tax in respect of previous periods | (4) | (3) | |||
| Adjustments to deferred tax in respect of previous periods | – | 2 | |||
| Effect on deferred tax resulting from changes to tax rates | – | (26) | |||
| Differential in movement in deferred taxes to the statutory tax rate | – | (14) | |||
| Income tax (expense) | (57) | (354) | |||
|
1
Withholding taxes are included within income taxes.
|
|||||
| Group and Bank | 2023 | 2022 | |||
| Deferred tax (USD million) | |||||
| Deferred tax assets | 97 | 163 | |||
| Deferred tax liabilities | (156) | (163) | |||
| Net position | (59) | – | |||
| Balance at 1 January | – | 284 | |||
| Debit to statement of income for the period | (77) | (344) | |||
| Adjustments in respect of previous periods | – | 2 | |||
| Tax impact on Unrealised gain/(loss) on designated financial liabilities relating to credit risk | 3 | (3) | |||
| Tax impact of remeasurement of defined benefit pension plan assets | 15 | 90 | |||
| Tax Impact on gain on cashflow hedges | – | (3) | |||
| Effect of change in tax rate credited to income statement | – | (26) | |||
| Balance at 31 December | (59) | – | |||
| Group and Bank | 2023 | 2022 | |||
| Components of net deferred tax assets (USD million) | |||||
| Employee benefits | – | 24 | |||
| Decelerated tax depreciation | 38 | 120 | |||
| Other provisions | – | 18 | |||
| Tax losses | 59 | – | |||
| Leases | – | 1 | |||
| Deferred tax assets netted against deferred tax liabilities | (97) | (163) | |||
| Balance at 31 December | – | – | |||
| Group and Bank | 2023 | 2022 | |||
| Components of net deferred tax liabilities (USD million) | |||||
| Pensions and other post-retirement benefits | (156) | (159) | |||
| Derivative financial instrument | – | (4) | |||
| Deferred tax liabilities netted against deferred tax assets | 97 | 163 | |||
| Balance at 31 December | (59) | – | |||
| Group and Bank | 2023 | 2022 | |||
| Tax effect of temporary differences (USD million) | |||||
| Derivative financial instruments | 1 | (3) | |||
| Employee benefits | (24) | (54) | |||
| Defined benefit pension assets | (12) | 89 | |||
| Decelerated tax depreciation | (82) | (38) | |||
| Other provisions | (18) | (6) | |||
| Unpaid interest | – | (79) | |||
| Leases | (1) | (1) | |||
| Tax losses | 59 | (276) | |||
| Total deferred tax (expense) in the Statement of Income | (77) | (368) | |||
| Group and Bank | 2023 | 2022 | |||
| Income Tax (expense)/benefit recognised in Equity (USD million) | |||||
| Unrealised gain/ (loss) on designated financial liabilities relating to credit risk | 3 | (3) | |||
| Re-measurement of defined benefit pension assets | 15 | 90 | |||
| Gain/(loss) on cash flow hedges | – | (3) | |||
| Total Income Tax benefit recognised in Equity | 18 | 84 | |||
| Group and Bank | 2023 | 2022 | |||
| Securities purchased under resale agreements and securities borrowing transactions (USD million) | |||||
| Securities purchased under resale agreements | 641 | 7,668 | |||
| Deposits paid for securities borrowed | 663 | 2,859 | |||
| Total securities purchased under resale agreements and securities borrowing transactions | 1,304 | 10,527 | |||
| Group and Bank | 2023 | 2022 | |||
| Securities sold under repurchase agreements and securities lending transactions (USD million) | |||||
| Securities sold under repurchase agreements | 52 | 86 | |||
| Deposits received for securities lent | 306 | 2,838 | |||
| Total securities sold under repurchase agreements and securities lending transactions | 358 | 2,924 | |||
| Group | Bank | ||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||
| Trading financial assets at fair value through profit or loss (USD million) | |||||||||
| Debt securities | 1,841 | 8,353 | 1,886 | 8,248 | |||||
| Equity securities | 3,968 | 9,237 | 3,968 | 9,235 | |||||
| Derivative instruments | 57,337 | 90,067 | 57,337 | 90,188 | |||||
| Loans | 162 | 312 | 162 | 312 | |||||
| Other | 1 | 4 | 1 | 4 | |||||
| Trading financial assets at fair value through profit or loss | 63,309 | 107,973 | 63,354 | 107,987 | |||||
| Trading financial liabilities at fair value through profit or loss (USD million) | |||||||||
| Short positions | 1,957 | 4,921 | 1,957 | 4,921 | |||||
| Derivative instruments | 58,562 | 88,473 | 58,562 | 88,737 | |||||
| Other | – | 3 | – | 3 | |||||
| Trading financial liabilities at fair value through profit or loss | 60,519 | 93,397 | 60,519 | 93,661 | |||||
|
|
|||||||||
| Group | Bank | ||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss (USD million) | |||||||||
| Loans and advances | 270 | 1,105 | 274 | 700 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | 23,910 | 21,093 | 23,910 | 21,093 | |||||
| Other non-trading financial assets mandatorily at fair value through profit or loss 1 | 408 | 633 | 211 | 465 | |||||
| Total non-trading financial assets mandatorily at fair value through profit or loss | 24,588 | 22,831 | 24,395 | 22,258 | |||||
|
1
This includes balances relating to Failed Purchases USD 385 million (2022:USD 603 million).
|
|||||||||
| Group | Bank | ||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||
| Financial Liabilities designated at fair value through profit or loss (USD million) | |||||||||
| Structured notes and other hybrid instruments | 7,073 | 9,838 | 6,914 | 9,558 | |||||
| Commercial Paper | – | 558 | – | – | |||||
| Securities sold under repurchase agreement and securities lending transactions | 8,000 | 15,190 | 8,000 | 15,191 | |||||
| Other 1 | 977 | 1,583 | 977 | 1,583 | |||||
| Total financial liabilities designated at fair value through profit or loss | 16,050 | 27,169 | 15,891 | 26,332 | |||||
|
1
This includes balances relating to Failed Sales USD 969 million (2022: USD 1,554 million).
|
|||||||||
| 2023 | 2022 | ||||
| Changes in fair value of financial liabilities designated at fair value through profit or loss due to credit risk (USD million) | |||||
| Financial liabilities designated at fair value through profit or loss that present the effects of changes in that liability’s credit risk in OCI | |||||
| Cumulative change in the fair value | |||||
| Debt in issuance | |||||
| of which structured notes over two years | 17 | 40 | |||
| Total Cumulative Change | 17 | 40 | |||
| YTD change in the fair value | |||||
| Debt in issuance | |||||
| of which structured notes over two years | (23) | 30 | |||
| Total YTD Change | (23) | 30 | |||
| Group and Bank | 2023 | 2022 | |||
| Loans and advances (USD million) | |||||
| Loans and advances other than leases | 3,187 | 2,752 | |||
| Net investment in leases | 224 | 221 | |||
| Loans and advances | 3,411 | 2,973 | |||
| Group and Bank | 2023 | 2022 | |||
| Loans and advances other than leases (USD million) | |||||
| Gross loans and advances | 3,290 | 2,774 | |||
| of which domestic | 3,114 | 2,596 | |||
| of which foreign | 176 | 178 | |||
| Net unearned income | (2) | (2) | |||
| Allowance for credit losses | (101) | (20) | |||
| Loans and advances | 3,187 | 2,752 | |||
| Gross impaired loans | 74 | 28 | |||
| of which loans with an individual allowance | 74 | 28 | |||
| Group and Bank | 2023 | 2022 | |||
| Loans and advances by geography (USD million) | |||||
| Gross loans and advances | 3,290 | 2,774 | |||
| of which domestic | 3,114 | 2,596 | |||
| of which foreign | 176 | 178 | |||
| -Netherlands | 64 | 37 | |||
| -Luxembourg | 55 | 76 | |||
| -Others | 57 | 65 | |||
| Group and Bank (USD million) | 2023 | 2022 | |||
| Net investment in leases | |||||
| Receivable within 1 year | 32 | 28 | |||
| Receivable between 1 and 2 years | 32 | 29 | |||
| Receivable between 2 and 3 years | 33 | 29 | |||
| Receivable between 3 and 4 years | 29 | 29 | |||
| Receivable between 4 and 5 years | 20 | 26 | |||
| Receivable after 5 years | 119 | 120 | |||
| Total lease payments receivable | 265 | 261 | |||
| Unearned finance income | (41) | (40) | |||
| Net investment in leases | 224 | 221 | |||
| Total | |||
| Group and Bank Allowance for credit losses (USD million) | |||
| Balance at 1 January 2023 | (20) | ||
| Additional allowances for credit losses | (85) | ||
| Reversal of allowances for credit losses | 4 | ||
| Movement recognised in Consolidated Statement of Income | (81) | ||
| Balance at 31 December 2023 | (101) | ||
| Balance at 1 January 2022 | (12) | ||
| Additional allowances for credit losses | (10) | ||
| Reversal of allowances for credit losses | 2 | ||
| Movement recognised in Consolidated Statement of Income | (8) | ||
| Balance at 31 December 2022 | (20) | ||
| Group and Bank | 2023 | 2022 | |||
| Other Assets (USD million) | |||||
| Brokerage receivables | |||||
| Due from customers | 399 | 1,144 | |||
| Due from banks, brokers and dealers | 255 | 687 | |||
| Interest and fees receivable | 378 | 392 | |||
| Cash collateral on derivative instruments | |||||
| Banks | 7,121 | 6,563 | |||
| Customers | 8,607 | 11,658 | |||
| Cash collateral on non-derivative instruments | 139 | 421 | |||
| Net defined benefit asset 1 | 556 | 567 | |||
| Others | 174 | 312 | |||
| Total other assets | 17,629 | 21,744 | |||
|
1
For more information on net defined benefit asset, refer Note 30 - Retirement Benefit Obligations
|
|||||
|
|
|||||
| Group | 2023 | 2022 | |||
| Other Liabilities (USD million) | |||||
| Brokerage payables | |||||
| Due to customers | 119 | 388 | |||
| Due to banks, brokers and dealers | 126 | 696 | |||
| Interest and fees payable | 613 | 942 | |||
| Cash collateral on derivative instruments | |||||
| Banks | 6,347 | 8,767 | |||
| Customers | 1,207 | 2,793 | |||
| Cash collateral on non-derivative instruments 2 | 239 | 2,497 | |||
| Share-based compensation liability | 37 | 53 | |||
| Others 1 | 337 | 539 | |||
| Total other liabilities | 9,025 | 16,675 | |||
|
1
Others for Bank is USD 337 million in 2023 and USD 538 million in 2022.
|
|||||
|
2
It includes USD 100 million (2022 USD: 2,050 million) inter-company deposit which is security for a separate guarantee agreement.
|
|||||
| Group and Bank (USD million) | 2023 | 2022 | |||
| Maturity of contractual lease liabilities | |||||
| Due within 1 year | 65 | 64 | |||
| Due between 1 and 2 years | 65 | 61 | |||
| Due between 2 and 3 years | 65 | 61 | |||
| Due between 3 and 4 years | 62 | 61 | |||
| Due between 4 and 5 years | 46 | 58 | |||
| Thereafter | 301 | 318 | |||
| Total | 604 | 623 | |||
| Future interest payable | (92) | (94) | |||
| Lease liabilities | 512 | 529 | |||
| Group and Bank | 2023 | 2022 | |||
| Property and equipment (USD million) | |||||
| Leasehold improvements | 12 | 230 | |||
| Equipment | 5 | 18 | |||
| Right of use assets | 10 | 124 | |||
| Property and equipment | 27 | 372 | |||
| Group and Bank (USD million) | 2023 | 2022 | ||
| Right- of- use assets (USD million) | ||||
| Balance as of 1 January | 124 | 134 | ||
| Less : | ||||
| Investment in Sub lease | (12) | – | ||
| Impairment | (53) | (3) | ||
| Lease modification | 16 | 15 | ||
| Retirement | (8) | (1) | ||
| Indexation | – | (11) | ||
| Depreciation | (57) | (10) | ||
| Balance as of 31 December | 10 | 124 | ||
| 2023 | 2022 | ||||||||||||
|
Group and Bank Property and equipment (USD million) |
Leasehold Improvements |
Equipment |
Total |
Leasehold Improvements |
Equipment |
Total |
|||||||
| Cost: | |||||||||||||
| Cost as at 1 January | 326 | 73 | 399 | 439 | 123 | 562 | |||||||
| Additions | 7 | – | 7 | 1 | 17 | 18 | |||||||
| Disposals | (6) | – | (6) | (111) | (59) | (170) | |||||||
| Transfer (out)/in | (1) | (3) | (4) | – | (8) | (8) | |||||||
| Impairment | (150) | (5) | (155) | (3) | – | (3) | |||||||
| Cost as at 31 December | 176 | 65 | 241 | 326 | 73 | 399 | |||||||
| Accumulated depreciation: | |||||||||||||
| Accumulated depreciation as at 1 January | (96) | (55) | (151) | (179) | (110) | (289) | |||||||
| Charge for the year | (68) | (5) | (73) | (28) | (9) | (37) | |||||||
| Disposals | – | – | – | 111 | 59 | 170 | |||||||
| Transfer (in)/out | – | – | – | – | 5 | 5 | |||||||
| Accumulated depreciation as at 31 December | (164) | (60) | (224) | (96) | (55) | (151) | |||||||
| Net book value as at 1 January | 230 | 18 | 248 | 260 | 13 | 273 | |||||||
| Net book value as at 31 December | 12 | 5 | 17 | 230 | 18 | 248 | |||||||
| Group and Bank | 2023 | 2022 | |||
| Group and Bank Intangible Assets (USD million) | Total | Total | |||
| Cost: | |||||
| Cost as at 1 January | 1,717 | 1,604 | |||
| Additions | 129 | 166 | |||
| Reclassification | (98) | – | |||
| Disposals | – | – | |||
| Impairment | (751) | (53) | |||
| Cost as at 31 December | 997 | 1,717 | |||
| Accumulated amortisation: | |||||
| Accumulated amortisation as at 1 January | (1,235) | (1,109) | |||
| Amortisation for the year | (98) | (149) | |||
| Impairment | 419 | 23 | |||
| Accumulated amortisation as at 31 December | (914) | (1,235) | |||
| Net book value as at 1 January | 482 | 495 | |||
| Net book value as at 31 December | 83 | 1 | 482 | ||
|
1
Intangible Assets includes Work-in-progress of USD 5 million (2022: USD 132 million) and not subject to amortisation.
|
|||||
| Group and Bank | Property | Litigation | Total | ||||
| 2023 Provisions (USD million) | |||||||
| Balance at 1 January 2023 | 16 | 29 | 45 | ||||
| Charges/Additions during the year | 151 | 172 | 323 | ||||
| Released during the year | – | – | – | ||||
| Utilised during the year | (4) | (196) | (200) | ||||
| Balance at 31 December 2023 | 163 | 5 | 168 | ||||
| 2022 Provisions (USD million) | |||||||
| Balance at 1 January 2022 | 15 | 298 | 313 | ||||
| Charges/Additions during the year | 3 | 128 | 131 | ||||
| Released during the year | – | (17) | (17) | ||||
| Utilised during the year | – | (380) | (380) | ||||
| Revaluation | (2) | – | (2) | ||||
| Balance at 31 December 2022 | 16 | 29 | 45 | ||||
| Building | Provision | Utilisation period | |||
| 5 Canada Square, London | USD 2 million | 30 October 2027 | |||
| 5 Canada Square | USD 3 million | 31 December 2027 | |||
| Global Switch | USD 2 million | 30 September 2025 |
| Group | Bank | ||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||
| Debt in issuance (USD million) | |||||||||
| Senior debt | 8,108 | 18,306 | 8,108 | 18,305 | |||||
| Subordinated debt | – | 3 | – | 3 | |||||
| Total debt in issuance | 8,108 | 18,309 | 8,108 | 18,308 | |||||
|
Group Category of instrument |
Counterparty Name |
Currency |
2023 (In USD million) |
2022 (In USD million) |
Interest Rate Type |
||||||
| Senior Debt | |||||||||||
| CS AG, London Branch | EUR | 1,107 | 1 | 8,990 | 1 | Variable | |||||
| CS AG, London Branch | GBP | – | 2,317 | Variable | |||||||
| CS AG, London Branch | USD | 4,586 | 4,586 | Variable | |||||||
| DLJ Group | USD | 2,405 | 2,405 | Fixed | |||||||
| DLJ UK Holding | USD | 8 | 8 | Fixed | |||||||
| ARGENTUM CAPITAL S.A. A/C ARGENTUM CAPITAL SA - SERIES 2022-26 | USD | 2 | – | Variable | |||||||
| Total Senior debt | 8,108 | 1 | 18,306 | 1 | |||||||
| Subordinated Bonds | |||||||||||
| Credit Suisse First Boston Finance B.V. | USD | – | 3 | Variable | |||||||
| Total Subordinated debt | – | 3 | |||||||||
|
1
For Bank, this number is USD 1,107 million (2022: USD 8,989 million) and the total senior debt is USD 8,108 million (2022: USD 18,305 million).
|
|||||||||||
|
Cash Flows |
Non Cash Changes |
||||||||||
|
Debt in issuance (USD million) |
Balance as at 1 January |
Issuances |
Repayments |
Transactional FX |
Balance as at 31 December |
||||||
| 2023 | |||||||||||
| Group | 18,309 | 8,452 | (19,039) | 386 | 8,108 | ||||||
| Bank | 18,308 | 8,452 | (19,038) | 386 | 8,108 | ||||||
| 2022 | |||||||||||
| Group | 40,224 | 646 | (20,218) | (2,343) | 18,309 | ||||||
| Bank | 40,224 | 645 | (20,218) | (2,343) | 18,308 | ||||||
|
Group and Bank |
Cash flow hedges |
Gains/ (losses) on designated financial liabilities relating to credit risk |
Unrealised Gains/ (losses) on Pension Fund |
Accumu- lated other compre- hensive income |
|||||
| Accumulated other comprehensive income (USD million) | |||||||||
| Balance at 1 January 2023 | (9) | 15 | (407) | (401) | |||||
| (Increase)/decrease: | |||||||||
| Unrealised loss on designated financial liabilities relating to credit risk | – | (23) | – | (23) | |||||
| Related tax on unrealised gain/ (loss) on designated financial liabilities relating to credit risk | – | 3 | – | 3 | |||||
| Cash flow hedges – effective portion of changes in fair value | 12 | – | – | 12 | |||||
| Remeasurement of defined benefit pension assets | – | – | (56) | (56) | |||||
| Related tax on remeasurement of defined benefit pension assets | – | – | 16 | 16 | |||||
| Balance at 31 December 2023 | 3 | (5) | (447) | (449) | |||||
| Balance at 1 January 2022 | (9) | (12) | (139) | (160) | |||||
| (Increase)/decrease: | |||||||||
| Realised gain relating to credit risk on designated financial liabilities extinguished during year reclassed to retained earnings | – | (1) | – | (1) | |||||
| Unrealised gain on designated financial liabilities relating to credit risk | – | 31 | – | 31 | |||||
| Related tax on unrealised gain/ (loss) on designated financial liabilities relating to credit risk | – | (3) | – | (3) | |||||
| Cash flow hedges – effective portion of changes in fair value | 3 | – | – | 3 | |||||
| Related tax on cash flow hedges – effective portion of changes in fair value | (3) | – | – | (3) | |||||
| Remeasurement of defined benefit pension assets | – | – | (358) | (358) | |||||
| Related tax on remeasurement of defined benefit pension assets | – | – | 90 | 90 | |||||
| Balance at 31 December 2022 | (9) | 15 | (407) | (401) | |||||
| Group and Bank | 2023 | 2022 | |||
| Share Capital Allotted called-up and fully paid (USD million) | |||||
| Total allotted called-up and fully paid capital as at 1 January 2023 | |||||
| 131,158,070,611 Ordinary shares of USD 0.08666 each | 11,366 | 11,366 | |||
| 26 September 2023: | |||||
| Capital reduction of Ordinary shares (131,158,070,611 of USD 0.03125 each) | (4,099) | – | |||
| Total allotted called-up and fully paid capital as at 31 December 2023 | |||||
| 131,158,070,611 Ordinary shares of USD 0.05541 each | 7,267 | 11,366 | |||
| Capital Contribution | |||||
| Capital Contribution | 887 | 887 | |||
| Not credit impaired | Credit impaired | ||||||||||||||||
| Group and Bank |
12 Month ECL Stage 1 |
Lifetime ECL Stage 2 |
Lifetime ECL (excluding purchased / originated credit impaired) Stage 3 |
Total |
Total |
||||||||||||
|
2023 |
Gross carrying amount |
Allowance for ECL |
Gross carrying amount |
Allowance for ECL |
Gross carrying amount |
Allowance for ECL |
Gross carrying amount |
Allowance for ECL |
|||||||||
| Loans and advances (USD million) | |||||||||||||||||
| Opening balance | 2,717 | 4 | 29 | 1 | 28 | 15 | 2,774 | 20 | |||||||||
| Transfer to 12 Month ECL | 4 | 1 | (4) | (1) | – | – | – | – | |||||||||
| Transfer to lifetime ECL not credit impaired | (68) | – | 68 | (1) | – | – | – | (1) | |||||||||
| Transfer to lifetime ECL credit impaired financial assets | (53) | – | – | – | 53 | 51 | – | 51 | |||||||||
| Net remeasurement of loss allowance | – | – | – | 31 | – | – | – | 31 | |||||||||
| New financial assets originated or purchased | 548 | 1 | 62 | – | 2 | – | 612 | 1 | |||||||||
| Financial assets that have been derecognised (including write-offs) | (77) | (2) | (10) | – | (9) | – | (96) | (2) | |||||||||
| Changes in Model/ Risk parameters (model inputs) used for ECL calculation | – | – | – | – | – | 1 | – | 1 | |||||||||
| Other changes | – | – | – | – | – | – | – | – | |||||||||
| Foreign exchange | – | – | – | – | – | – | – | – | |||||||||
| Closing balance | 3,071 | 4 | 145 | 30 | 74 | 67 | 3,290 | 101 | |||||||||
| 2022 | |||||||||||||||||
| Loans and advances (USD million) | |||||||||||||||||
| Opening balance | 2,682 | 4 | 29 | – | 14 | 8 | 2,725 | 12 | |||||||||
| Transfer to 12 Month ECL | – | – | – | – | – | – | – | – | |||||||||
| Transfer to lifetime ECL not credit impaired | (4) | (1) | 10 | 1 | (6) | – | – | – | |||||||||
| Transfer to lifetime ECL credit impaired financial assets | (5) | – | (7) | – | 12 | – | – | – | |||||||||
| Net remeasurement of loss allowance | – | – | – | – | – | – | – | – | |||||||||
| New financial assets originated or purchased | 117 | 3 | – | – | 8 | 7 | 125 | 10 | |||||||||
| Financial assets that have been derecognised (including write-offs) | (73) | (2) | (3) | – | – | – | (76) | (2) | |||||||||
| Other changes | – | – | – | – | – | – | – | – | |||||||||
| Foreign exchange | – | – | – | – | – | – | – | – | |||||||||
| Closing balance | 2,717 | 4 | 29 | 1 | 28 | 15 | 2,774 | 20 | |||||||||
| Not credit impaired | Credit impaired | ||||||||||||||||
| Group and Bank |
12 Month ECL Stage 1 |
Lifetime ECL Stage 2 |
Lifetime ECL (excluding purchased / originated credit impaired) Stage 3 |
Total |
Total |
||||||||||||
|
2023 |
Gross commitment amount |
Allowance for ECL |
Gross commitment amount |
Allowance for ECL |
Gross commitment amount |
Allowance for ECL |
Gross commitment amount |
Allowance for ECL |
|||||||||
| Loan commitments (USD million) | |||||||||||||||||
| Opening balance | 985 | 2 | 186 | 1 | – | – | 1,171 | 3 | |||||||||
| Transfer to 12 Month ECL | 180 | 1 | (180) | (1) | – | – | – | – | |||||||||
| Transfer to lifetime ECL not credit impaired | (2) | – | 2 | – | – | – | – | – | |||||||||
| Transfer to Lifetime ECL Credit Impaired Financial Liabilities | – | – | – | – | – | – | – | – | |||||||||
| Net remeasurement of Loss Allowance | – | – | – | – | – | – | – | – | |||||||||
| New financial liabilities originated or purchased | 70 | – | – | – | – | – | 70 | – | |||||||||
| Financial liabilities that have been derecognised (including write-offs) | (758) | (2) | (6) | – | – | – | (764) | (2) | |||||||||
| Other changes | – | – | – | – | – | – | – | – | |||||||||
| Foreign exchange | – | – | – | – | – | – | – | – | |||||||||
| Closing balance | 475 | 1 | 2 | – | – | – | 477 | 1 | |||||||||
| 2022 | |||||||||||||||||
| Loan commitments (USD million) | |||||||||||||||||
| Opening balance | 1,192 | 3 | 116 | – | 4 | 2 | 1,312 | 5 | |||||||||
| Transfer to 12 Month ECL | – | – | – | – | – | – | – | – | |||||||||
| Transfer to lifetime ECL not credit impaired | (48) | – | 52 | 2 | (4) | (2) | – | – | |||||||||
| Transfer to Lifetime ECL Credit Impaired Financial Liabilities | – | – | – | – | – | – | – | – | |||||||||
| Net remeasurement of Loss Allowance | – | – | – | – | – | – | – | – | |||||||||
| New financial liabilities originated or purchased | 37 | – | 27 | 1 | – | – | 64 | 1 | |||||||||
| Financial liabilities that have been derecognised (including write-offs) | (196) | (1) | (9) | (2) | – | – | (205) | (3) | |||||||||
| Other changes | – | – | – | – | – | – | – | – | |||||||||
| Foreign exchange | – | – | – | – | – | – | – | – | |||||||||
| Closing balance | 985 | 2 | 186 | 1 | – | – | 1,171 | 3 | |||||||||
| 2023 | 2022 | ||||
| Interest bearing deposits (USD million) | |||||
| Opening balance | 1 | – | |||
| Net remeasurement of loss allowance | (1) | 1 | |||
| Closing balance | – | 1 | |||
| Group and Bank | 2023 | 2022 | |||
| Other assets- Stage 3 (USD million) | |||||
| Opening balance | 4,374 | 4,540 | |||
| Net remeasurement of loss allowance | (4,374) | (166) | |||
| Foreign exchange | – | – | |||
| Closing balance | – | 4,374 | |||
| Group and Bank | 2023 | 2022 | |||
| Cash and due from banks- Stage 3 (USD million) | |||||
| Opening balance | – | – | |||
| Net remeasurement of loss allowance | 10 | 1 | – | ||
| Foreign exchange | – | – | |||
| Closing balance | 10 | – | |||
|
1
The allowance relates to nostro balances with sanctioned counterparties.
|
|||||
|
Function- Corporates/ Financial Institutions |
ECL Scenario |
Assigned Probabili- ties |
Latest data |
1 |
End Period Projections |
Impact on ECL from an increase in MEF |
|||||||||||||||
|
As at 31 December 2023 Macroeconomic Factors (MEF) |
|
|
% |
December 23 % |
2024 % |
2025 % |
2026 % |
2027 % |
2028 % |
|
|||||||||||
| Eurozone Real GDP Growth Rate (%YoY) |
|
||||||||||||||||||||
| Both | Downside | 15 | -0.8 | -1.1 | 0.5 | 1.7 | 1.5 | 1.1 | |||||||||||||
| Both | Baseline | 60 | 0.0 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | |||||||||||||
| Both | Severe Downside | 25 | -2.4 | -3.8 | -0.5 | 1.1 | 1.2 | 1.1 | |||||||||||||
| US Real GDP (%YoY) |
|
||||||||||||||||||||
| Global Corporates | Downside | 15 | 1.7 | -1.0 | 0.8 | 1.9 | 1.9 | 1.8 | |||||||||||||
| Global Corporates | Baseline | 60 | 2.0 | 1.0 | 2.5 | 1.8 | 1.8 | 1.8 | |||||||||||||
| Global Corporates | Severe Downside | 25 | 0.4 | -3.5 | -0.4 | 1.8 | 1.9 | 1.8 | |||||||||||||
| US Nominal GDP (%YoY) |
|
||||||||||||||||||||
| Fallback IB | Downside | 15 | 3.9 | -1.1 | 1.8 | 3.9 | 3.9 | 3.8 | |||||||||||||
| Fallback IB | Baseline | 60 | 6.6 | 2.4 | 4.2 | 3.8 | 3.8 | 3.8 | |||||||||||||
| Fallback IB | Severe Downside | 25 | 6.5 | 3.3 | 2.3 | 3.9 | 3.9 | 3.8 | |||||||||||||
| iTraxx Crossover 3Y (Basis points) |
|
||||||||||||||||||||
| Global Corporates | Downside | 15 | 461.4 | 676.2 | 619.8 | 482.0 | 405.2 | 328.3 | |||||||||||||
| Global Corporates | Baseline | 60 | 364.1 | 388.3 | 388.3 | 384.5 | 353.5 | 322.6 | |||||||||||||
| Global Corporates | Severe Downside | 25 | 559.6 | 1,034.5 | 1,000.8 | 860.7 | 605.7 | 350.6 | |||||||||||||
| CDX HY (Basis points) |
|
||||||||||||||||||||
| Global Corporates | Downside | 15 | 540.3 | 791.9 | 725.9 | 562.7 | 459.1 | 355.5 | |||||||||||||
| Global Corporates | Baseline | 60 | 388.3 | 402.9 | 405.1 | 401.8 | 373.9 | 346.0 | |||||||||||||
| Global Corporates | Severe Downside | 25 | 655.3 | 1,211.9 | 1,172.4 | 1,006.5 | 694.1 | 381.6 | |||||||||||||
| iTraxx Senior Financial 5Y (Basis points) |
|
||||||||||||||||||||
| Financial Institutions | Downside | 15 | 130.4 | 167.6 | 147.8 | 120.6 | 101.5 | 82.4 | |||||||||||||
| Financial Institutions | Baseline | 60 | 81.3 | 87.5 | 89.2 | 89.0 | 84.7 | 80.5 | |||||||||||||
| Financial Institutions | Severe Downside | 25 | 144.8 | 246.3 | 210.5 | 197.8 | 142.3 | 86.9 | |||||||||||||
|
1
Latest estimates have been used for the MEFs used for 4Q23 ECL valuation
|
|||||||||||||||||||||
|
Function- Corporates/ Financial Institutions |
ECL Scenario |
Assigned Probabili- ties |
Latest data |
1 |
End Period Projections |
Impact on ECL from an increase in MEF |
|||||||||||||||
|
As at 31 December 2022 EMEA Macroeconomic Factors (MEF) |
|
|
% |
December 22 % |
2023 % |
2024 % |
2025 % |
2026 % |
2027 % |
|
|||||||||||
| Eurozone Real GDP Growth Rate (%YoY) |
|
||||||||||||||||||||
| Both | Downside | 40 | 0.7 | -2.1 | 0.4 | 1.3 | 1.4 | 1.4 | |||||||||||||
| Both | Baseline | 50 | 0.8 | 0.7 | 1.6 | 1.6 | 1.4 | 1.4 | |||||||||||||
| Both | Upside | 10 | 1.1 | 1.4 | 1.7 | 1.6 | 1.4 | 1.4 | |||||||||||||
| G10 Real GDP Growth Rate (%YoY) |
|
||||||||||||||||||||
| Corporates | Downside | 40 | 2.0 | -1.5 | 0.5 | 1.1 | 1.4 | 1.4 | |||||||||||||
| Corporates | Baseline | 50 | 2.4 | 0.4 | 1.5 | 1.7 | 1.5 | 1.4 | |||||||||||||
| Corporates | Upside | 10 | 3.3 | 0.9 | 1.9 | 2.0 | 1.6 | 1.4 | |||||||||||||
| Eurostoxx 50 Market Volatility Index (V2X Qmax, levels) |
|
||||||||||||||||||||
| Financial Institutions | Downside | 40 | 40.0 | 45.8 | 32.5 | 27.9 | 27.3 | 26.7 | |||||||||||||
| Financial Institutions | Baseline | 50 | 35.0 | 29.0 | 28.4 | 27.9 | 27.3 | 26.7 | |||||||||||||
| Financial Institutions | Upside | 10 | 33.6 | 23.5 | 24.5 | 27.9 | 27.3 | 26.7 | |||||||||||||
|
1
Latest estimates have been used for the MEFs used for 4Q22 ECL valuation
|
|||||||||||||||||||||
|
Function- Corporates/ Financial Institutions |
ECL Scenario |
Assigned Probabili- ties |
Latest data |
1 |
End Period Projections |
Impact on ECL from an increase in MEF |
|||||||||||||||
|
As at 31 December 2022 NORTH AMERICA Macroeconomic Factors (MEF) |
|
|
% |
December 22 % |
2023 % |
2024 % |
2025 % |
2026 % |
2027 % |
|
|||||||||||
| US Unemployment Rate (%) |
|
||||||||||||||||||||
| Both | Downside | 40 | 3.9 | 5.6 | 4.8 | 4.6 | 4.3 | 4.1 | |||||||||||||
| Both | Baseline | 50 | 3.5 | 3.7 | 4.4 | 4.2 | 4.1 | 4.0 | |||||||||||||
| Both | Upside | 10 | 3.4 | 2.9 | 3.6 | 4.0 | 4.1 | 4.0 | |||||||||||||
| US Real GDP Growth Rate (%YoY) |
|
||||||||||||||||||||
| Corporates | Downside | 40 | -0.1 | -2.0 | 1.1 | 1.1 | 1.6 | 1.5 | |||||||||||||
| Corporates | Baseline | 50 | 0.3 | 0.8 | 2.1 | 1.6 | 1.6 | 1.5 | |||||||||||||
| Corporates | Upside | 10 | 0.5 | 1.0 | 2.6 | 1.9 | 1.7 | 1.5 | |||||||||||||
| World Industrial Production (%YoY) |
|
||||||||||||||||||||
| Corporates | Downside | 40 | 1.2 | -6.4 | 0.9 | 1.4 | 1.7 | 1.8 | |||||||||||||
| Corporates | Baseline | 50 | 2.5 | 1.6 | 1.8 | 1.8 | 1.8 | 1.8 | |||||||||||||
| Corporates | Upside | 10 | 4.2 | 3.6 | 4.0 | 2.8 | 1.9 | 1.8 | |||||||||||||
| Dow Jones Total Stock Market Index (levels) |
|
||||||||||||||||||||
| Financial Institutions | Downside | 40 | 37,000 | 28,087 | 36,610 | 43,378 | 44,880 | 46,383 | |||||||||||||
| Financial Institutions | Baseline | 50 | 41,226 | 40,380 | 41,878 | 43,378 | 44,880 | 46,383 | |||||||||||||
| Financial Institutions | Upside | 10 | 41,383 | 44,090 | 43,469 | 43,378 | 44,880 | 46,383 | |||||||||||||
| US Market Volatility Index (VIX Qmax, levels) |
|
||||||||||||||||||||
| Financial Institutions | Downside | 40 | 40.0 | 44.5 | 31.3 | 26.5 | 25.8 | 25.0 | |||||||||||||
| Financial Institutions | Baseline | 50 | 35.0 | 28.0 | 27.3 | 26.5 | 25.8 | 25.0 | |||||||||||||
| Financial Institutions | Upside | 10 | 33.6 | 23.5 | 23.8 | 26.5 | 25.8 | 25.0 | |||||||||||||
|
1
Latest estimates have been used for the MEFs used for 4Q22 ECL valuation
|
|||||||||||||||||||||
| UK DB Plan | |||||
| Group and Bank | 2023 | 2022 | |||
| Defined benefit pension plans (USD million) | |||||
| Operating Cost | |||||
| Current service costs on benefit obligation | 2 | 1 | |||
| Past service costs (including curtailments) | – | 4 | |||
| Administrative expense | 2 | 2 | |||
| Financing Cost | |||||
| Net Interest credits | (29) | (16) | |||
| Defined benefit costs/(credits) | (25) | (9) | |||
| UK DB Plan | |||||
| Group and Bank | 2023 | 2022 | |||
| Defined benefit pension plans (USD million) | |||||
| Defined benefit obligation – 1 January | 1,008 | 1,904 | |||
| Current service cost | 2 | 1 | |||
| Interest cost | 50 | 30 | |||
| Actuarial gains on assumptions | (25) | (734) | |||
| arising out of changes in demographic assumptions | (12) | (1) | |||
| arising out of changes in financial assumptions | (13) | (733) | |||
| Actuarial (gains)/losses - experience | 25 | 40 | |||
| Benefit payments | (30) | (33) | |||
| Past service costs (including curtailments) | – | 4 | |||
| Exchange rate gains/(losses) | 57 | (204) | |||
| Defined benefit obligation – 31 December | 1,087 | 1,008 | |||
| Fair value of plan assets – 1 January | 1,575 | 2,928 | |||
| Interest on plan assets | 79 | 46 | |||
| Actuarial losses on plan assets | (56) | (1,052) | |||
| Actual return on plan assets | 23 | (1,006) | |||
| Employer contributions | (11) | – | |||
| Administrative expense | (2) | (2) | |||
| Benefit payments | (30) | (33) | |||
| Exchange rate gains/(losses) | 88 | (312) | |||
| Fair value of plan assets – 31 December | 1,643 | 1,575 | |||
| Total funded status – 31 December | |||||
| Plan assets | 1,643 | 1,575 | |||
| Defined benefit obligation related to funded plans | (1,087) | (1,008) | |||
| Funded status for funded plans | 556 | 567 | |||
| Funded status recognised – 31 December | 556 | 567 | |||
| Group and Bank | 2023 | 2022 | |||
| Benefit obligation (%) | |||||
| Discount rate | 4.80% | 4.78% | |||
| Retail Price Inflation | 3.02% | 3.22% | |||
| Consumer Price Inflation | 2.40% | 2.43% | |||
| Pension increases 1 | 2.81% | 2.98% | |||
| Salary increases | 3.65% | 3.68% | |||
| Defined benefit cost (%) | |||||
| Discount rate - Service cost | 5.13% | 1.82% | |||
| Discount rate - Interest cost | 5.18% | 1.75% | |||
| Salary increases | 3.68% | 3.81% | |||
|
1
Pensions earned pre 6 April 1997 which are subject to pension increases on a discretionary basis are considered to be Nil.
|
|||||
| 2023 | 2022 | ||||
| Life expectancy at age 60 for current pensioners aged 60 (years) | |||||
| Males | 27.8 | 28.3 | |||
| Females | 29.6 | 30.0 | |||
| Life expectancy at age 60 for future pensioners currently aged 40 (years) | |||||
| Males | 29.3 | 29.8 | |||
| Females | 31.0 | 31.4 | |||
|
Defined Benefit obligation |
Defined Benefit Obligation (USD million) |
Increase % |
Defined Benefit Obligation (USD million) |
Decrease % |
|||||
| 2023 | |||||||||
| One-percentage point change | |||||||||
| - 1%/ +1% Discount rate | 1,277 | 17 | 937 | (14) | |||||
| +1% / -1% Inflation rate | 1,186 | 9 | 999 | (8) | |||||
| +1% / -1% Salary increases rate | 1,088 | – | 1,087 | – | |||||
| +1 / -1 year to life expectancy at 60 | 1,117 | 3 | 1,057 | (3) | |||||
| 2022 | |||||||||
| One-percentage point change | |||||||||
| - 1%/ +1% Discount rate | 1,197 | 19 | 860 | (15) | |||||
| +1% / -1% Inflation rate | 1,107 | 10 | 920 | (9) | |||||
| +1% / -1% Salary increases rate | 1,010 | – | 1,007 | – | |||||
| +1 / -1 year to life expectancy at 60 | 1,035 | 3 | 981 | (3) | |||||
|
Quoted |
Un- quoted |
Total |
% of total fair value of scheme assets |
||||||
| Plan assets measured at fair value (USD million) | |||||||||
| 2023 | |||||||||
| Cash and cash equivalents | – | 262 | 262 | 15.9% | |||||
| Debt Securities | 1,393 | – | 1,393 | 84.8% | |||||
| of which governments | 1,159 | – | 1,159 | 70.5% | |||||
| of which corporates | 234 | – | 234 | 14.2% | |||||
| Derivatives | – | (12) | (12) | (0.7)% | |||||
| Total plan assets UK Plans | 1,393 | 250 | 1,643 | 100.0% | |||||
| 2022 | |||||||||
| Cash and cash equivalents | – | 110 | 110 | 7.0% | |||||
| Debt Securities | 1,529 | – | 1,529 | 97.1% | |||||
| of which governments | 1,307 | – | 1,307 | 83.0% | |||||
| of which corporates | 222 | – | 222 | 14.1% | |||||
| Derivatives | – | (64) | (64) | (4.1)% | |||||
| Total plan assets UK Plans | 1,529 | 46 | 1,575 | 100.0% | |||||
| Group and Bank | 2023 | 2022 | |||
| Number of units (millions) | |||||
| As at 1 January | 15.49 | 14.07 | |||
| Granted | 24.59 | 8.93 | |||
| Shares transferred in/out | (0.15) | 0.16 | |||
| Delivered | (4.48) | (6.71) | |||
| Forfeited | (1.26) | (0.96) | |||
| Conversion to UBS Shares | (33.09) | – | |||
| As at 31 December | 1.10 | 15.49 | |||
| Group and Bank | 2023 | 2022 | |||
| Number of units (millions) | |||||
| As at 1 January | 8.72 | 13.48 | |||
| Granted | (0.44) | 1 | (0.46) | 1 | |
| Shares transferred in/out | 0.02 | 0.24 | |||
| Delivered | (2.86) | (3.43) | |||
| Forfeited | (0.68) | (1.11) | |||
| Conversion to UBS shares | (4.58) | – | |||
| As at 31 December | 0.18 | 8.72 | |||
|
1
Includes downward adjustment applied to outstanding performance share awards.
|
|||||
| Group and Bank | 2023 | 2022 | |||
| SDP Stock Awards (millions) | |||||
| As at 1 January | 6.04 | – | |||
| Granted | (0.37) | 6.68 | |||
| Share transferred in/out | 0.02 | 0.02 | |||
| Delivered | – | – | |||
| Forfeited | (0.29) | (0.66) | |||
| Conversion to UBS share | (5.18) | – | |||
| As at 31 December | 0.22 | 6.04 | |||
| Group and Bank | 2023 | 2022 | |||
| Transformation Phantom Share awards (millions) | |||||
| As at 1 January | – | – | |||
| Granted | 5.55 | – | |||
| Share transferred in/out | – | – | |||
| Delivered | – | – | |||
| Forfeited | (0.02) | – | |||
| Conversion to UBS share | (5.31) | – | |||
| As at 31 December | 0.22 | – | |||
| 31 December 2023 | 31 December 2022 | ||||||||||||
|
Group |
Parent |
1 |
Fellow group companies |
Total |
Parent |
2 |
Fellow group companies |
Total |
|||||
| Assets (USD million) | |||||||||||||
| Cash and due from banks | 2,905 | 45 | 2,950 | 2,898 | 22 | 2,920 | |||||||
| Interest-bearing deposits with banks | 8,319 | – | 8,319 | 12,086 | – | 12,086 | |||||||
| Securities purchased under resale agreements and securities borrowing transactions | 601 | 695 | 1,296 | 8,447 | 1,985 | 10,432 | |||||||
| Trading financial assets mandatorily at fair value through profit or loss | 19,373 | 4,334 | 23,707 | 25,530 | 4,909 | 30,439 | |||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 2,426 | 1,106 | 3,532 | 5,524 | 4,017 | 9,541 | |||||||
| Loans and advances | 665 | 2,504 | 3,169 | 167 | 2,504 | 2,671 | |||||||
| Other assets | 218 | 1,776 | 1,994 | 745 | 1,598 | 2,343 | |||||||
| Total assets | 34,507 | 10,460 | 44,967 | 55,397 | 15,035 | 70,432 | |||||||
| Liabilities and Equity (USD million) | |||||||||||||
| Due to banks | – | 1 | 1 | 8 | – | 8 | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 42 | 311 | 353 | 1,686 | 1,160 | 2,846 | |||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 16,768 | 4,485 | 21,253 | 20,534 | 5,722 | 26,256 | |||||||
| Financial liabilities designated at fair value through profit or loss | 7,043 | 1,801 | 8,844 | 9,997 | 3,352 | 13,349 | |||||||
| Borrowings | 12,622 | – | 12,622 | 6,025 | – | 6,025 | |||||||
| Debt in issuance | 5,693 | 2,413 | 8,106 | 15,892 | 2,416 | 18,308 | |||||||
| Other liabilities | 2,094 | 617 | 2,711 | 6,293 | 607 | 6,900 | |||||||
| Share capital | 7,267 | – | 7,267 | 11,366 | – | 11,366 | |||||||
| Other Equity Instrument | 1,200 | – | 1,200 | 1,200 | – | 1,200 | |||||||
| Total liabilities and equity | 52,729 | 9,628 | 62,357 | 73,001 | 13,257 | 86,258 | |||||||
|
1
The term parent refers to the ultimate parent, UBS Group AG (for 2023) above table includes other liabilities balances with UBS Group AG of Nil (2022: Nil).
|
|||||||||||||
|
2
The term parent refers to the immediate parent, Credit Suisse AG and also the ultimate parent CSG. Above table includes other liabilities balances with CSG of USD NIL (2022: USD 135 million)
|
|||||||||||||
| 31 December 2023 | 31 December 2022 | |||||||||||||||
|
Bank |
Parent |
1 |
Fellow group companies |
Subsidiaries |
Total |
Parent |
2 |
Fellow group companies |
Subsidiaries |
Total |
||||||
| Assets (USD million) | ||||||||||||||||
| Cash and due from banks | 2,905 | 45 | – | 2,950 | 2,898 | 22 | – | 2,920 | ||||||||
| Interest-bearing deposits with banks | 8,319 | – | – | 8,319 | 12,086 | – | – | 12,086 | ||||||||
| Securities purchased under resale agreements and securities borrowing transactions | 601 | 695 | – | 1,296 | 8,446 | 1,985 | – | 10,431 | ||||||||
| Trading financial assets mandatorily at fair value through profit or loss | 19,373 | 4,334 | (33) | 23,674 | 25,530 | 4,909 | 120 | 30,559 | ||||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 2,229 | 1,106 | 4 | 3,339 | 5,356 | 4,017 | 8 | 9,381 | ||||||||
| Loans and advances | 665 | 2,504 | – | 3,169 | 167 | 2,504 | – | 2,671 | ||||||||
| Other assets | 223 | 1,771 | – | 1,994 | 746 | 1,598 | – | 2,344 | ||||||||
| Total assets | 34,315 | 10,455 | (29) | 44,741 | 55,229 | 15,035 | 128 | 70,392 | ||||||||
| Liabilities and Equity (USD million) | ||||||||||||||||
| Due to banks | – | 1 | – | 1 | 8 | – | – | 8 | ||||||||
| Securities sold under repurchase agreements and securities lending transactions | 43 | 311 | – | 354 | 1,687 | 1,160 | – | 2,847 | ||||||||
| Trading financial liabilities at fair value through profit or loss | 16,767 | 4,485 | 159 | 21,411 | 20,533 | 5,722 | (262) | 25,993 | ||||||||
| Financial liabilities designated at fair value through profit or loss | 7,043 | 1,801 | (1) | 8,843 | 9,997 | 3,352 | – | 13,349 | ||||||||
| Borrowings | 12,622 | – | – | 12,622 | 6,025 | – | – | 6,025 | ||||||||
| Debt in issuance | 5,693 | 2,414 | – | 8,107 | 15,892 | 2,417 | – | 18,309 | ||||||||
| Other liabilities | 2,099 | 616 | – | 2,715 | 6,293 | 606 | – | 6,899 | ||||||||
| Share capital | 7,267 | – | – | 7,267 | 11,366 | – | – | 11,366 | ||||||||
| Other Equity Instrument | 1,200 | – | – | 1,200 | 1,200 | – | – | 1,200 | ||||||||
| Total liabilities and equity | 52,734 | 9,628 | 158 | 62,520 | 73,001 | 13,257 | (262) | 85,996 | ||||||||
|
1
The term parent refers to the ultimate parent, UBS Group AG (for 2023) above table includes other liabilities balances with UBS Group AG of Nil (2022: Nil).
|
||||||||||||||||
|
2
The term parent refers to the immediate parent, Credit Suisse AG and also the ultimate parent CSG. Above table includes other liabilities balances with CSG of USD NIL (2022:USD 135 million)
|
||||||||||||||||
| 31 December 2023 | 31 December 2022 | ||||||||||||
|
Group and Bank (USD million) |
Parent |
Fellow group companies |
Total |
Parent |
Fellow group companies |
Total |
|||||||
| Guarantees and Commitments | |||||||||||||
| Irrevocable loan commitments | – | 173 | 173 | – | 173 | 173 | |||||||
| Gross Irrevocable Loan commitments | – | 173 | 173 | – | 173 | 173 | |||||||
| Irrevocable Loan commitments - sub-participation | – | – | – | – | – | – | |||||||
| Net Irrevocable Loan commitments | – | 173 | 173 | – | 173 | 173 | |||||||
| 2023 | 2022 | ||||||||||||
|
Group (USD million) |
Parent |
2 |
Fellow group companies |
Total |
Parent |
3 |
Fellow group companies |
Total |
|||||
| Interest income | 920 | 709 | 1,629 | 519 | 438 | 957 | |||||||
| Interest expense | (1,599) | (357) | (1,956) | (936) | (210) | (1,146) | |||||||
| Net interest expense | (679) | 352 | (327) | (417) | 228 | (189) | |||||||
| Commissions and fees | 22 | (35) | (13) | 35 | (47) | (12) | |||||||
| Transfer pricing arrangements | 12 | 41 | 53 | 36 | 107 | 143 | |||||||
| Other revenue | (2) | (32) | (34) | 18 | – | 18 | |||||||
| Total non-interest revenues | 32 | (26) | 6 | 89 | 60 | 149 | |||||||
| Net operating income | (647) | 326 | (321) | (328) | 288 | (40) | |||||||
| Total operating expenses 1 | (585) | (467) | (1,052) | (547) | (688) | (1,235) | |||||||
|
1
Net overheads allocated to other CS group entities of USD 180 million (2022: USD 220 million) are not included in the Total operating expenses.
|
|||||||||||||
|
2
Above table includes commission and fees with UBS Group AG of USD Nil (2022: Nil) and operating expenses balances with UBS Group AG of USD 7 million (2022: Nil)
|
|||||||||||||
|
3
Above table includes commission and fees with CSG of USD NIL (2022: USD 60 million) and operating expenses balances with CSG of USD NIL (2022: USD 2 million)
|
|||||||||||||
| (USD '000) | 2023 | 2022 | |||
| Emoluments | 4,435 | 5,677 | |||
| Long term incentive schemes: | |||||
| Amounts Paid under Deferred Cash Awards | 654 | 402 | |||
| Amounts Delivered under Share Based Awards | 544 | 963 | |||
| Total | 5,633 | 7,042 | |||
| Compensation for loss of office | 950 | 95 | |||
| Bank’s contributions to defined contribution | 56 | 12 | |||
| Total | 6,639 | 7,149 |
| (Number of Directors) | 2023 | 2022 | |||
| Retirement benefits are accruing to the following number of Directors under: | |||||
| Defined contribution schemes | 3 | 2 | |||
| No scheme | 9 | 8 | |||
| Directors in respect of whom services were received or receivable under long term incentive scheme | 5 | 4 |
| (USD’ 000) | 2023 | 2022 | |||
| Remuneration of Key Management Personnel | |||||
| Emoluments | 11,717 | 18,274 | |||
| Long term incentive schemes | 1,874 | (11,491) | |||
| Total | 13,591 | 6,783 | |||
| Compensation for loss of office | 398 | 393 | |||
| Bank’s contributions to defined contribution plan | 200 | 158 | |||
| Total | 14,189 | 7,334 | |||
| 2023 | 1 | 2022 | 1 | ||
| Number of shares | 115,589 | 3,090,376 | |||
|
1
2023 number of shares are UBS shares and 2022 number of shares were CS shares.
|
|||||
| 31 December 2023 | 31 December 2022 | ||||||||||||||||
| Trading | Hedging | Trading | Hedging | ||||||||||||||
|
Group |
Gross Derivative Assets |
Gross Derivative Liabilities |
Gross Derivative Assets |
Gross Derivative Liabilities |
Gross Derivative Assets |
Gross Derivative Liabilities |
Gross Derivative Assets |
Gross Derivative Liabilities |
|||||||||
| Trading and hedging derivatives instruments (USD million) | |||||||||||||||||
| Interest rate products | 33,876 | 33,284 | – | – | 43,494 | 43,022 | – | – | |||||||||
| Foreign exchange products | 13,457 | 15,156 | 3 | – | 21,904 | 20,634 | 7 | 17 | |||||||||
| Equity/indexed-related products | 9,073 | 8,891 | – | – | 28,703 | 29,258 | – | – | |||||||||
| Credit products | 1,851 | 2,107 | – | – | 4,777 | 4,608 | – | – | |||||||||
| Other products | 76 | 64 | – | – | 294 | 320 | – | – | |||||||||
| Total derivative instruments | 58,333 | 59,502 | 3 | – | 99,172 | 97,842 | 7 | 17 | |||||||||
| 2023 | 2022 | ||||||||
|
Group |
Derivative Assets |
Derivative Liabilities |
Derivative Assets |
Derivative Liabilities |
|||||
| Derivative Assets and Liabilities (USD million) | |||||||||
| Derivative Assets and Liabilities (trading and hedging) before netting | 58,336 | 59,502 | 99,179 | 97,859 | |||||
| Derivative Assets and Liabilities (trading and hedging) after netting | 57,340 | 58,562 | 90,074 | 88,490 | |||||
| 2023 | 2022 | ||||||||
|
Bank |
Derivative Assets |
Derivative Liabilities |
Derivative Assets |
Derivative Liabilities |
|||||
| Derivative Assets and Liabilities (USD million) | |||||||||
| Derivative Assets and Liabilities (trading and hedging) before netting | 58,336 | 59,502 | 99,300 | 98,123 | |||||
| Derivative Assets and Liabilities (trading and hedging) after netting | 57,340 | 58,562 | 90,195 | 88,754 | |||||
| Nominal amount of the hedging instrument |
Carrying amount of the hedging instrument |
Line item in the statement of financial position where the hedging instrument is recorded |
Changes in fair value used for calculating hedge ineffectiveness during the period |
||||||||
|
Group and Bank As at 31 December 2023 (USD million) |
|
Assets |
Liabilities |
|
|
||||||
| Cash flow hedges (USD million) | |||||||||||
| Foreign exchange risk | |||||||||||
| Forward contracts | 69 | 3 | – | Non-trading financial assets mandatorily at fair value through profit or loss | 12 | ||||||
|
Group and Bank As at 31 December 2022 (USD million) |
|
|
|
|
|
||||||
| Cash flow hedges (USD million) | |||||||||||
| Foreign exchange risk | |||||||||||
| Forward contracts | 465 | 7 | (17) | Non-trading financial assets mandatorily at fair value through profit or loss/ Financial liabilities designated at fair value through profit or loss | 1 | ||||||
|
Group and Bank As at 31 December 2023 (USD million) |
< 6 months |
< 1 year |
|||
| Cash Flow Hedges | |||||
| Foreign exchange price risk | |||||
| Forward contracts | 69 | – | |||
| Average exchange rate - GBP/USD | 1.23 | – | |||
|
Group and Bank As at 31 December 2022 (USD million) |
|
|
|||
| Cash Flow Hedges | |||||
| Foreign exchange price risk | |||||
| Forward contracts | 254 | 211 | |||
| Average exchange rate - GBP/USD | 1.29 | 1.17 |
|
Group and Bank Cash flow hedges as at 31 December 2023 (USD million) |
Change in value of the hedged item |
Cash flow hedge reserve |
|||
| Foreign exchange price risk | |||||
| Professional services, salaries and payroll taxes | – | 3 | |||
|
Group and Bank Cash flow hedges as at 31 December 2022 (USD million) |
|
|
|||
| Foreign exchange price risk | |||||
| Professional services, salaries and payroll taxes | – | (9) |
| 2023 | 2022 | ||||
|
Foreign exchange price risk |
Foreign exchange price risk |
||||
| Cash flow hedges (USD million) | Forward contract | Forward contract | |||
| Hedging gain/(loss) recognised in OCI | 16 | (62) | |||
| Amount reclassified to profit or loss because hedged item has affected profit or loss | 4 | (63) | |||
| Line item that includes the reclassification adjustments | Total Operating expenses: a. General, administrative and trading expenses b. Compensation and benefits | Total Operating expenses: a. General, administrative and trading expenses b. Compensation and benefits |
| 2023 | 2022 | ||||
| Cash flow hedge reserve (USD million) | Cash flow hedging reserve | Cash flow hedging reserve | |||
| Opening balance at 1 January | (9) | (10) | |||
| Cash flow hedges | |||||
| Effective portion of changes in fair value: | |||||
| Foreign Exchange Currency risk | 16 | (62) | |||
| Net amount reclassified to profit or loss: | |||||
| Foreign Exchange Currency risk | (4) | 63 | |||
| Closing balance at 31 December | 3 | (9) |
| Maturity | |||||||||||||||
|
Group and Bank |
<1 year |
1-3 years |
3-5 years |
>5 years |
Total gross amount |
Secured by collateral |
Net of collateral |
||||||||
| 31 December 2023 | |||||||||||||||
| Guarantees (USD million) | |||||||||||||||
| Credit guarantees and similar instruments | 118 | 25 | – | – | 143 | 3 | 140 | ||||||||
| Forward reverse repurchase agreements | 183 | – | – | – | 183 | 175 | 7 | ||||||||
| Total guarantees | 301 | 25 | – | – | 326 | 178 | 147 | ||||||||
| Other commitments (USD million) | |||||||||||||||
| Loan commitments | 189 | 680 | 151 | 114 | 1,134 | 372 | 763 | ||||||||
| Other commitments - commitments to purchase cash securities <1 year | 222 | 5 | – | – | 227 | – | 228 | ||||||||
| Total other commitments | 411 | 685 | 151 | 114 | 1,361 | 372 | 991 | ||||||||
| 31 December 2022 | |||||||||||||||
| Guarantees (USD million) | |||||||||||||||
| Credit guarantees and similar instruments | 67 | 83 | – | – | 150 | – | 150 | ||||||||
| Forward reverse repurchase agreements | 990 | – | – | – | 990 | 990 | – | ||||||||
| Total guarantees | 1,057 | 83 | – | – | 1,140 | 990 | 150 | ||||||||
| Other commitments (USD million) | |||||||||||||||
| Loan commitments | 807 | 794 | 836 | 77 | 2,514 | 716 | 1,798 | ||||||||
| Other commitments - commitments to purchase cash securities <1 year | 3,850 | – | – | – | 3,850 | – | 3,850 | ||||||||
| Total other commitments | 4,657 | 794 | 836 | 77 | 6,364 | 716 | 5,648 | ||||||||
|
Entity Name |
Domicile |
Currency |
Percentage of ownership held 2023 |
Percentage of ownership held 2022 |
|||||
| 31 December 2023 | |||||||||
| AI3 (USD) Segregated Portfolio | Cayman Islands | USD | 100 | 100 | |||||
| Albalatin LLC | Qatar | USD | 100 | – | |||||
| Andrea Cell 1000 EUR 1 | Jersey | EUR | 100 | 100 | |||||
| Andrea Cell 1000 USD 1 | Jersey | USD | 100 | 100 | |||||
| Andrea Investments (Jersey) PCC (MASTER VEHICLE) 1 | Jersey | GBP | 100 | 100 | |||||
| Andrea Investments (Jersey) PCC: 1000 1 | Jersey | USD | 100 | 100 | |||||
| Argentum Capital Series 2015-32 | Luxembourg | USD | 100 | 100 | |||||
| Argentum Capital Series 2016-36 | Luxembourg | USD | 100 | – | |||||
| Argentum Capital Series 2015-53, 2016-25, 2016-33, 2016-50, 2016-63, 2017-54, 2017-64, 2019-75, 2022-11 | Luxembourg | USD | – | 100 | |||||
| Argentum Series 2018-22 | Luxembourg | USD | – | 100 | |||||
| Ascent Finance Limited 2020-25 | Cayman Islands | USD | 100 | 100 | |||||
| Ascent Finance Limited 2021-9015 | Cayman Islands | USD | 100 | – | |||||
| Ascent Finance Limited Series 2021-1800, 2021-1801, 2021-1802, 2022-1801, 2022-1802 | Cayman Islands | USD | – | 100 | |||||
| Boats Investments (Jersey) Ltd Series 630, 641, 647, 663 1 | Jersey | USD | 100 | 100 | |||||
| Boats Investments (Jersey) Ltd Series 628, 631, 633, 639, 642, 648, 655, 656, 658, 659, 661, 662, 664 1 | Jersey | USD | – | 100 | |||||
| Clearwater Seller Limited 2 | United Kingdom | USD | 100 | 100 | |||||
| Credit Suisse First Boston Trustees Limited | Ireland, Republic of | USD | 100 | 100 | |||||
| Custom Markets QIAIF plc | Ireland, Republic of | USD | 100 | 100 | |||||
| Global Bond Fund | Ireland, Republic of | USD | 100 | 100 | |||||
| GIFMS Capital Company LLC | United States | USD | – | 100 | |||||
| GIFS Capital Company LLC Silo 2 Technical purpose | United States | USD | 100 | – | |||||
| Interleuvenlaan 15 Real Estate Ltd | Gibraltar | EUR | 100 | 100 | |||||
| M&M Iris SPC | Cayman Islands | USD | – | 100 | |||||
| Morstan Investments B.V. | Netherlands | USD | 100 | 100 | |||||
| New Jersey S.A. | Luxembourg | EUR | 100 | 100 | |||||
| Platinum Securities Cayman SPC Limited | Cayman Islands | USD | 100 | 100 | |||||
| Platinum Securities Netherlands B.V. | Netherlands | EUR | – | 100 | |||||
| Silver Hake Limited | Gibraltar | EUR | 100 | 100 | |||||
| VAULT Investments plc - Series 060 3 | Ireland, Republic of | EUR | – | 100 | |||||
| Westwood S.A | Portugal | EUR | 100 | 100 | |||||
| YI Active Spezial ESPA Fund. 3 | Austria | EUR | – | 100 | |||||
|
1
For these entities, the financial year ends on 30 September each year.
|
|||||||||
|
2
For these entities, the financial year ends on 31 March each year.
|
|||||||||
|
3
For these entities, the financial year ends on 30 June each year.
|
|||||||||
| Security | Immediate Parent | Ultimate Parent | Country | Registered Office | |||||||
| 31 December 2023 Subsidiaries | |||||||||||
| AI3 Segregated Portfolio | USD 100 Participating shares | Credit Suisse International | UBS Group AG | Cayman Islands | Walkers SPV Limited Walker House, Mary Street PO Box 908GT George Town, Grand Cayman, Cayman Islands | ||||||
| Albalatin LLC | No shares | TMF Group LLC | TMF Group EMEA B.V | Qatar | Office No. 1422 14th Floor, Al Fardan Office Towers No. 12 Doha - Qatar | ||||||
| Andrea Investments (Jersey) PCC – Cell Series 1000 EUR | EUR Preference shares | Andrea Investments (Jersey) PCC | Borowska Trust | Jersey | 22 Grenville Street, St Helier, Channel Islands JE4 8PX, Jersey | ||||||
| Andrea Investments (Jersey) PCC – Cell Series 1000 USD | USD Preference shares | Andrea Investments (Jersey) PCC | Borowska Trust | Jersey | 22 Grenville Street, St Helier, Channel Islands JE4 8PX, Jersey | ||||||
| Andrea Investments (Jersey) PCC | No shares | Borowska Trust | Borowska Trust | Jersey | 22 Grenville Street, St Helier, Channel Islands JE4 8PX,Jersey | ||||||
| Andrea Investments (Jersey) PCC – Cell Series 1000 PC | No shares | Andrea Investments (Jersey) PCC | Borowska Trust | Jersey | 22 Grenville Street, St Helier, Channel Islands JE4 8PX, Jersey | ||||||
| Argentum Capital Series 2015-32, 2015-53, 2016-25, 2017-64, 2019-75, 2022-11, 2016-33, 2016-50,2016-63, 2017-54, 2018-22, 2016-36 | No shares | Argentum Capital S.A. | Argentum Capital S.A. | Luxembourg | 51, avenue John F. Kennedy, Luxembourg L-1855, Luxembourg | ||||||
| Ascent Finance Limited 2021-1800, 2021-1801 | No shares | Credit Suisse International | UBS Group AG | Cayman Islands | One Nexus Way,Camana Bay, Grand Cayman – Cayman Islands | ||||||
| Ascent Finance Limited Series 2021-1802, 2022-1801, 2022-1802, 2020-25 | No shares | Ascent Fiance Limited | Ascent Fiance Limited | Cayman Islands | One Nexus Way,Camana Bay, Grand Cayman – Cayman Islands | ||||||
| Boats Investments (Jersey) Ltd Series 630, 641, 647, 663, 628, 631, 633, 639, 642, 648, 655, 656, 658, 659, 661, 662, 664 | No shares | Boats Investments (Jersey) Limited (Master Vehicle) | Boats Investments (Jersey) Limited (Master Vehicle) | Jersey | 22 Grenville Street, St Helier JE2 4UF, Jersey | ||||||
| Clearwater Seller Limited | No shares | Credit Suisse International | UBS Group AG | United Kingdom | 35 Great St. Helen's,London EC3A 6AP, United Kingdom | ||||||
| Credit Suisse First Boston Trustees Limited | Ordinary Shares | Credit Suisse International | UBS Group AG | United Kingdom | One Cabot Square London E14 4QJ – United Kingdom | ||||||
| CQS Total Return Credit Fund 1 | No voting shares | Credit Suisse International | UBS Group AG | Republic of Ireland | 5 George’s Dock, IFSC , Dublin – Ireland, Republic of Ireland | ||||||
| Custom Markets QIF PLC | No shares | Credit Suisse International | UBS Group AG | Republic of Ireland | MFD Secretaries Limited, 2nd Floor Beaux Lane House, Dublin 2, Republic of Ireland | ||||||
| Global Bond Fund | Investment Fund Share | Credit Suisse International | UBS Group AG | Republic of Ireland | 2nd Floor, Block E, Iveagh Court, Harcourt Road, Dublin 2, Republic of Ireland | ||||||
| GIFMS Capital Company LLC | No shares | Guggenheim Treasury Services, LLC | Guggenheim Partners (via Liberty Hampshire Holdings, LLC) | United States of America | 227 West Monroe Suite 4900 Chicago, Illinois 60606 - USA | ||||||
| GIFS Capital Company LLC Silo 2 Technical purpose | No shares | Guggenheim Treasury Services, LLC | Guggenheim Partners (via Liberty Hampshire Holdings, LLC) | United States of America | 227 West Monroe Suite 4900 Chicago, Illinois 60606 - USA | ||||||
| Interleuvenlaan 15 Real Estate Ltd | No shares | Credit Suisse International | UBS Group AG | Gibraltar | 124 Irish Town, Gibraltar, Gibraltar | ||||||
| M & M Irs SPC | No shares | Credit Suisse International | UBS Group AG | Cayman Islands | Queensgate House, South Church Street, George Town, Grand Cayman KY1-1102, Cayman Islands | ||||||
| Morstan Investments B.V. | No shares | Credit Suisse International | UBS Group AG | Jersey | Prins Hendriklaan 26, Amsterdam 1075 BD,Netherlands | ||||||
| New Jersey S.A. | No shares | Credit Suisse International | UBS Group AG | Luxembourg | 51, avenue John F. Kennedy , Luxembourg L-1855, Luxembourg | ||||||
| Platinum Securities Cayman SPC Limited | No shares | Credit Suisse International | UBS Group AG | Cayman Islands | c/o Maples Corporate Services Limited, Limited Islands P.O. Box 309, Ugland House,George Town, Grand Cayman KY1-1104 – Cayman Islands | ||||||
| Platinum Securities Netherlands B.V. | No shares | Platinum Securities Netherlands B.V. | Platinum Securities Netherlands B.V. | Netherlands | Prins Bernhardplein 200, Amsterdam 1097 JB,Netherlands | ||||||
| Silver Hake Limited | No shares | Credit Suisse International | UBS Group AG | Gibraltar | Suite 7b & 8b, Finsbury Trust, 50 Town Range, PO Box 472, Gibraltar | ||||||
| VAULT Investments plc - Series 060 | No shares | Credit Suisse International | UBS Group AG | Republic of Ireland | 1st Grant Road, Lower Mount Street, Series 060 Ireland Dublin, Republic of Ireland | ||||||
| Westwood S.A | No shares | Credit Suisse International | UBS Group AG | Portugal | Edificio Atrium Saldanha Praca Duque de Saldanha, Lisbon 1050 094, Portugal | ||||||
| Xanthos Holding – Segregated Portfolio 1 | Non-Participating USD 1 shares | Credit Suisse International | UBS Group AG | Cayman Islands | Walkers SPV Limited Walker House, Mary Street PO Box 908GT George Town, Grand Cayman, Cayman Islands | ||||||
| YI Active Spezial ESPA Fund. | Non-voting shares | Credit Suisse International | UBS Group AG | Austria | Am Belvedere 1, Vienna 1100, Austria | ||||||
|
1
All subsidiaries in above table are consolidated except Xanthos Holding – Segregated Portfolio and CQS Total Return Credit Fund.
|
|||||||||||
| (USD million) | 2023 | 2022 | |||
| Cash Consideration | 1 | – | |||
| Carrying value of net assets | (1) | – | |||
| Gain/(Loss) on disposal of interests recorded | – | – |
| Type of structured entity | |||||||||||||
|
Line item in consolidated statement of financial position (USD million) |
CDO |
Securiti- sations |
Funds |
Loans |
Other Financial intermediation |
Total |
|||||||
| 31 December 2023 | |||||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Equity securities | – | – | 17 | – | – | 17 | |||||||
| Derivative instruments | 20 | 99 | 6 | – | 201 | 326 | |||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Loans | – | – | – | 1 | – | 1 | |||||||
| Other Assets | |||||||||||||
| Other Assets | – | – | 1 | – | – | 1 | |||||||
| Total assets | 20 | 99 | 24 | 1 | 201 | 345 | |||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | |||||||||||||
| Derivative instruments | – | 28 | 7 | – | – | 35 | |||||||
| Financial liabilities designated at fair value through profit or loss | |||||||||||||
| Structured Notes | – | – | – | – | 88 | 88 | |||||||
| Total liabilities | – | 28 | 7 | – | 88 | 123 | |||||||
| Maximum exposure to loss | 20 | 99 | 24 | 1 | 201 | 345 | |||||||
| Unconsolidated structured entity assets | 93 | 1,989 | 1,866,284 | 57 | 1,330 | 1,869,753 | |||||||
| Type of structured entity | |||||||||||||
|
Line item in consolidated statement of financial position (USD million) |
CDO |
Securiti- sations |
Funds |
Loans |
Other Financial intermediation |
Total |
|||||||
| 31 December 2022 | |||||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Debt securities | – | – | – | – | – | 0 | |||||||
| Equity securities | – | – | 38 | – | – | 38 | |||||||
| Derivative instruments | 22 | 124 | 11 | – | 480 | 637 | |||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Loans | – | – | – | 2 | – | 2 | |||||||
| Securities purchased under repurchase agreements and securities borrowing transactions | 26 | – | – | – | 77 | 103 | |||||||
| Total assets | 48 | 124 | 49 | 2 | 557 | 780 | |||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | |||||||||||||
| Equity securities | – | – | – | – | 11 | 11 | |||||||
| Derivative instruments | – | 49 | 3 | – | – | 52 | |||||||
| Financial liabilities designated at fair value through profit or loss | |||||||||||||
| Debt in issuance | – | – | – | – | 187 | 187 | |||||||
| Securities sold under repurchase agreements and securities lending transactions | – | 3 | – | – | – | 3 | |||||||
| Total liabilities | – | 52 | 3 | – | 198 | 253 | |||||||
| Maximum exposure to loss | 48 | 124 | 49 | 2 | 557 | 780 | |||||||
| Unconsolidated structured entity assets | 373 | 2,203 | 2,034,025 | 54 | 5,909 | 2,042,564 | |||||||
| (Losses)/Income | |||||||||||||||
|
Structured entity type (USD million) |
Derivative (Loss)/Gain |
Other Fair Value (Loss)/Gain |
(Loss)/Gain on Sale of Assets |
Interest (Expense)/ Income |
(Other Losses)/ Other Income |
(Other Expenses)/ Commission and Fees |
Total |
||||||||
| 31 December 2023 | |||||||||||||||
| Securitisations | 7 | – | – | – | – | 1 | 8 | ||||||||
| Funds | (3) | 48 | (16) | – | 3 | – | 32 | ||||||||
| Other | 12 | 2 | – | (2) | – | – | 12 | ||||||||
| Total | 16 | 50 | (16) | (2) | 3 | 1 | 52 | ||||||||
| 31 December 2022 | |||||||||||||||
| Securitisations | (94) | – | – | – | 6 | 5 | (83) | ||||||||
| Funds | – | (79) | (64) | – | 5 | – | (138) | ||||||||
| Other | (119) | (1) | – | 2 | – | – | (118) | ||||||||
| Total | (213) | (80) | (64) | 2 | 11 | 5 | (339) | ||||||||
| (Losses)/Income | |||||||||||||||
|
Structured entity type (USD million) |
Derivative (Loss)/Gain |
(Loss)/Gain on Sale of Assets |
(Other Losses)/ Other Income |
(Other Expenses)/ Commission and Fees |
Interest (Expense)/ Income |
Total |
Carrying Value of Assets transferred |
||||||||
| 31 December 2023 | |||||||||||||||
| Securitisations | (1) | (1) | (1) | – | (6) | (9) | 121 | ||||||||
| Funds | – | – | (38) | – | – | (38) | – | ||||||||
| Other | 2 | – | – | – | – | 2 | – | ||||||||
| Total | 1 | (1) | (39) | – | (6) | (45) | 121 | ||||||||
| 31 December 2022 | |||||||||||||||
| Securitisations | 109 | (16) | 8 | – | – | 101 | 2,600 | ||||||||
| Funds | (5) | – | – | – | – | (5) | 98 | ||||||||
| CDO | 2 | – | – | – | – | 2 | – | ||||||||
| Loans | – | – | 1 | – | – | 1 | – | ||||||||
| Other | 23 | (7) | 11 | – | – | 27 | – | ||||||||
| Total | 129 | (23) | 20 | – | 126 | 2,698 | |||||||||
| As at 31 December 2023 |
Carrying value |
Total fair value |
|||||||||
|
Group |
Total carrying value |
Mandatorily at FVTPL |
Designated at FVTPL |
Amortised cost |
|
||||||
| Financial assets (USD million) | |||||||||||
| Cash and due from banks | 3,627 | – | – | 3,627 | 3,627 | ||||||
| Interest-bearing deposits with banks | 8,319 | – | – | 8,319 | 8,319 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | 1,304 | – | – | 1,304 | 1,304 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 63,309 | 63,309 | – | – | 63,309 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 24,588 | 24,588 | – | – | 24,588 | ||||||
| Loans and advances | 3,187 | – | – | 3,187 | 3,254 | ||||||
| Other assets | 16,977 | – | – | 16,977 | 16,977 | ||||||
| Total financial assets | 121,311 | 87,897 | – | 33,414 | 121,378 | ||||||
| Financial liabilities (USD million) | |||||||||||
| Due to banks | 31 | – | – | 31 | 31 | ||||||
| Securities sold under repurchase agreements and securities lending transactions | 358 | – | – | 358 | 358 | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 60,519 | 60,519 | – | – | 60,519 | ||||||
| Financial liabilities designated at fair value through profit or loss | 16,050 | – | 16,050 | – | 16,050 | ||||||
| Borrowings | 12,622 | – | – | 12,622 | 12,622 | ||||||
| Other liabilities | 8,604 | – | – | 8,604 | 8,604 | ||||||
| Debt in issuance | 8,108 | – | – | 8,108 | 8,125 | ||||||
| Total financial liabilities | 106,292 | 60,519 | 16,050 | 29,723 | 106,309 | ||||||
| As at 31 December 2023 |
Carrying value |
Total fair value |
|||||||||
|
Bank |
Total carrying value |
Mandatorily at FVTPL |
Designated at fair value |
Amortised cost |
|
||||||
| Financial assets (USD million) | |||||||||||
| Cash and due from banks | 3,616 | – | – | 3,616 | 3,616 | ||||||
| Interest-bearing deposits with banks | 8,319 | – | – | 8,319 | 8,319 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | 1,304 | – | – | 1,304 | 1,304 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 63,354 | 63,354 | – | – | 63,354 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 24,395 | 24,395 | – | – | 24,395 | ||||||
| Loans and advances | 3,187 | – | – | 3,187 | 3,254 | ||||||
| Other assets | 16,977 | – | – | 16,977 | 16,977 | ||||||
| Total financial assets | 121,152 | 87,749 | – | 33,403 | 121,219 | ||||||
| Financial liabilities (USD million) | |||||||||||
| Due to banks | 31 | – | – | 31 | 31 | ||||||
| Securities sold under repurchase agreements and securities lending transactions | 358 | – | – | 358 | 358 | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 60,519 | 60,519 | – | – | 60,519 | ||||||
| Financial liabilities designated at fair value through profit or loss | 15,891 | – | 15,891 | – | 15,891 | ||||||
| Borrowings | 12,622 | – | – | 12,622 | 12,622 | ||||||
| Other liabilities | 8,604 | – | – | 8,604 | 8,604 | ||||||
| Debt in issuance | 8,108 | – | – | 8,108 | 8,125 | ||||||
| Total financial liabilities | 106,133 | 60,519 | 15,891 | 29,723 | 106,150 | ||||||
| As at 31 December 2022 |
Carrying value |
Total fair value |
|||||||||
|
Group |
Total carrying value |
Mandatorily at FVTPL |
Designated at fair value |
Amortised cost |
|
||||||
| Financial assets (USD million) | |||||||||||
| Cash and due from banks | 4,149 | – | – | 4,149 | 4,149 | ||||||
| Interest-bearing deposits with banks | 12,085 | – | – | 12,085 | 12,085 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | 10,527 | – | – | 10,527 | 10,527 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 107,973 | 107,973 | – | – | 107,973 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 22,831 | 22,831 | – | – | 22,831 | ||||||
| Loans and advances | 2,752 | – | – | 2,752 | 2,717 | ||||||
| Other assets | 21,178 | – | – | 21,178 | 21,178 | ||||||
| Total financial assets | 181,495 | 130,804 | – | 50,691 | 181,460 | ||||||
| Financial liabilities (USD million) | |||||||||||
| Due to banks | 266 | – | – | 266 | 266 | ||||||
| Securities sold under repurchase agreements and securities lending transactions | 2,924 | – | – | 2,924 | 2,924 | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 93,397 | 93,397 | – | – | 93,397 | ||||||
| Financial liabilities designated at fair value through profit or loss | 27,169 | – | 27,169 | – | 27,169 | ||||||
| Borrowings | 6,025 | – | – | 6,025 | 6,025 | ||||||
| Other liabilities | 16,379 | – | – | 16,379 | 16,379 | ||||||
| Debt in issuance | 18,309 | – | – | 18,309 | 18,079 | ||||||
| Total financial liabilities | 164,469 | 93,397 | 27,169 | 43,903 | 164,239 | ||||||
| As at 31 December 2022 |
Carrying value |
Total fair value |
|||||||||
|
Bank |
Total carrying value |
Mandatorily at FVTPL |
Designated at fair value |
Amortised cost |
|
||||||
| Financial assets (USD million) | |||||||||||
| Cash and due from banks | 4,133 | – | – | 4,133 | 4,133 | ||||||
| Interest-bearing deposits with banks | 12,085 | – | – | 12,085 | 12,085 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | 10,527 | – | – | 10,527 | 10,527 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 107,987 | 107,987 | – | – | 107,987 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 22,258 | 22,258 | – | – | 22,258 | ||||||
| Loans and advances | 2,752 | – | – | 2,752 | 2,717 | ||||||
| Other assets | 21,178 | – | – | 21,178 | 21,178 | ||||||
| Total financial assets | 180,920 | 130,245 | – | 50,675 | 180,885 | ||||||
| Financial liabilities (USD million) | |||||||||||
| Due to banks | 266 | – | – | 266 | 266 | ||||||
| Securities sold under repurchase agreements and securities lending transactions | 2,924 | – | – | 2,924 | 2,924 | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 93,661 | 93,661 | – | – | 93,661 | ||||||
| Financial liabilities designated at fair value through profit or loss | 26,332 | – | 26,332 | – | 26,332 | ||||||
| Borrowings | 6,025 | – | – | 6,025 | 6,025 | ||||||
| Other liabilities | 16,379 | – | – | 16,379 | 16,379 | ||||||
| Debt in issuance | 18,308 | – | – | 18,308 | 18,079 | ||||||
| Total financial liabilities | 163,895 | 93,661 | 26,332 | 43,902 | 163,666 | ||||||
|
As at 31 December 2023 (Group) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Assets (USD million) | |||||||||||
| Debt securities | 60 | 1,681 | 100 | – | 1,841 | ||||||
| Equity securities | 3,110 | 718 | 140 | – | 3,968 | ||||||
| Derivatives | 1,342 | 56,088 | 903 | (996) | 57,337 | ||||||
| of which interest rate products | 8 | 33,685 | 183 | (17) | 33,859 | ||||||
| of which foreign exchange products | – | 13,280 | 177 | – | 13,457 | ||||||
| of which equity/index-related products | 1,330 | 7,403 | 340 | (979) | 8,094 | ||||||
| of which credit derivatives | – | 1,648 | 203 | – | 1,851 | ||||||
| of which other derivative products | 4 | 72 | – | – | 76 | ||||||
| Other | – | 160 | 3 | – | 163 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 4,512 | 58,647 | 1,146 | (996) | 63,309 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 25,236 | – | (1,326) | 23,910 | ||||||
| Loans | – | 283 | 43 | (56) | 270 | ||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 2 | 401 | 5 | – | 408 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 2 | 25,920 | 48 | (1,382) | 24,588 | ||||||
| Total assets at fair value | 4,514 | 84,567 | 1,194 | (2,378) | 87,897 | ||||||
|
1
Derivative contracts/ Securities purchased under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2023 (Group) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Liabilities (USD million) | |||||||||||
| Debt securities | 115 | 69 | – | – | 184 | ||||||
| Equity securities | 1,741 | 611 | 5 | (584) | 1,773 | ||||||
| Derivatives | 1,135 | 57,720 | 647 | (940) | 58,562 | ||||||
| of which interest rate products | 1 | 33,197 | 86 | (2) | 33,282 | ||||||
| of which foreign exchange products | – | 15,151 | 5 | – | 15,156 | ||||||
| of which equity/index-related products | 1,129 | 7,404 | 358 | (938) | 7,953 | ||||||
| of which credit derivatives | – | 1,909 | 198 | – | 2,107 | ||||||
| of which other derivative products | 5 | 59 | – | – | 64 | ||||||
| Other | – | – | – | – | – | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 2,991 | 58,400 | 652 | (1,524) | 60,519 | ||||||
| Securities sold under resale agreements and securities borrowing transactions | – | 8,835 | – | (835) | 8,000 | ||||||
| Borrowings | – | 2,484 | 3 | – | 2,487 | ||||||
| Debt in issuance | – | 4,331 | 255 | – | 4,586 | ||||||
| Other financial liabilities designated at fair value through profit or loss | – | 973 | 4 | – | 977 | ||||||
| Financial liabilities designated at fair value through profit or loss | – | 16,623 | 262 | (835) | 16,050 | ||||||
| Total liabilities at fair value | 2,991 | 75,023 | 914 | (2,359) | 76,569 | ||||||
| Net assets/(liabilities) at fair value | 1,523 | 9,544 | 280 | (19) | 11,328 | ||||||
|
1
Derivative contracts/Securities sold under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2023 (Bank) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Assets (USD million) | |||||||||||
| Debt securities | 60 | 1,744 | 82 | – | 1,886 | ||||||
| Equity securities | 3,110 | 718 | 140 | – | 3,968 | ||||||
| Derivatives | 1,342 | 56,088 | 903 | (996) | 57,337 | ||||||
| of which interest rate products | 8 | 33,685 | 183 | (17) | 33,859 | ||||||
| of which foreign exchange products | – | 13,280 | 177 | – | 13,457 | ||||||
| of which equity/index-related products | 1,330 | 7,403 | 340 | (979) | 8,094 | ||||||
| of which credit derivatives | – | 1,648 | 203 | – | 1,851 | ||||||
| of which other derivative products | 4 | 72 | – | – | 76 | ||||||
| Other | – | 160 | 3 | – | 163 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 4,512 | 58,710 | 1,128 | (996) | 63,354 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 25,236 | – | (1,326) | 23,910 | ||||||
| Loans | – | 287 | 43 | (56) | 274 | ||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 2 | 204 | 5 | – | 211 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 2 | 25,727 | 48 | (1,382) | 24,395 | ||||||
| Total assets at fair value | 4,514 | 84,437 | 1,176 | (2,378) | 87,749 | ||||||
|
1
Derivative contracts/ Securities purchased under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2023 (Bank) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Liabilities (USD million) | |||||||||||
| Debt securities | 115 | 69 | – | – | 184 | ||||||
| Equity securities | 1,741 | 611 | 5 | (584) | 1,773 | ||||||
| Derivatives | 1,135 | 57,720 | 647 | (940) | 58,562 | ||||||
| of which interest rate products | 1 | 33,197 | 86 | (2) | 33,282 | ||||||
| of which foreign exchange products | – | 15,151 | 5 | – | 15,156 | ||||||
| of which equity/index-related products | 1,129 | 7,404 | 358 | (938) | 7,953 | ||||||
| of which credit derivatives | – | 1,909 | 198 | – | 2,107 | ||||||
| of which other derivative products | 5 | 59 | – | – | 64 | ||||||
| Other | – | – | – | – | – | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 2,991 | 58,400 | 652 | (1,524) | 60,519 | ||||||
| Securities sold under resale agreements and securities borrowing transactions | – | 8,835 | – | (835) | 8,000 | ||||||
| Borrowings | – | 2,484 | 3 | – | 2,487 | ||||||
| Debt in issuance | – | 4,199 | 228 | – | 4,427 | ||||||
| Other financial liabilities designated at fair value through profit or loss | – | 973 | 4 | – | 977 | ||||||
| Financial liabilities designated at fair value through profit or loss | – | 16,491 | 235 | (835) | 15,891 | ||||||
| Total liabilities at fair value | 2,991 | 74,891 | 887 | (2,359) | 76,410 | ||||||
| Net assets/liabilities at fair value | 1,523 | 9,546 | 289 | (19) | 11,339 | ||||||
|
1
Derivative contracts/Securities sold under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2022 (Group) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Assets (USD million) | |||||||||||
| Debt securities | 2,862 | 4,846 | 645 | – | 8,353 | ||||||
| Equity securities | 8,266 | 597 | 374 | – | 9,237 | ||||||
| Derivatives | 5,680 | 92,388 | 1,104 | (9,105) | 90,067 | ||||||
| of which interest rate products | 8 | 43,270 | 216 | (1,662) | 41,832 | ||||||
| of which foreign exchange products | 19 | 21,741 | 144 | – | 21,904 | ||||||
| of which equity/index-related products | 5,650 | 22,481 | 572 | (7,443) | 21,260 | ||||||
| of which credit derivatives | – | 4,605 | 172 | – | 4,777 | ||||||
| of which other derivative products | 3 | 291 | – | – | 294 | ||||||
| Other | – | 246 | 70 | – | 316 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 16,808 | 98,077 | 2,193 | (9,105) | 107,973 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 27,885 | – | (6,792) | 21,093 | ||||||
| Loans | – | 1,143 | 28 | (66) | 1,105 | ||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 104 | 526 | 3 | – | 633 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 104 | 29,554 | 31 | (6,858) | 22,831 | ||||||
| Total assets at fair value | 16,912 | 127,631 | 2,224 | (15,963) | 130,804 | ||||||
|
1
Derivative contracts/ Securities purchased under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2022 (Group) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Liabilities (USD million) | |||||||||||
| Debt securities | 771 | 1,249 | 20 | – | 2,040 | ||||||
| Equity securities | 2,859 | 676 | 8 | (662) | 2,881 | ||||||
| Derivatives | 5,248 | 91,132 | 1,462 | (9,369) | 88,473 | ||||||
| of which interest rate products | – | 42,865 | 157 | (1,775) | 41,247 | ||||||
| of which foreign exchange products | 19 | 20,610 | 5 | – | 20,634 | ||||||
| of which equity/index-related products | 5,221 | 22,965 | 1,072 | (7,594) | 21,664 | ||||||
| of which credit derivatives | – | 4,380 | 228 | – | 4,608 | ||||||
| of which other derivative products | 8 | 312 | – | – | 320 | ||||||
| Other | 3 | – | – | – | 3 | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 8,881 | 93,057 | 1,490 | (10,031) | 93,397 | ||||||
| Securities sold under resale agreements and securities borrowing transactions | – | 21,469 | – | (6,279) | 15,190 | ||||||
| Borrowings | – | 1,766 | 242 | – | 2,008 | ||||||
| Debt in issuance | – | 6,426 | 1,962 | – | 8,388 | ||||||
| Other financial liabilities designated at fair value through profit or loss | 117 | 1,459 | 7 | – | 1,583 | ||||||
| Financial liabilities designated at fair value through profit or loss | 117 | 31,120 | 2,211 | (6,279) | 27,169 | ||||||
| Total liabilities at fair value | 8,998 | 124,177 | 3,701 | (16,310) | 120,566 | ||||||
| Net assets/liabilities at fair value | 7,914 | 3,454 | (1,477) | 347 | 10,238 | ||||||
|
1
Derivative contracts/Securities sold under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2022 (Bank) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Assets (USD million) | |||||||||||
| Debt securities | 2,862 | 4,806 | 580 | – | 8,248 | ||||||
| Equity securities | 8,266 | 596 | 373 | – | 9,235 | ||||||
| Derivatives | 5,681 | 92,508 | 1,104 | (9,105) | 90,188 | ||||||
| of which interest rate products | 8 | 43,274 | 216 | (1,662) | 41,836 | ||||||
| of which foreign exchange products | 19 | 21,741 | 144 | – | 21,904 | ||||||
| of which equity/index-related products | 5,651 | 22,480 | 572 | (7,443) | 21,260 | ||||||
| of which credit derivatives | – | 4,722 | 172 | – | 4,894 | ||||||
| of which other derivative products | 3 | 291 | – | – | 294 | ||||||
| Other | – | 246 | 70 | – | 316 | ||||||
| Trading financial assets mandatorily at fair value through profit or loss | 16,809 | 98,156 | 2,127 | (9,105) | 107,987 | ||||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 27,885 | – | (6,792) | 21,093 | ||||||
| Loans | – | 738 | 28 | (66) | 700 | ||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 104 | 358 | 3 | – | 465 | ||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 104 | 28,981 | 31 | (6,858) | 22,258 | ||||||
| Total assets at fair value | 16,913 | 127,137 | 2,158 | (15,963) | 130,245 | ||||||
|
1
Derivative contracts/Securities sold under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
|
As at 31 December 2022 (Bank) |
Level 1 |
Level 2 |
Level 3 |
Impact of netting |
1 |
Total at fair value |
|||||
| Liabilities (USD million) | |||||||||||
| Debt securities | 771 | 1,249 | 20 | – | 2,040 | ||||||
| Equity securities | 2,859 | 676 | 8 | (662) | 2,881 | ||||||
| Derivatives | 5,248 | 91,396 | 1,462 | (9,369) | 88,737 | ||||||
| of which interest rate products | – | 42,809 | 157 | (1,775) | 41,191 | ||||||
| of which foreign exchange products | 19 | 20,610 | 5 | – | 20,634 | ||||||
| of which equity/index-related products | 5,221 | 22,963 | 1,072 | (7,594) | 21,662 | ||||||
| of which credit derivatives | – | 4,702 | 228 | – | 4,930 | ||||||
| of which other derivative products | 8 | 312 | – | – | 320 | ||||||
| Other | 3 | – | – | – | 3 | ||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 8,881 | 93,321 | 1,490 | (10,031) | 93,661 | ||||||
| Securities sold under resale agreements and securities borrowing transactions | – | 21,470 | – | (6,279) | 15,191 | ||||||
| Borrowings | – | 1,208 | 242 | – | 1,450 | ||||||
| Debt in issuance | – | 6,210 | 1,898 | – | 8,108 | ||||||
| Other financial liabilities designated at fair value through profit or loss | 117 | 1,459 | 7 | – | 1,583 | ||||||
| Financial liabilities designated at fair value through profit or loss | 117 | 30,347 | 2,147 | (6,279) | 26,332 | ||||||
| Total liabilities at fair value | 8,998 | 123,668 | 3,637 | (16,310) | 119,993 | ||||||
| Net assets/liabilities at fair value | 7,915 | 3,469 | (1,479) | 347 | 10,252 | ||||||
|
1
Derivative contracts/Securities sold under resale agreements and securities borrowing transactions are reported on a gross basis by Level. The impact of netting represents an adjustment related to counterparty netting.
|
|||||||||||
| 2023 | 2022 | ||||||||
|
USD million |
Transfers out of Level 1 to Level 2 |
Transfers to Level 1 out of Level 2 |
Transfers out of Level 1 to Level 2 |
Transfers to Level 1 out of Level 2 |
|||||
| Assets | |||||||||
| Trading financial assets mandatorily at fair value through profit or loss | 67 | 1,982 | 148 | 6,462 | |||||
| Total transfers in assets at fair value | 67 | 1,982 | 148 | 6,462 | |||||
| Liabilities | |||||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 16 | 2,217 | 36 | 7,792 | |||||
| Total transfers in liabilities at fair value | 16 | 2,217 | 36 | 7,792 | |||||
| Trading revenues | |||||||||||||||||||||
|
Group |
Balance as at 1 January 2023 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2023 |
||||||||
| Assets at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 645 | 82 | (70) | 660 | (1,048) | – | – | (22) | (147) | 100 | |||||||||||
| Equity securities | 374 | 25 | (39) | 8 | (200) | – | – | (2) | (26) | 140 | |||||||||||
| Derivatives | 1,104 | 513 | (521) | – | – | 483 | (645) | 81 | (112) | 903 | |||||||||||
| of which interest rate products | 216 | 33 | (35) | – | – | 41 | (68) | (1) | (3) | 183 | |||||||||||
| of which foreign exchange products | 144 | 17 | (11) | – | – | 26 | (45) | 3 | 43 | 177 | |||||||||||
| of which equity/index-related products | 572 | 264 | (373) | – | – | 349 | (402) | 78 | (148) | 340 | |||||||||||
| of which credit derivatives | 172 | 199 | (102) | – | – | 67 | (130) | 1 | (4) | 203 | |||||||||||
| of which other derivative products | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Other | 70 | 3 | (54) | 1 | (10) | – | (12) | 1 | 4 | 3 | |||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | 2,193 | 623 | (684) | 669 | (1,258) | 483 | (657) | 58 | (281) | 1,146 | |||||||||||
| Loans | 28 | 27 | – | – | (3) | – | (17) | – | 8 | 43 | |||||||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 3 | 6 | – | – | (4) | – | (7) | 7 | – | 5 | |||||||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 31 | 33 | – | – | (7) | – | (24) | 7 | 8 | 48 | |||||||||||
| Total assets at fair value | 2,224 | 656 | (684) | 669 | (1,265) | 483 | (681) | 65 | (273) | 1,194 | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events, all gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is paid on a derivative contract. Settlement of derivatives is where cash is received on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Group |
Balance as at 1 January 2023 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2023 |
||||||||
| Liabilities at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 20 | – | – | – | – | – | – | – | (20) | – | |||||||||||
| Equity securities | 8 | – | – | – | (51) | – | – | – | 48 | 5 | |||||||||||
| Derivatives | 1,462 | 439 | (660) | – | – | 475 | (1,260) | 212 | (21) | 647 | |||||||||||
| of which interest rate products | 157 | 26 | (18) | – | – | 26 | (125) | 12 | 8 | 86 | |||||||||||
| of which foreign exchange products | 5 | 10 | (13) | – | – | 5 | (6) | 1 | 3 | 5 | |||||||||||
| of which equity/index-related products | 1,072 | 244 | (559) | – | – | 408 | (946) | 197 | (58) | 358 | |||||||||||
| of which credit derivatives | 228 | 159 | (70) | – | – | 36 | (183) | 2 | 26 | 198 | |||||||||||
| of which other derivative products | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Other | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 1,490 | 439 | (660) | – | (51) | 475 | (1,260) | 212 | 7 | 652 | |||||||||||
| Borrowings | 242 | 15 | (37) | – | – | 47 | (212) | (95) | 43 | 3 | |||||||||||
| Debt in issuance | 1,962 | 124 | (221) | – | – | 55 | (1,695) | 13 | 17 | 255 | |||||||||||
| Other financial liabilities designated at fair value through profit or loss | 7 | – | (1) | – | (1) | – | – | (1) | – | 4 | |||||||||||
| Financial liabilities designated at fair value through profit or loss | 2,211 | 139 | (259) | – | (1) | 102 | (1,907) | (83) | 60 | 262 | |||||||||||
| Total liabilities at fair value | 3,701 | 578 | (919) | – | (52) | 577 | (3,167) | 129 | 67 | 914 | |||||||||||
| Net assets/liabilities at fair value | (1,477) | 78 | 235 | 669 | (1,213) | (94) | 2,486 | (64) | (340) | 280 | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events, all gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is received on a derivative contract. Settlement of derivatives is where cash is paid on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Bank |
Balance as at 1 January 2023 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2023 |
||||||||
| Assets at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 580 | 82 | (70) | 656 | (1,047) | – | – | (22) | (97) | 82 | |||||||||||
| Equity securities | 373 | 25 | (38) | 8 | (200) | – | – | (2) | (26) | 140 | |||||||||||
| Derivatives | 1,104 | 513 | (522) | – | – | 483 | (644) | 81 | (112) | 903 | |||||||||||
| of which interest rate products | 216 | 33 | (35) | – | – | 41 | (68) | (1) | (3) | 183 | |||||||||||
| of which foreign exchange products | 144 | 17 | (12) | – | – | 26 | (44) | 3 | 43 | 177 | |||||||||||
| of which equity/index-related products | 572 | 264 | (373) | – | – | 349 | (402) | 78 | (148) | 340 | |||||||||||
| of which credit derivatives | 172 | 199 | (102) | – | – | 67 | (130) | 1 | (4) | 203 | |||||||||||
| of which other derivative products | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Other | 70 | 3 | (54) | 1 | (10) | – | (12) | 1 | 4 | 3 | |||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | 2,127 | 623 | (684) | 665 | (1,257) | 483 | (656) | 58 | (231) | 1,128 | |||||||||||
| Loans | 28 | 27 | – | – | (3) | – | (17) | – | 8 | 43 | |||||||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 3 | 6 | – | – | (4) | – | (7) | 7 | – | 5 | |||||||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 31 | 33 | – | – | (7) | – | (24) | 7 | 8 | 48 | |||||||||||
| Total assets at fair value | 2,158 | 656 | (684) | 665 | (1,264) | 483 | (680) | 65 | (223) | 1,176 | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events only gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is paid on a derivative contract. Settlement of derivatives is where cash is received on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Bank |
Balance as at 1 January 2023 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2023 |
||||||||
| Liabilities at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 20 | – | – | – | – | – | – | – | (20) | – | |||||||||||
| Equity securities | 8 | – | – | – | (51) | – | – | – | 48 | 5 | |||||||||||
| Derivatives | 1,462 | 439 | (660) | – | – | 475 | (1,260) | 212 | (21) | 647 | |||||||||||
| of which interest rate products | 157 | 26 | (18) | – | – | 26 | (125) | 12 | 8 | 86 | |||||||||||
| of which foreign exchange products | 5 | 10 | (13) | – | – | 5 | (6) | 1 | 3 | 5 | |||||||||||
| of which equity/index-related products | 1,072 | 244 | (559) | – | – | 408 | (946) | 197 | (58) | 358 | |||||||||||
| of which credit derivatives | 228 | 159 | (70) | – | – | 36 | (183) | 2 | 26 | 198 | |||||||||||
| of which other derivative products | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Other | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 1,490 | 439 | (660) | – | (51) | 475 | (1,260) | 212 | 7 | 652 | |||||||||||
| Borrowings | 242 | 15 | (37) | – | – | 47 | (212) | (95) | 43 | 3 | |||||||||||
| Debt in issuance | 1,898 | 124 | (221) | – | – | 52 | (1,685) | 12 | 48 | 228 | |||||||||||
| Other financial liabilities designated at fair value through profit or loss | 7 | – | (1) | – | (1) | – | – | (1) | – | 4 | |||||||||||
| Financial liabilities designated at fair value through profit or loss | 2,147 | 139 | (259) | – | (1) | 99 | (1,897) | (84) | 91 | 235 | |||||||||||
| Total liabilities at fair value | 3,637 | 578 | (919) | – | (52) | 574 | (3,157) | 128 | 98 | 887 | |||||||||||
| Net assets/liabilities at fair value | (1,479) | 78 | 235 | 665 | (1,212) | (91) | 2,477 | (63) | (321) | 289 | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events only gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is received on a derivative contract. Settlement of derivatives is where cash is paid on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Group |
Balance as at 1 January 2022 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2022 |
||||||||
| Assets at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 1,183 | 318 | (464) | 3,980 | (3,917) | – | – | (94) | (361) | 645 | |||||||||||
| Equity securities | 613 | 80 | (4) | 79 | (303) | – | – | – | (91) | 374 | |||||||||||
| Derivatives | 994 | 583 | (1,653) | – | – | 1,047 | (938) | 637 | 434 | 1,104 | |||||||||||
| of which interest rate products | 67 | 33 | (30) | – | – | 27 | (27) | 1 | 145 | 216 | |||||||||||
| of which foreign exchange products | 129 | 9 | (85) | – | – | 42 | (37) | 27 | 59 | 144 | |||||||||||
| of which equity/index-related products | 476 | 398 | (1,258) | – | – | 888 | (731) | 575 | 224 | 572 | |||||||||||
| of which credit derivatives | 322 | 143 | (271) | – | – | 90 | (143) | 26 | 5 | 172 | |||||||||||
| of which other derivative products | – | – | (9) | – | – | – | – | 8 | 1 | – | |||||||||||
| Other | 70 | – | – | 58 | – | – | (129) | – | 71 | 70 | |||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | 2,860 | 981 | (2,121) | 4,117 | (4,220) | 1,047 | (1,067) | 543 | 53 | 2,193 | |||||||||||
| Loans | 8 | 6 | (14) | 71 | (10) | 96 | (124) | – | (5) | 28 | |||||||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 10 | 46 | (56) | 7 | (2) | – | – | 44 | (46) | 3 | |||||||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 18 | 52 | (70) | 78 | (12) | 96 | (124) | 44 | (51) | 31 | |||||||||||
| Total assets at fair value | 2,878 | 1,033 | (2,191) | 4,195 | (4,232) | 1,143 | (1,191) | 587 | 2 | 2,224 | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events, all gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is paid on a derivative contract. Settlement of derivatives is where cash is received on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Group |
Balance as at 1 January 2022 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2022 |
||||||||
| Liabilities at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 5 | 83 | (17) | 37 | (7) | – | – | 3 | (84) | 20 | |||||||||||
| Equity securities | – | 26 | (4) | – | (11) | – | – | – | (3) | 8 | |||||||||||
| Derivatives | 1,901 | 617 | (998) | – | – | 679 | (731) | 264 | (270) | 1,462 | |||||||||||
| of which interest rate products | 24 | 51 | (96) | – | – | 30 | (17) | 25 | 140 | 157 | |||||||||||
| of which foreign exchange products | 64 | 5 | (82) | – | – | 14 | (24) | 28 | – | 5 | |||||||||||
| of which equity/index-related products | 1,469 | 347 | (570) | – | – | 564 | (504) | 184 | (418) | 1,072 | |||||||||||
| of which credit derivatives | 344 | 214 | (241) | – | – | 71 | (186) | 19 | 7 | 228 | |||||||||||
| of which other derivative products | – | – | (9) | – | – | – | – | 8 | 1 | – | |||||||||||
| Other | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 1,906 | 726 | (1,019) | 37 | (18) | 679 | (731) | 267 | (357) | 1,490 | |||||||||||
| Borrowings | 433 | 31 | (128) | – | – | 181 | (238) | – | (37) | 242 | |||||||||||
| Debt in issuance | 2,355 | 355 | (775) | – | – | 533 | (371) | (89) | (46) | 1,962 | |||||||||||
| Other financial liabilities designated at fair value through profit or loss | 22 | 131 | (138) | 9 | (46) | – | – | 85 | (56) | 7 | |||||||||||
| Financial liabilities designated at fair value through profit or loss | 2,810 | 517 | (1,041) | 9 | (46) | 714 | (609) | (4) | (139) | 2,211 | |||||||||||
| Total liabilities at fair value | 4,716 | 1,243 | (2,060) | 46 | (64) | 1,393 | (1,340) | 263 | (496) | 3,701 | |||||||||||
| Net assets/liabilities at fair value | (1,838) | (210) | (131) | 4,149 | (4,168) | (250) | 149 | 324 | 498 | (1,477) | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events, all gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is received on a derivative contract. Settlement of derivatives is where cash is paid on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Bank |
Balance as at 1 January 2022 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2022 |
||||||||
| Assets at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 1,183 | 318 | (464) | 3,946 | (3,916) | – | – | (94) | (393) | 580 | |||||||||||
| Equity securities | 598 | 80 | (4) | 79 | (303) | – | – | – | (77) | 373 | |||||||||||
| Derivatives | 994 | 583 | (1,653) | – | – | 1,047 | (938) | 637 | 434 | 1,104 | |||||||||||
| of which interest rate products | 67 | 33 | (30) | – | – | 27 | (27) | 1 | 145 | 216 | |||||||||||
| of which foreign exchange products | 129 | 9 | (85) | – | – | 42 | (37) | 27 | 59 | 144 | |||||||||||
| of which equity/index-related products | 476 | 398 | (1,258) | – | – | 888 | (731) | 575 | 224 | 572 | |||||||||||
| of which credit derivatives | 322 | 143 | (271) | – | – | 90 | (143) | 26 | 5 | 172 | |||||||||||
| of which other derivative products | – | – | (9) | – | – | – | – | 8 | 1 | – | |||||||||||
| Other | 70 | – | – | 58 | – | – | (129) | – | 71 | 70 | |||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | 2,845 | 981 | (2,121) | 4,083 | (4,219) | 1,047 | (1,067) | 543 | 35 | 2,127 | |||||||||||
| Loans | 29 | 6 | (14) | 71 | (31) | 96 | (124) | – | (5) | 28 | |||||||||||
| Other non-trading financial assets mandatorily at fair value through profit or loss | 10 | 46 | (56) | 7 | (1) | – | – | 44 | (47) | 3 | |||||||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | 39 | 52 | (70) | 78 | (32) | 96 | (124) | 44 | (52) | 31 | |||||||||||
| Total assets at fair value | 2,884 | 1,033 | (2,191) | 4,161 | (4,251) | 1,143 | (1,191) | 587 | (17) | 2,158 | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events, all gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is paid on a derivative contract. Settlement of derivatives is where cash is received on a derivative contract.
|
|||||||||||||||||||||
| Trading revenues | |||||||||||||||||||||
|
Bank |
Balance as at 1 January 2022 |
Transfers in |
Transfers out |
Purchases |
Sales |
Issuances |
2 |
Settlements |
2 |
On transfers in/out |
1 |
On all other |
Balance as at 31 December 2022 |
||||||||
| Liabilities at fair value (USD million) | |||||||||||||||||||||
| Debt securities | 5 | 83 | (17) | 37 | (7) | – | – | 3 | (84) | 20 | |||||||||||
| Equity securities | – | 26 | (4) | – | (11) | – | – | – | (3) | 8 | |||||||||||
| Derivatives | 1,901 | 617 | (998) | – | – | 679 | (731) | 264 | (270) | 1,462 | |||||||||||
| of which interest rate products | 24 | 51 | (96) | – | – | 30 | (17) | 25 | 140 | 157 | |||||||||||
| of which foreign exchange products | 64 | 5 | (82) | – | – | 14 | (24) | 28 | – | 5 | |||||||||||
| of which equity/index-related products | 1,469 | 347 | (570) | – | – | 564 | (504) | 184 | (418) | 1,072 | |||||||||||
| of which credit derivatives | 344 | 214 | (241) | – | – | 71 | (186) | 19 | 7 | 228 | |||||||||||
| of which other derivative products | – | – | (9) | – | – | – | – | 8 | 1 | – | |||||||||||
| Other | – | – | – | – | – | – | – | – | – | – | |||||||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 1,906 | 726 | (1,019) | 37 | (18) | 679 | (731) | 267 | (357) | 1,490 | |||||||||||
| Borrowings | 433 | 31 | (127) | – | – | 181 | (238) | (31) | (7) | 242 | |||||||||||
| Debt in issuance | 2,350 | 355 | (775) | – | – | 472 | (367) | (90) | (47) | 1,898 | |||||||||||
| Other financial liabilities designated at fair value through profit or loss | 22 | 131 | (138) | 9 | (46) | – | – | 85 | (56) | 7 | |||||||||||
| Financial liabilities designated at fair value through profit or loss | 2,805 | 517 | (1,040) | 9 | (46) | 653 | (605) | (36) | (110) | 2,147 | |||||||||||
| Total liabilities at fair value | 4,711 | 1,243 | (2,059) | 46 | (64) | 1,332 | (1,336) | 231 | (467) | 3,637 | |||||||||||
| Net assets/liabilities at fair value | (1,827) | (210) | (132) | 4,115 | (4,187) | (189) | 145 | 356 | 450 | (1,479) | |||||||||||
|
1
For all transfers to Level 3 or out of Level 3, the CSi group determines and discloses as Level 3 events, all gains or losses through the last day of the reporting period.
|
|||||||||||||||||||||
|
2
Issuance of derivatives is where cash is received on a derivative contract. Settlement of derivatives is where cash is paid on a derivative contract.
|
|||||||||||||||||||||
| Group and Bank | 2023 | 2022 | |||
| Trading revenues (USD million) | |||||
| Net realised/unrealised (losses)/gains included in net revenues | (404) | 1 | 822 | 1 | |
| Whereof: | |||||
| Trading financial assets mandatorily at fair value through profit or loss | 138 | 572 | |||
| Non-trading financial assets mandatorily at fair value through profit or loss | 4 | (1) | |||
| Trading financial liabilities mandatorily at fair value through profit or loss | (187) | (100) | |||
| Financial liabilities designated at fair value through profit or loss | 31 | 3 | |||
| Total changes in unrealised (losses)/gains relating to assets and liabilities still held as of the reporting date | (14) | 474 | |||
|
1
Bank loss of USD 384 million (2022: USD 806 million gain)
|
|||||
|
As at 31 December 2023 Group (USD million except as indicated) |
Fair Value |
Valuation technique |
Unobservable input |
Lower value |
Upper value |
Weighted average |
|||||||
| Assets at fair value | |||||||||||||
| Debt securities | 100 | ||||||||||||
| of which | 21 | Option model | Correlation, in % | (50) | 100 | 69 | |||||||
| 4 | Credit spread, in bp | 30 | 148 | 132 | |||||||||
| 8 | Fund Gap Risk, in % | – | – | – | |||||||||
| 3 | Price in % | 30 | 100 | 40 | |||||||||
| 23 | Volatility, in % | 2 | 142 | 26 | |||||||||
| of which | 17 | Discounted cash flow | Credit spread in bp | 4 | 370 | 318 | |||||||
| of which | 17 | Market comparable | Price in % | 1 | 62 | 11 | |||||||
| Equity securities | 140 | ||||||||||||
| of which | 30 | Price | Price, in actuals | – | 119 | 35 | |||||||
| 110 | Unadjusted NAV | – | 54,565 | 1,655 | |||||||||
| Derivatives | 903 | ||||||||||||
| of which interest rate products | 183 | ||||||||||||
| of which | 9 | Option model | Correlation in % | 25 | 100 | 65 | |||||||
| 145 | Mean reversion, in % | (21) | 25 | 15 | |||||||||
| – | Prepayment rate in % | 15 | 21 | 18 | |||||||||
| 17 | Volatility, in % | – | 142 | 21 | |||||||||
| of which foreign exchange products | 177 | ||||||||||||
| of which | 3 | Option model | Correlation, in % | 55 | 55 | 55 | |||||||
| 160 | Mean reversion, in % | (55) | 20 | (5) | |||||||||
| of which | 13 | Discounted Cash Flow | Credit spread, in bp | 6 | 62 | 42 | |||||||
| of which equity/index-related products | 340 | ||||||||||||
| of which | 128 | Option model | Correlation, in % | (50) | 100 | 69 | |||||||
| 6 | Fund Gap Risk, in % | – | – | – | |||||||||
| – | Mean reversion, in % | 7 | 25 | 16 | |||||||||
| 197 | Volatility, in % | 2 | 142 | 26 | |||||||||
| of which | 8 | Price | Price, in actuals | – | 119 | 35 | |||||||
| of which credit derivatives | 203 | ||||||||||||
| of which | 63 | Discounted cash flow | Credit spread, in bp | 3 | 2,002 | 199 | |||||||
| 55 | Discount Rate, in % | 10 | 10 | 10 | |||||||||
| 20 | Recovery rate, in % | – | – | – | |||||||||
| of which | 57 | Price | Price, in % | 76 | 102 | 100 | |||||||
| Other | 8 | ||||||||||||
| of which trading | |||||||||||||
| of which | 3 | Market comparable | Price, in % | – | 43 | 42 | |||||||
| of which other | |||||||||||||
| of which | 2 | Discounted cash flow | Credit spread in bp | – | 35 | 27 | |||||||
| Loans | 43 | ||||||||||||
| of which | 15 | Price | Price in % | 76 | 76 | 76 | |||||||
| of which | 25 | Discounted cash flow | Credit spread, in bp | 1,217 | 1,217 | 1,217 | |||||||
|
As at 31 December 2023 (USD million except as indicated) |
Fair Value |
Valuation technique |
Unobservable input |
Lower value |
Upper value |
Weighted average |
|||||||
| Liabilities at fair value | |||||||||||||
| Equity securities | 5 | ||||||||||||
| of which | 5 | Price | Price, in actuals | – | 119 | 35 | |||||||
| Derivatives | 647 | ||||||||||||
| of which interest rate products | 86 | ||||||||||||
| of which | 2 | Option model | Correlation, in % | (25) | 100 | 62 | |||||||
| 4 | Mean reversion, in % | – | 25 | 17 | |||||||||
| 4 | Prepayment rate, in % | 15 | 21 | 18 | |||||||||
| 74 | Volatility, in % | – | 142 | 7 | |||||||||
| of which foreign exchange products | 5 | ||||||||||||
| of which | 1 | Option model | Correlation, in % | 55 | 55 | 55 | |||||||
| 1 | Mean reversion, in % | (21) | 20 | – | |||||||||
| of which equity/index-related products | 358 | ||||||||||||
| of which | 42 | Option model | Correlation, in % | (50) | 100 | 69 | |||||||
| 294 | Volatility, in % | 2 | 142 | 26 | |||||||||
| of which | 22 | Price | Price, in actuals | – | 119 | 35 | |||||||
| of which credit derivatives | 198 | ||||||||||||
| of which | 68 | Discounted cash flow | Credit spread, in bp | 3 | 2,002 | 293 | |||||||
| 55 | Discount Rate, in % | 10 | 10 | 10 | |||||||||
| 20 | Recovery rate, in % | – | – | – | |||||||||
| of which | 51 | Price | Price, in % | 102 | 102 | 102 | |||||||
| Debt in issuance | 255 | ||||||||||||
| of which structured notes over two years | 128 | ||||||||||||
| of which | 8 | Option model | Correlation, in % | (50) | 100 | 69 | |||||||
| 110 | Unadjusted NAV | – | 54,565 | 1,655 | |||||||||
| 10 | Volatility, in % | 2 | 142 | 26 | |||||||||
| of which other debt instruments over two years | 31 | ||||||||||||
| of which | 31 | Option model | Unadjusted NAV | – | 54,565 | 1,655 | |||||||
| of which structured notes between one and two years | 21 | ||||||||||||
| of which | 2 | Option model | Correlation, in % | (50) | 100 | 69 | |||||||
| 18 | Unadjusted NAV | – | 54,565 | 1,655 | |||||||||
| of which other debt instruments between one and two years | 48 | ||||||||||||
| of which | 48 | Option Model | Unadjusted NAV | – | 54,565 | 1,655 | |||||||
| of which non-recourse liabilities | 27 | ||||||||||||
| of which | 26 | Market Comparable | Price, in % | 1 | 40 | 10 | |||||||
| Borrowings | 3 | ||||||||||||
| of which | 3 | Option model | Correlation, in % | (50) | 100 | 69 | |||||||
| Other Financial liabilities designated at fair value | 4 | ||||||||||||
| of which other | |||||||||||||
| of which loan commitment at fair value | – | Discounted cash flow | Price, in % | – | – | – | |||||||
| 4 | Market Comparable | Price, in % | – | 1 | – | ||||||||
|
As at 31 December 2022 Group (USD million except as indicated) |
Fair Value |
Valuation technique |
Unobservable input |
Lower value |
Upper value |
Weighted average |
|||||||
| Assets at fair value | |||||||||||||
| Debt securities | 645 | ||||||||||||
| of which | 46 | Option model | Correlation, in % | (50) | 100 | 75 | |||||||
| 4 | Buyback probability, in % | 50 | 100 | 76 | |||||||||
| 100 | Credit spread, in bp | 27 | 358 | 326 | |||||||||
| 5 | Fund Gap Risk, in % | – | 1 | – | |||||||||
| 24 | Mean reversion, in % | 25 | 25 | 25 | |||||||||
| 366 | Volatility, in % | 5 | 148 | 24 | |||||||||
| of which | 16 | Discounted cash flow | Credit spread in bp | 10 | 750 | 347 | |||||||
| of which | 57 | Market comparable | Price in % | – | 99 | 50 | |||||||
| 17 | Price, in actuals | 1 | 218 | 29 | |||||||||
| of which | 4 | Price | Price in % | 30 | 100 | 60 | |||||||
| Equity securities | 374 | ||||||||||||
| of which | 59 | Price | Price, in actuals | – | 1,197 | 16 | |||||||
| 320 | Unadjusted NAV | 1 | 54,565 | 1,432 | |||||||||
| Derivatives | 1,104 | ||||||||||||
| of which interest rate products | 216 | ||||||||||||
| of which | 8 | Option model | Correlation in % | 9 | 78 | 52 | |||||||
| 175 | Mean reversion, in % | (21) | 25 | 21 | |||||||||
| 5 | Contingent probability, in % | 95 | 95 | 95 | |||||||||
| 8 | Prepayment rate in % | 6 | 19 | 10 | |||||||||
| 13 | Volatility, in % | (3) | 148 | 4 | |||||||||
| of which | 1 | Discounted Cash Flow | Volatility, in % | 95 | 110 | 103 | |||||||
| of which foreign exchange products | 144 | ||||||||||||
| of which | 4 | Option model | Correlation, in % | (50) | 100 | 55 | |||||||
| 129 | Mean reversion, in % | (55) | 20 | (5) | |||||||||
| of which | 6 | Discounted Cash Flow | Credit spread, in bp | 17 | 209 | 168 | |||||||
| of which equity/index-related products | 572 | ||||||||||||
| of which | 1 | Option model | Buyback probability, in % | 50 | 100 | 76 | |||||||
| 245 | Correlation, in % | (50) | 100 | 75 | |||||||||
| 10 | Fund Gap Risk, in % | – | 1 | – | |||||||||
| – | Gap risk, in % | – | 2 | – | |||||||||
| – | Mean reversion, in % | 25 | 25 | 25 | |||||||||
| 304 | Volatility, in % | 5 | 148 | 24 | |||||||||
| 2 | Dividend Yield, in % | – | 13 | 5 | |||||||||
| of which | 9 | Price | Price, in actuals | – | 1,197 | 28 | |||||||
| of which credit derivatives | 172 | ||||||||||||
| of which | 96 | Discounted cash flow | Credit spread, in bp | 3 | 2,078 | 242 | |||||||
| 63 | Discount Rate, in % | 6 | 13 | 11 | |||||||||
| – | Recovery rate, in % | 25 | 25 | 25 | |||||||||
| of which | 4 | Price | Price, in % | 102 | 102 | 102 | |||||||
| of which commodity, emission and energy products | – | ||||||||||||
| of which | – | Option Model | Volatility, in % | 5 | 148 | 24 | |||||||
| of which precious metals products | |||||||||||||
| of which | 1 | Option Model | Correlation, in % | (50) | 100 | 75 | |||||||
| of which other derivative product | – | ||||||||||||
| of which | (1) | Discounted cash flow | Discount Rate, in % | – | – | – | |||||||
| Other | 70 | ||||||||||||
| of which trading | 1 | Discounted cash flow | Tax Swap rate (Percentage of VAT receivable PV) | 30 | 30 | 30 | |||||||
| 69 | Market comparable | Price, in % | – | 97 | 90 | ||||||||
| of which other | – | Market Comparable | Price, in % | – | 10 | 10 | |||||||
| 2 | Discounted cash flow | Credit spread in bp | – | 35 | 27 | ||||||||
| Loans | 28 | ||||||||||||
| of which | 24 | Price | Price in % | 74 | 74 | 74 | |||||||
|
As at 31 December 2022 Group (USD million except as indicated) |
Fair Value |
Valuation technique |
Unobservable input |
Lower value |
Upper value |
Weighted average |
|||||||
| Liabilities at fair value | |||||||||||||
| Debt | 20 | ||||||||||||
| of which | 20 | Price | Price, in % | 30 | 100 | 41 | |||||||
| Equity securities | 8 | ||||||||||||
| of which | 8 | Price | Price, in actuals | – | 1,197 | 28 | |||||||
| Derivatives | 1,462 | ||||||||||||
| of which interest rate products | 157 | ||||||||||||
| of which | – | Option model | Correlation, in % | 9 | 20 | 13 | |||||||
| (27) | Mean reversion, in % | (21) | 25 | 4 | |||||||||
| (5) | Prepayment rate, in % | 7 | 19 | 8 | |||||||||
| (5) | Contingent probability, in % | 95 | 95 | 95 | |||||||||
| (89) | Volatility, in % | (3) | 1 | – | |||||||||
| of which | (20) | Discounted cash flow | Discount Rate, in % | – | – | – | |||||||
| (1) | Volatility, in % | 95 | 110 | 103 | |||||||||
| of which foreign exchange products | 5 | ||||||||||||
| of which | (2) | Discounted cash flow | Credit spread, in bp | 77 | 468 | 123 | |||||||
| (1) | Option model | Correlation, in % | 55 | 55 | 55 | ||||||||
| – | Mean reversion, in % | (55) | 20 | (3) | |||||||||
| of which equity/index-related products | 1,072 | ||||||||||||
| of which | – | Option model | Buyback probability, in % | 50 | 100 | 76 | |||||||
| (38) | Correlation, in % | (50) | 100 | 68 | |||||||||
| – | Fund Gap Risk, in % | – | 1 | – | |||||||||
| (997) | Volatility, in % | 5 | 148 | 24 | |||||||||
| (3) | Dividend Yield, in % | – | 13 | 5 | |||||||||
| of which | (33) | Price | Price, in actuals | – | 1,197 | 28 | |||||||
| of which | (1) | Market Comparable | Price, in actuals | (1) | (1) | (1) | |||||||
| of which credit derivatives | 228 | ||||||||||||
| of which | (134) | Discounted cash flow | Credit spread, in bp | 3 | 2,149 | 332 | |||||||
| (63) | Discount Rate, in % | 6 | 17 | 11 | |||||||||
| (20) | Recovery rate, in % | – | – | – | |||||||||
| of which | (2) | Price | Price, in % | 74 | 102 | 102 | |||||||
| of which | (7) | Option model | Credit spread, in bp | 47 | 1,528 | 194 | |||||||
| Debt in issuance | 1,962 | ||||||||||||
| of which structured notes over two years | 1,727 | ||||||||||||
| of which | 1,490 | Discounted cash flow | Credit spread, in bp | 250 | 250 | 250 | |||||||
| of which | 110 | Option model | Buyback probability, in % | 50 | 100 | 76 | |||||||
| 23 | Correlation, in % | (50) | 100 | 74 | |||||||||
| 10 | Fund Gap Risk, in % | – | 1 | – | |||||||||
| 78 | Unadjusted NAV | 1 | 54,565 | 1,432 | |||||||||
| 16 | Volatility, in % | 5 | 148 | 17 | |||||||||
| of which other debt instruments over two years | 73 | ||||||||||||
| of which | 72 | Option model | Buyback probability, in % | 50 | 100 | 76 | |||||||
| of which | 1 | Market Comparable | Price, in actuals | 218 | 218 | 218 | |||||||
| of which structured notes between one and two years | 71 | ||||||||||||
| of which | 6 | Option model | Buyback probability, in % | 50 | 100 | 76 | |||||||
| 63 | Correlation, in % | (50) | 100 | 75 | |||||||||
| 2 | Gap risk, in % | – | 2 | – | |||||||||
| 1 | Volatility, in % | 5 | 148 | 24 | |||||||||
| – | Volatility, in % | ||||||||||||
| of which other debt instruments between one and two years | 27 | ||||||||||||
| of which | 27 | Option Model | Unadjusted NAV | 1 | 54,565 | 1,432 | |||||||
| of which non-recourse liabilities | 64 | ||||||||||||
| of which | 64 | Market Comparable | Price, in % | (1) | 26 | 9 | |||||||
| Borrowings | 242 | ||||||||||||
| of which | 165 | Option model | Buyback probability, in % | 50 | 100 | 76 | |||||||
| 78 | Correlation, in % | (50) | 100 | 75 | |||||||||
| – | Volatility, in % | 5 | 148 | 24 | |||||||||
| Other Financial liabilities designated at fair value | 7 | ||||||||||||
| of which failed sales | – | ||||||||||||
| of which | – | Market Comparable | Price, in % | – | 1 | 1 | |||||||
| of which other | 7 | ||||||||||||
| of which loan commitment at fair value | – | Option Model | Contingent probability, in % | 95 | 95 | 95 | |||||||
| 3 | Market comparable | Price in % | – | 93 | 43 | ||||||||
| As at 31 December 2023 | As at 31 December 2022 | ||||||||
|
Group and Bank |
Favourable changes |
Unfavourable changes |
Favourable changes |
Unfavourable changes |
|||||
| Impact on net income/(loss) (USD million) | |||||||||
| Derivative assets and liabilities | 159 | (150) | 248 | (246) | |||||
| Debt and equity securities | 3 | (3) | 3 | (3) | |||||
| Loans | 11 | (4) | 11 | (5) | |||||
| Other | 17 | (15) | – | – | |||||
| Total | 190 | (172) | 262 | (254) | |||||
| 2023 | 2022 | ||||
| Deferred trade date profit (USD million) | |||||
| Balance at the beginning of period | 472 | 519 | |||
| Increase due to new trades | 48 | 160 | |||
| Reduction due to passage of time | (58) | (91) | |||
| Reduction due to redemption, sales, transfers or improved observability | (233) | (116) | |||
| Balance at the end of period | 229 | 472 | |||
|
As at 31 December 2023 Group (USD million) |
Level 1 |
Level 2 |
Level 3 |
Fair value |
|||||
| Financial assets | |||||||||
| Cash and due from banks | 754 | 2,873 | – | 3,627 | |||||
| Interest-bearing deposits with banks | – | 8,319 | – | 8,319 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 1,304 | – | 1,304 | |||||
| Loans and advances | – | 499 | 2,755 | 3,254 | |||||
| Other assets | – | 16,977 | – | 16,977 | |||||
| Total fair value of financial assets | 754 | 29,972 | 2,755 | 33,481 | |||||
| Financial liabilities | |||||||||
| Due to banks | 31 | – | – | 31 | |||||
| Securities sold under repurchase agreements and securities lending transactions | – | 358 | – | 358 | |||||
| Borrowings | – | 12,622 | – | 12,622 | |||||
| Debt in issuance | – | 5,728 | 2,397 | 8,125 | |||||
| Other financial liabilities | – | 8,604 | – | 8,604 | |||||
| Total fair value of financial liabilities | 31 | 27,312 | 2,397 | 29,740 | |||||
|
As at 31 December 2023 Bank (USD million) |
|
|
|
|
|||||
| Financial assets | |||||||||
| Cash and due from banks | 743 | 2,873 | – | 3,616 | |||||
| Interest-bearing deposits with banks | – | 8,319 | – | 8,319 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 1,304 | – | 1,304 | |||||
| Loans and advances | – | 499 | 2,755 | 3,254 | |||||
| Other assets | – | 16,977 | – | 16,977 | |||||
| Total fair value of financial assets | 743 | 29,972 | 2,755 | 33,470 | |||||
| Financial liabilities | |||||||||
| Due to banks | 31 | – | – | 31 | |||||
| Securities sold under repurchase agreements and securities lending transactions | – | 358 | – | 358 | |||||
| Borrowings | – | 12,622 | – | 12,622 | |||||
| Debt in issuance | – | 5,728 | 2,397 | 8,125 | |||||
| Other financial liabilities | – | 8,604 | – | 8,604 | |||||
| Total fair value of financial liabilities | 31 | 27,312 | 2,397 | 29,740 | |||||
|
As at 31 December 2022 Group (USD million) |
Level 1 |
Level 2 |
Level 3 |
Fair value |
|||||
| Financial assets | |||||||||
| Cash and due from banks | 4,143 | 6 | – | 4,149 | |||||
| Interest-bearing deposits with banks | – | 12,085 | – | 12,085 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 10,527 | – | 10,527 | |||||
| Loans and advances | – | 183 | 2,534 | 2,717 | |||||
| Other assets | – | 21,178 | – | 21,178 | |||||
| Total fair value of financial assets | 4,143 | 43,979 | 2,534 | 50,656 | |||||
| Financial liabilities | |||||||||
| Due to banks | 266 | – | – | 266 | |||||
| Securities sold under repurchase agreements and securities lending transactions | – | 2,924 | – | 2,924 | |||||
| Borrowings | – | 6,025 | – | 6,025 | |||||
| Debt in issuance | – | 18,079 | – | 18,079 | |||||
| Other financial liabilities | – | 16,379 | – | 16,379 | |||||
| Total fair value of financial liabilities | 266 | 43,407 | – | 43,673 | |||||
|
As at 31 December 2022 Bank (USD million) |
Level 1 |
Level 2 |
Level 3 |
Fair value |
|||||
| Financial assets | |||||||||
| Cash and due from banks | 4,127 | 6 | – | 4,133 | |||||
| Interest-bearing deposits with banks | – | 12,085 | – | 12,085 | |||||
| Securities purchased under resale agreements and securities borrowing transactions | – | 10,527 | – | 10,527 | |||||
| Loans and advances | – | 183 | 2,534 | 2,717 | |||||
| Other assets | – | 21,178 | – | 21,178 | |||||
| Total fair value of financial assets | 4,127 | 43,979 | 2,534 | 50,640 | |||||
| Financial liabilities | |||||||||
| Due to banks | 266 | – | – | 266 | |||||
| Securities sold under repurchase agreements and securities lending transactions | – | 2,924 | – | 2,924 | |||||
| Borrowings | – | 6,025 | – | 6,025 | |||||
| Debt in issuance | – | 18,079 | – | 18,079 | |||||
| Other financial liabilities | – | 16,379 | – | 16,379 | |||||
| Total fair value of financial liabilities | 266 | 43,407 | – | 43,673 | |||||
| Group and Bank | 2023 | 2022 | |||
| Assets pledged or assigned (USD million) | |||||
| Trading financial assets at fair value through profit or loss 1 | 3,742 | 10,616 | |||
| Collateral received (USD million) | |||||
| Fair value of collateral received with the right to resell or repledge 2 | 32,676 | 61,221 | |||
| Of which sold or repledged 3 | 15,844 | 47,467 | |||
|
1
Includes USD 779 million (2022 : USD 1,197 million) assets recognised on the balance sheet but are encumbered due to failed sale financing transactions.
|
|||||
|
2
Includes USD 283 million (2022 : USD 102 million) of collateral assets received from failed purchased financing transactions.
|
|||||
|
3
Includes USD 163 million (2022: USD 100 million) collateral assets not already recognised on the balance sheet relating to failed sale financing transactions.
|
|||||
|
Carrying amount of continuing involvement in statement of financial position |
Fair value of continuing involvement |
Maximum exposure to loss |
Loss from transfer |
(Expense)/Income from continuing involvement |
|||||||||||||
|
Type of continuing involvement Group and Bank (USD million) |
Trading financial assets at fair value through profit or loss |
Trading financial liabilities at fair value through profit or loss |
Assets |
Liabilities |
|
|
For the year ended 31 December |
Cumulative to 31 December |
|||||||||
| 2023 | |||||||||||||||||
| Derivatives | |||||||||||||||||
| Swaps | 86 | (33) | 86 | (33) | 67 | 28 | (3) | (32) | |||||||||
| Total | 86 | (33) | 86 | (33) | 67 | 28 | (3) | (32) | |||||||||
| 2022 | |||||||||||||||||
| Derivatives | |||||||||||||||||
| Options | – | (1) | – | (1) | – | – | (1) | (1) | |||||||||
| Swaps | 93 | (38) | 93 | (38) | 56 | 27 | (53) | (18) | |||||||||
| Total | 93 | (39) | 93 | (39) | 56 | 27 | (54) | (19) | |||||||||
|
Type of continuing involvement Group and Bank (USD million) |
Total |
On demand |
|||
| 2023 | |||||
| Derivatives | |||||
| Swaps | (23) | (23) | |||
| 2022 | |||||
| Derivatives | |||||
| Swaps | (30) | (30) | |||
|
|
|||||
| 2023 | 2022 | ||||||||
|
Group and Bank (USD million) |
Carrying amount of assets |
Carrying amount of asso- ciated liabilities |
Carrying amount of assets |
Carrying amount of asso- ciated liabilities |
|||||
| Financial assets not derecognised due to the following transactions | |||||||||
| Repurchase & Securities lending agreements | 3,742 | 3,742 | 9,419 | 9,419 | |||||
| Total Return Swaps | 792 | 802 | 817 | 846 | |||||
| Callable asset swap | 130 | 146 | 340 | 380 | |||||
| Options | 26 | 20 | – | – | |||||
| Other | – | – | 148 | 133 | |||||
|
End of period |
Interest rate and credit spread |
4 |
Foreign exchange |
1,4 |
Commodity |
1,4 |
Equity |
4 |
Diversifi- cation benefit |
2 |
Total |
||
| 2023 (USD million) | |||||||||||||
| Average | 32 | 3 | 4 | 23 | (34) | 28 | |||||||
| Minimum | 20 | – | 1 | 12 | – | 3 | 13 | ||||||
| Maximum | 61 | 11 | 12 | 48 | – | 3 | 55 | ||||||
| End of period | 20 | 5 | 2 | 12 | (22) | 16 | |||||||
| 2022 (USD million) | |||||||||||||
| Average | 48 | 138 | 7 | 102 | (240) | 55 | |||||||
| Minimum | 26 | 42 | 4 | 53 | – | 3 | 31 | ||||||
| Maximum | 66 | 209 | 29 | 173 | – | 3 | 75 | ||||||
| End of period | 29 | 169 | 6 | 112 | (283) | 32 | |||||||
|
1
Along with the trading related market risk exposure, foreign exchange and commodity risks in the banking book is included in the VaR computation.
|
|||||||||||||
|
2
VaR is calculated separately for each risk type and for the whole portfolio using the historical simulation methodology. Diversification benefit reflects the net difference between the sum of the 99% percentile VaR for each risk type compared to the whole portfolio.
|
|||||||||||||
|
3
As the minimum and maximum occur on different days for different risk types, it is not meaningful to calculate a portfolio diversification benefit.
|
|||||||||||||
|
4
Asset class VaR for 2023 is updated to be calculated using risk based approach. This change in approach is driving large reductions in Foreign exchange and Equity VaR
|
|||||||||||||
|
Group 31 December 2023 |
On Demand |
Due within 3 months |
Due between 3 and 12 months |
Due between 1 and 5 years |
Due after 5 years |
Total |
|||||||
| Financial liabilities (USD million) | |||||||||||||
| Due to banks | 31 | – | – | – | – | 31 | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 125 | – | 233 | – | – | 358 | |||||||
| Trading financial liabilities at fair value through profit or loss | 60,519 | – | – | – | – | 60,519 | |||||||
| Financial liabilities designated at fair value through profit or loss 1 | 3,073 | 8,103 | 979 | 3,356 | 539 | 16,050 | |||||||
| Borrowings | – | 341 | 12,281 | – | – | 12,622 | |||||||
| Debt in issuance | – | 129 | 4,256 | 4,494 | 2 | 8,881 | |||||||
| Other liabilities | 8,604 | – | – | – | – | 8,604 | |||||||
| Total | 72,352 | 8,573 | 17,749 | 7,850 | 541 | 107,065 | |||||||
|
Group 31 December 2022 |
|
|
|
|
|
|
|||||||
| Financial liabilities (USD million) | |||||||||||||
| Due to banks | 266 | – | – | – | – | 266 | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 1,564 | 472 | 888 | – | – | 2,924 | |||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 93,397 | – | – | – | – | 93,397 | |||||||
| Financial liabilities designated at fair value through profit or loss 1 | 8,145 | 9,603 | 2,177 | 6,824 | 420 | 27,169 | |||||||
| Borrowings | – | 416 | 5,609 | – | – | 6,025 | |||||||
| Debt in issuance | – | 233 | 3,039 | 16,648 | 3 | 19,923 | |||||||
| Other liabilities | 16,149 | – | – | – | – | 16,149 | |||||||
| Total | 119,521 | 10,724 | 11,713 | 23,472 | 423 | 165,853 | |||||||
|
1
Financial liabilities designated at fair value through profit or loss includes certain structured notes and some other other financial instruments that are reported at their fair values, rather than their undiscounted amounts, since these best represent the expected future outflow for these balances. In addition, there are certain structured notes that have mandatory early redemption features based on stipulated movements in markets or the occurrence of a market event. With respect to these notes those that have an observable likelihood of redemption occurring within one year based on a modelling assessment are also included in current liabilities. Within the population this includes USD 17 million (2022: USD 73 million) of such notes with a contractual maturity of between 1 and 5 years.
|
|||||||||||||
|
Bank 31 December 2023 |
On Demand |
Due within 3 months |
Due between 3 and 12 months |
Due between 1 and 5 years |
Due after 5 years |
Total |
|||||||
| Financial liabilities (USD million) | |||||||||||||
| Due to banks | 31 | – | – | – | – | 31 | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 125 | – | 233 | – | – | 358 | |||||||
| Trading financial liabilities at fair value through profit or loss | 60,519 | – | – | – | – | 60,519 | |||||||
| Financial liabilities designated at fair value through profit or loss 1 | 3,073 | 8,103 | 963 | 3,332 | 420 | 15,891 | |||||||
| Borrowings | – | 341 | 12,281 | – | – | 12,622 | |||||||
| Debt in issuance | – | 129 | 4,256 | 4,494 | 2 | 8,881 | |||||||
| Other liabilities | 8,604 | – | – | – | – | 8,604 | |||||||
| Total | 72,352 | 8,573 | 17,733 | 7,826 | 422 | 106,906 | |||||||
|
Bank 31 December 2022 |
|
|
|
|
|
|
|||||||
| Financial liabilities (USD million) | |||||||||||||
| Due to banks | 266 | – | – | – | – | 266 | |||||||
| Securities sold under repurchase agreements and securities lending transactions | 1,564 | 472 | 888 | – | – | 2,924 | |||||||
| Trading financial liabilities mandatorily at fair value through profit or loss | 93,661 | – | – | – | – | 93,661 | |||||||
| Financial liabilities designated at fair value through profit or loss 1 | 8,147 | 9,306 | 1,903 | 6,556 | 420 | 26,332 | |||||||
| Borrowings | – | 416 | 5,609 | – | – | 6,025 | |||||||
| Debt in Issuance | – | 233 | 3,039 | 16,648 | 3 | 19,923 | |||||||
| Other liabilities | 16,148 | – | – | – | – | 16,148 | |||||||
| Total | 119,786 | 10,427 | 11,439 | 23,204 | 423 | 165,279 | |||||||
|
1
Financial liabilities designated at fair value through profit or loss includes certain structured notes and some other other financial instruments that are reported at their fair values, rather than their undiscounted amounts, since these best represent the expected future outflow for these balances. In addition, there are certain structured notes that have mandatory early redemption features based on stipulated movements in markets or the occurrence of a market event. With respect to these notes those that have an observable likelihood of redemption occurring within one year based on a modelling assessment are also included in current liabilities. Within the population this includes USD 17 million (2022: USD 73 million) of such notes with a contractual maturity of between 1 and 5 years.
|
|||||||||||||
| Group | Bank | ||||||||||||
|
2023 (USD million) |
Gross |
Collateral and other credit enhance- ments |
Net |
Gross |
Collateral and other credit enhance- ments |
Net |
|||||||
| Maximum exposure to credit risk | |||||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Debt securities | 1,841 | – | 1,841 | 1,886 | – | 1,886 | |||||||
| Derivative trading positions | 57,337 | 56,006 | 1,331 | 57,337 | 56,006 | 1,331 | |||||||
| Other | 164 | – | 164 | 164 | – | 164 | |||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Loans | 270 | 270 | – | 274 | 270 | 4 | |||||||
| Reverse repurchase agreements | 23,910 | 23,910 | – | 23,910 | 23,910 | – | |||||||
| Other | 408 | 189 | 219 | 211 | 189 | 22 | |||||||
| Maximum exposure to credit risk – total assets | 83,930 | 80,375 | 3,555 | 83,782 | 80,375 | 3,407 | |||||||
| Off-balance sheet items | |||||||||||||
| loan commitments and other credit related commitments | 800 | 103 | 697 | 800 | 103 | 697 | |||||||
| Maximum exposure to credit risk – total off-balance sheet | 800 | 103 | 697 | 800 | 103 | 697 | |||||||
| Maximum exposure to credit risk | 84,730 | 80,478 | 4,252 | 84,582 | 80,478 | 4,104 | |||||||
| 2022 (USD million) | |||||||||||||
| Maximum exposure to credit risk | |||||||||||||
| Trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Debt securities | 8,353 | – | 8,353 | 8,248 | – | 8,248 | |||||||
| Derivative trading positions | 90,067 | 83,545 | 6,522 | 90,188 | 83,545 | 6,643 | |||||||
| Other | 316 | – | 316 | 316 | – | 316 | |||||||
| Non-trading financial assets mandatorily at fair value through profit or loss | |||||||||||||
| Loans | 1,105 | 49 | 1,056 | 700 | 49 | 651 | |||||||
| Reverse repurchase agreements | 21,093 | 21,082 | 11 | 21,093 | 21,082 | 11 | |||||||
| Other | 633 | 435 | 198 | 465 | 435 | 30 | |||||||
| Maximum exposure to credit risk – total assets | 121,567 | 105,111 | 16,456 | 121,010 | 105,111 | 15,899 | |||||||
| Off-balance sheet items | |||||||||||||
| loan commitments and other credit related commitments | 1,494 | 254 | 1,240 | 1,494 | 254 | 1,240 | |||||||
| Maximum exposure to credit risk – total off-balance sheet | 1,494 | 254 | 1,240 | 1,494 | 254 | 1,240 | |||||||
| Maximum exposure to credit risk | 123,061 | 105,365 | 17,696 | 122,504 | 105,365 | 17,139 | |||||||
| Classes of Financial assets | |||||||
|
As at 31 December, 2023 Group In millions of USD |
Interest bearing deposits with banks |
Securities purchases under resale agreements and securities borrowing transactions |
Total |
||||
| AA+ to AA- | – | – | – | ||||
| A+ to A- | 8,319 | 616 | 8,935 | ||||
| BBB+ to BBB- | – | 688 | 688 | ||||
| BB+ to BB- | – | – | – | ||||
| B+ and below | – | – | – | ||||
| Gross Carrying amount | 8,319 | 1,304 | 9,623 | ||||
| Loss allowance | – | – | – | ||||
| Net Carrying amount | 8,319 | 1,304 | 9,623 | ||||
| Classes of Financial assets | |||||||
|
As at 31 December, 2022 Group In millions of USD |
Interest bearing deposits with banks |
Securities purchases under resale agreements and securities borrowing transactions |
Total |
||||
| AA+ to AA- | – | 5 | 5 | ||||
| A+ to A- | 12,086 | 8,843 | 20,929 | ||||
| BBB+ to BBB- | – | 1,652 | 1,652 | ||||
| BB+ to BB- | – | 7 | 7 | ||||
| B+ and below | – | 20 | 20 | ||||
| Gross Carrying amount | 12,086 | 10,527 | 22,613 | ||||
| Loss allowance | – | 1 | 1 | ||||
| Net Carrying amount | 12,086 | 10,526 | 22,612 | ||||
|
Group In millions of USD |
12-month ECL (Stage 1) |
Lifetime ECL not credit-impaired (Stage 2) |
Lifetime ECL credit-impaired (Stage 3) |
Purchased credit-impaired |
Total |
||||||
| 2023 | |||||||||||
| AA+ to AA- | 291 | – | – | – | 291 | ||||||
| A+ to A- | 3,131 | – | – | – | 3,131 | ||||||
| BBB+ to BBB- | 22 | – | – | – | 22 | ||||||
| BB+ to BB- | 4 | – | – | – | 4 | ||||||
| B+ and below | 150 | – | 30 | – | 180 | ||||||
| Gross Carrying amount | 3,598 | – | 30 | – | 3,628 | ||||||
| Loss allowance | – | – | 10 | – | 10 | ||||||
| Net Carrying amount | 3,598 | – | 20 | – | 3,618 | ||||||
| 2022 | |||||||||||
| AA+ to AA- | 537 | – | – | – | 537 | ||||||
| A+ to A- | 3,530 | – | – | – | 3,530 | ||||||
| BBB+ to BBB- | 27 | – | – | – | 27 | ||||||
| BB+ to BB- | 5 | – | – | – | 5 | ||||||
| B+ and below | 50 | – | – | – | 50 | ||||||
| Gross Carrying amount | 4,149 | – | – | – | 4,149 | ||||||
| Loss allowance | – | – | – | – | – | ||||||
| Net Carrying amount | 4,149 | – | – | – | 4,149 |
|
Group and Bank In millions of USD |
12-month ECL (Stage 1) |
Lifetime ECL not credit-impaired (Stage 2) |
Lifetime ECL credit-impaired (Stage 3) |
Purchased credit-impaired |
Total |
||||||
| 2023 | |||||||||||
| BBB+ to BBB- | 3,003 | – | – | – | 3,003 | ||||||
| BB+ to BB- | – | – | – | – | – | ||||||
| B+ and below | 68 | 145 | 74 | – | 287 | ||||||
| Gross Carrying amount | 3,071 | 145 | 74 | – | 3,290 | ||||||
| Loss allowance | 3 | 30 | 67 | 100 | |||||||
| Net Carrying amount | 3,068 | 115 | 7 | – | 3,190 | ||||||
| 2022 | |||||||||||
| BBB+ to BBB- | 2,557 | – | – | – | 2,557 | ||||||
| BB+ to BB- | 79 | – | – | – | 79 | ||||||
| B+ and below | 81 | 29 | 28 | – | 138 | ||||||
| Gross Carrying amount | 2,717 | 29 | 28 | – | 2,774 | ||||||
| Loss allowance | 4 | 1 | 15 | – | 20 | ||||||
| Net Carrying amount | 2,713 | 28 | 13 | – | 2,754 |
|
Group and Bank In millions of USD |
12-month ECL (Stage 1) |
Lifetime ECL not credit-impaired (Stage 2) |
Lifetime ECL credit-impaired (Stage 3) |
Purchased credit-impaired |
Total |
||||||
| 2023 | |||||||||||
| AA+ to AA- | 27 | – | – | – | 27 | ||||||
| A+ to A- | – | – | – | – | – | ||||||
| BBB+ to BBB- | 173 | – | – | – | 173 | ||||||
| BB+ to BB- | 115 | – | – | – | 115 | ||||||
| B+ and below | 160 | 2 | – | – | 162 | ||||||
| Gross Carrying amount | 475 | 2 | – | – | 477 | ||||||
| Loss allowance | 1 | – | – | – | 1 | ||||||
| Net Carrying amount | 474 | 2 | – | – | 476 | ||||||
| 2022 | |||||||||||
| AA+ to AA- | 15 | – | – | – | 15 | ||||||
| A+ to A- | – | – | – | – | – | ||||||
| BBB+ to BBB- | 707 | – | – | – | 707 | ||||||
| BB+ to BB- | 75 | – | – | – | 75 | ||||||
| B+ and below | 188 | 186 | – | – | 374 | ||||||
| Gross Carrying amount | 985 | 186 | – | – | 1,171 | ||||||
| Loss allowance | 2 | 1 | – | – | 3 | ||||||
| Net Carrying amount | 983 | 185 | – | – | 1,168 |
|
Group and Bank In millions of USD |
12-month ECL (Stage 1) |
Lifetime ECL not credit-impaired (Stage 2) |
Lifetime ECL credit-impaired (Stage 3) |
Purchased credit-impaired |
Total |
||||||
| 2023 | |||||||||||
| AAA | 595 | – | – | – | 595 | ||||||
| AA+ to AA- | 4,618 | – | – | – | 4,618 | ||||||
| A+ to A- | 5,955 | – | – | – | 5,955 | ||||||
| BBB+ to BBB- | 3,357 | – | – | – | 3,357 | ||||||
| BB+ to BB- | 58 | – | – | – | 58 | ||||||
| B+ and below | 2,394 | – | – | – | 2,394 | ||||||
| Gross Carrying amount | 16,977 | – | – | – | 16,977 | ||||||
| Loss allowance | 0 | 0 | – | – | 0 | ||||||
| Net Carrying amount | 16,977 | (0) | – | – | 16,977 | ||||||
| 2022 | |||||||||||
| AAA | 495 | – | – | – | 495 | ||||||
| AA+ to AA- | 4,236 | – | – | – | 4,236 | ||||||
| A+ to A- | 8,824 | – | – | – | 8,824 | ||||||
| BBB+ to BBB- | 2,870 | – | – | – | 2,870 | ||||||
| BB+ to BB- | 248 | – | – | – | 248 | ||||||
| B+ and below | 47 | – | 4,374 | – | 4,421 | ||||||
| Gross Carrying amount | 16,720 | – | 4,374 | – | 21,094 | ||||||
| Loss allowance | 0 | – | 4,374 | – | 4,374 | ||||||
| Net Carrying amount | 16,720 | – | 0 | – | 16,720 |
| Financial instruments yet to transition to alternative benchmarks, by main benchmark | |||||||||||
| 31 December 2022 (USD millions) | USD Libor | GBP Libor | JPY Libor | SGD SOR | Total | ||||||
| Notional value of non-derivative financial assets | 8 | – | – | – | 8 | ||||||
| Notional value of non-derivative financial liabilities | 30 | – | – | – | 30 | ||||||
| Derivative notional contract amount | 140,764 | 0 | 0 | 230 | 140,994 | ||||||
|
1
This table does not include financial instruments that reference a benchmark interest rate that is required to transition to an alternative benchmark rate, but which will mature prior to that transition date. The table also does not include financial instruments that reference a benchmark interest rate having effective fallback provisions.
|
|||||||||||
| 2023 (USD Million) |
Amounts subject to enforceable master netting agreements |
Amounts not offset in the Consolidated statement of Financial Position |
|||||||||||||||
|
Group |
Gross |
Offsetting |
Net |
Financial instruments |
2 |
Cash collateral received/ pledged |
2 |
Net exposure |
Amounts not subject to enforceable master netting agreements |
1 |
Total |
||||||
| Financial Assets | |||||||||||||||||
| Derivative assets | 57,961 | (996) | 56,965 | (49,745) | (6,261) | 959 | 375 | 57,340 | |||||||||
| of which recorded in trading financial assets mandatorily at fair value through profit or loss | 57,958 | (996) | 56,962 | (49,745) | (6,261) | 956 | 375 | 57,337 | |||||||||
| of which recorded in non-trading financial assets mandatorily at fair value through profit or loss | 3 | – | 3 | – | – | 3 | – | 3 | |||||||||
| Securities purchased under resale agreements | 25,878 | (1,326) | 24,552 | (24,512) | (40) | – | – | 24,552 | |||||||||
| Securities borrowing transactions | 662 | – | 662 | (662) | – | – | – | 662 | |||||||||
| Loans | 326 | (56) | 270 | – | – | 270 | – | 270 | |||||||||
| Other Assets- cash collateral on derivative instruments | 15,525 | (3) | 15,522 | – | (7,917) | 7,605 | 206 | 15,728 | |||||||||
| Funded Derivatives Assets | – | – | – | – | – | – | – | – | |||||||||
| Financial Liabilities | |||||||||||||||||
| Derivative liabilities | 58,990 | (940) | 58,050 | (49,744) | (7,917) | 389 | 512 | 58,562 | |||||||||
| of which recorded in trading financial liabilities mandatorily at fair value through profit or loss | 58,990 | (940) | 58,050 | (49,744) | (7,917) | 389 | 512 | 58,562 | |||||||||
| of which recorded in financial liabilities designated at fair value through profit or loss | – | – | – | – | – | – | – | – | |||||||||
| Securities sold under resale agreements | 8,886 | (835) | 8,051 | (8,037) | – | 14 | – | 8,051 | |||||||||
| Securities lending transactions | 306 | – | 306 | (306) | – | – | – | 306 | |||||||||
| Short Positions | 2,541 | (584) | 1,957 | – | – | 1,957 | – | 1,957 | |||||||||
| Other Liabilities- cash collateral on derivative instruments | 7,521 | (22) | 7,499 | – | (6,261) | 1,238 | 55 | 7,554 | |||||||||
| Funded Derivatives Liabilities | – | – | – | – | – | – | – | – | |||||||||
|
1
Represents instruments where a legal opinion supporting the enforceability of netting in the event of default or termination under the agreement is not in place.
|
|||||||||||||||||
|
2
The total amount reported in financial instruments and cash collateral is limited to the net amount for the related instruments presented in the Consolidated Statement of Financial Position.
|
|||||||||||||||||
| 2022 (USD Million) |
Amounts subject to enforceable master netting agreements |
Amounts not offset in the Consolidated statement of Financial Position |
|||||||||||||||
|
Group |
Gross |
Offsetting |
Net |
Financial instruments |
Cash collateral received/ pledged |
Net exposure |
Amounts not subject to enforceable master netting agreements |
Total |
|||||||||
| Financial Assets | |||||||||||||||||
| Derivative assets | 98,249 | (9,105) | 89,144 | (73,748) | (9,797) | 5,599 | 930 | 90,074 | |||||||||
| of which recorded in trading financial assets mandatorily at fair value through profit or loss | 98,242 | (9,105) | 89,137 | (73,748) | (9,797) | 5,592 | 930 | 90,067 | |||||||||
| of which recorded in non-trading financial assets mandatorily at fair value through profit or loss | 7 | – | 7 | – | – | 7 | – | 7 | |||||||||
| Securities purchased under resale agreements | 33,476 | (6,792) | 26,684 | (26,450) | (234) | – | 2,024 | 28,708 | |||||||||
| Securities borrowing transactions | 2,905 | – | 2,905 | (2,857) | – | 48 | 7 | 2,912 | |||||||||
| Loans | 1,171 | (66) | 1,105 | – | – | 1,105 | – | 1,105 | |||||||||
| Other Assets- cash collateral on derivative instruments | 18,250 | (345) | 17,905 | – | (10,461) | 7,444 | 533 | 18,438 | |||||||||
| Funded Derivatives Assets | 6 | – | 6 | (6) | – | – | 43 | 49 | |||||||||
| Financial Liabilities | |||||||||||||||||
| Derivative liabilities | 96,886 | (9,369) | 87,517 | (72,926) | (10,461) | 4,130 | 973 | 88,490 | |||||||||
| of which recorded in trading financial liabilities mandatorily at fair value through profit or loss | 96,869 | (9,369) | 87,500 | (72,926) | (10,461) | 4,113 | 973 | 88,473 | |||||||||
| of which recorded in financial liabilities designated at fair value through profit or loss | 17 | – | 17 | – | – | 17 | – | 17 | |||||||||
| Securities sold under resale agreements | 20,999 | (6,279) | 14,720 | (14,553) | (166) | 1 | 556 | 15,276 | |||||||||
| Securities lending transactions | 2,838 | – | 2,838 | (2,615) | – | 223 | – | 2,838 | |||||||||
| Short Positions | 5,583 | (662) | 4,921 | – | – | 4,921 | – | 4,921 | |||||||||
| Other Liabilities- cash collateral on derivative instruments | 11,499 | (29) | 11,470 | – | (9,797) | 1,673 | 90 | 11,560 | |||||||||
| Funded Derivatives Liabilities | 914 | (527) | 387 | (6) | – | 381 | 3,054 | 3,441 | |||||||||
| Bank |
Amounts subject to enforceable master netting agreements |
Amounts not offset in the Consolidated statement of Financial Position |
||||||||||||||||
|
2023 (USD Million) |
Gross |
Offsetting |
Net |
Financial instruments |
Cash collateral received/ pledged |
Net exposure |
Amounts not subject to enforceable master netting agreements |
Total |
||||||||||
| Financial Assets | ||||||||||||||||||
| Loans | 330 | (56) | 274 | – | – | 274 | – | 274 | ||||||||||
| 2022 (USD Million) | ||||||||||||||||||
| Financial Assets | ||||||||||||||||||
| Derivative assets | 98,249 | (9,105) | 89,144 | (73,748) | (9,797) | 5,599 | 1,051 | 90,195 | ||||||||||
| of which recorded in trading financial liabilities mandatorily at fair value through profit or loss | 98,242 | (9,105) | 89,137 | (73,748) | (9,797) | 5,592 | 1,051 | 90,188 | ||||||||||
| of which recorded in other assets | 7 | – | 7 | – | 7 | |||||||||||||
| Financial Liabilities | ||||||||||||||||||
| Derivative liabilities | 96,886 | (9,369) | 87,517 | (72,926) | (10,461) | 4,130 | 1,237 | 88,754 | ||||||||||
| of which recorded in trading financial liabilities mandatorily at fair value through profit or loss | 96,869 | (9,369) | 87,500 | (72,926) | (10,461) | 4,113 | 1,237 | 88,737 | ||||||||||
| of which recorded in other liabilities | 17 | – | 17 | – | – | 17 | – | 17 | ||||||||||
| 2023 | 2022 | ||||
| Regulatory capital less deductions (USD million) | |||||
| Total regulatory capital less deductions at 1 January | 15,812 | 15,027 | |||
| Other equity instruments 3 | 1,200 | 1,200 | |||
| Net movement on Tier 2 capital 1 | (3) | (2) | |||
| Net Movement in shareholder's equity 2 | (2,941) | (925) | |||
| Net movement in regulatory deductions and prudential filters | 1,021 | 512 | |||
| Total regulatory capital less deductions at 31 December 3 | 13,889 | 15,812 | |||
|
1
Net movement on Tier 2 capital represents repayment of subordinated debt in 2023.
|
|||||
|
2
Net move in shareholders equity includes changes in retained earnings, other reserves and capital contribution reserve.
|
|||||
|
3
Changes in Tier 1 instruments are already covered in Note 2, and are of which disclosures. These need to be excluded for arriving at the final capital in above table.
|
|||||
| 2023 | 2022 | ||||
| Regulatory capital less deductions (USD millions) | |||||
| Total shareholders’ equity - Bank | 14,962 | 17,904 | |||
| Shareholders' equity | 14,962 | 17,904 | |||
| Other deductions: | |||||
| Regulatory deductions (Intangible assets) | (83) | (478) | |||
| Securitisation positions | (7) | (7) | |||
| DTA on non-temporary differences | (59) | – | |||
| Excess of expected loss amounts over credit risk adjustments | (37) | (49) | |||
| Defined benefit pension fund assets | (400) | (408) | |||
| Free Delivery | (2) | (16) | |||
| Prudential filters | (486) | (1,137) | |||
| Total Tier 1 capital | 13,889 | 15,809 | |||
| Tier 2 capital | |||||
| Subordinated debt | – | 3 | |||
| Total Tier 2 capital | – | 3 | |||
| Total Tier 1 plus Tier 2 capital less Deductions | 13,889 | 15,812 | |||
|
Name of Entity |
Parent, Subsidiary or Branch |
Nature of Activity |
Average Number of Employees |
Turnover (USD million) |
1 |
Profit/(Loss) before taxes (USD million) |
1 |
Corporation Taxes Paid (USD million) |
Public Subsidies Received (USD million) |
||||||
| United Kingdom | |||||||||||||||
| Credit Suisse International | Parent | Bank | 1,880 | 1,413 | (1,736) | – | – | ||||||||
| Credit Suisse International | Consolidated | 1 | 1,880 | 1,413 | (1,736) | – | – | ||||||||
|
1
Variable Interest entities are included in the above reporting. For a full list of other consolidated entities please refer Note 36 - Interest in Other Entities.
|
|||||||||||||||
|
Name of Entity |
Parent, Subsidiary or Branch |
Nature of Activity |
Average Number of Employees |
Turnover (USD million) |
1 |
Profit/(Loss) before taxes (USD million) |
1 |
Corporation Taxes Paid (USD million) |
Public Subsidies Received (USD million) |
||||||
| United Kingdom | |||||||||||||||
| Credit Suisse International | Parent | Bank | 2,424 | 2,328 | (331) | – | – | ||||||||
| Credit Suisse International | Consolidated | 2,424 | 2,328 | (331) | – | – | |||||||||
|
1
Variable Interest entities are included in the above reporting. For a full list of other consolidated entities please refer Note 36 - Interest in Other Entities.
|
|||||||||||||||